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ABSTRACT 
 
 The model organism Caenorhabditis elegans has been extensively studied in 
biogerontology. A putative mechanism of ageing is oxidative damage, but this has 
been challenged in recent studies. One piece of supporting evidence for the role of 
molecular damage in C. elegans ageing is the presence of blue fluorescent material 
within intestinal lysosome related organelles, believed to be lipofuscin. This 
heterogenous, cross-linked aggregate of oxidatively damaged lipids and proteins that 
accumulates in an age-dependent fashion in post-mitotic mammalian cells. Lipofuscin 
can be identified by its fluorescent properties, fluorescing blue under UV light. C. 
elegans intestinal fluorescence has been equated with lipofuscin based on its similar 
spectral properties, and its increase in ageing populations.  
 This investigation initially set out to verify this assumption. Individual animals 
were followed in situ on agar pads and their in vivo fluorescence measured from early 
adulthood until after death. Intestinal blue fluorescence proved to increase not with 
age, but instead in a striking burst at death. Such death fluorescence also appeared in 
young worms when killed, irrespective of age or cause of death. 
 Using NMR-based comparative metabolomics the blue fluorophore was 
identified as anthranilic acid, derived from tryptophan by kynurenine pathway 
activity. Death fluorescence is generated within intestinal cells, typically in an 
anterior to posterior wave, by action of the conserved calpain-cathepsin necrotic cell 
death pathway, a type of cell death previously only observed during 
neurodegeneration. Using mutational analysis and in vivo fluorescent reporters, we 
demonstrate that this wave is propagated by calcium influx. Strikingly, inhibition of 
systemic necrosis delays stress-induced mortality, demonstrating its role as a driver of 
organismal death. This first description of the biology of death in C. elegans implies 
that the passage from life to death entails a regulated, programmed transition that is 
amenable to analysis.  
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MOVIE LEGENDS 
 
Movies have been written onto a CD, placed on the inside back cover.  
 
Movie 1: Death fluorescence in worms dying from old age. 
Blue fluorescence in 5 class C (senescent, non-motile) wild-type worms, viewed with 
a DAPI filter set, over 5 hrs. The rise in fluorescence at death coincides with cessation 
of residual movement.  
 
Movie 2: Death fluorescence in a young adult worms dying from injury 
(dessication). 
Blue fluorescence in a young wild-type adult worm dying of desiccation over several 
hours. Note the rise and spread of death fluorescence in an anterior to posterior wave.  
 
Movie 3: Death fluorescence in a young adult worms dying from injury (heat).  
Here death has been induced more rapidly by placing a heated wire immediately 
adjacent to it. The fluorescence spreads down the length of the animal over the 6 mins 
of filming.  
 
Movie 4: Death fluorescence does not spread in an inx-16 mutant. 
Here a young adult inx-16 mutant adult on an agar plate is killed by placing a hot pick 
immediately adjacent to it. The fluorescence does not spread down the length of the 
animal and only fades in intensity during the six minutes of filming.  
 
Movie 5: Spread of a wave of calcium influx during death. 
Here, in two dying worms calcium levels rise first in the anterior intestine, followed 
by an anterior to posterior wave of increased calcium. High levels of calcium appear 
red.   
 
Movie 6: Loss of acridine orange-stained puncta as death fluorescence rises. 
Here the intestine of an young adult C. elegans is stained with the lysosomotropic dye 
acridine orange (AO). Initially the blue and  orange puncta co-localize in intestinal 
cell puncta (gut granules). However, as the animal dies from desiccation on the slide, 
death fluorescence rises, and the orange puncta disappear. AO cannot pass through 
membranes when it is fluorescent, implying that gut granule membranes become 
permeable at death.  
 
Movie 7: An anterior to posterior wave of cytosolic acidosis in the intestine 
during death. 
Here a group of worms die one after the other, in each case accompanied by an 
anterior to posterior wave of cytosolic acidosis in the intestine. Lower pH is show in 
dark blue. The second and third worms from the bottom died before the start of 
filming.  
 
 
 
 
	   12 
1. INTRODUCTION 
 
1.1 Ageing is not mandatory 
 
 “The thing that amazed me was that anything so perfect and beautiful should 
have matured and come forth from the interior of what, to me, was an old woman. It 
was like, I reflected, breaking open the old, brown, prickly husk of a chestnut and 
finding the lovely gleaming trophy inside.” 
 
  -- Gerald Durrell, observations on birth as a child,  
    Birds, Beasts and Relatives (Durrell, 2004) 
 
 Birth is often described as miraculous. A miracle is defined as “an 
extraordinary and welcome event that is not explicable by natural or scientific laws”. 
Even taking aside the fact that births happen with a monotonous regularity and so are 
precluded from being extraordinary, there are other reasons for discounting this 
statement. Great endeavor has gone into unraveling the science of birth, and we now 
have a good understanding of the processes of fertilization, development, growth and 
birth itself. The mechanics of birth are no longer miraculous. Nonetheless there is one 
aspect of birth which continues to elude our scientific understanding. I refer to the 
seemingly miraculous fact that babies are born young.  
In itself this does not seem so impressive, but it hides a startling implication. An 
infant is the product of two adults’ biological contributions. These adults, and their 
germ-line cells, are old. Somehow in creating new life, we manage to cheat time: we 
have, within us, the capacity to protect some cells from ageing.  
Ageing does not appear to be an inevitability of life. Studies of the simple 
freshwater animals belonging to the genus Hydra, and the sea anemone Urticina 
felina did not find any signs of ageing (Martinez, 1998; Schmich et al., 2007).  This 
realization allows us to ask fascinating and important questions. What purpose could 
ageing serve; why has it evolved? How does ageing happen to us – and could we 
prevent it? The burgeoning field of biogerontology is only now beginning to tackle 
these questions with systematic experimental rigor.  
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1.2 The evolution of ageing 
Denham Harman has defined as ageing as “the result of progressive 
accumulation of changes in the body which occur with the passing of time, and which 
cause the increase in the probability of diseases and death of the individual,” (Vina et 
al., 2007). Thus, ageing underlies multiple detrimental changes experienced by the 
elderly. In humans, these changes include loss of muscle elasticity, loss of sensory 
acuity and decreased motor and cognitive function (Vina et al., 2007). Decreased 
immune activity with age also increases both likelihood and severity of infections. 
Increased age also increases the likliehood of developing endogenous pathologies, 
such as cancer or neurodegeneration. Altogether, these increased numbers of age-
related pathology increase the possibility of death.  
Conseqeuently, ageing appears deleterious and non-adaptive: it is difficult, on 
the face of it, to see how ageing could have evolved. An organism which could 
mature and reproduce indefinitely would appear to have a selective advantage over 
one which matured and reproduced only for a finite length of time.   
This conundrum initially puzzled evolutionary biologists. Weismann advanced 
an early evolutionary theory of ageing in 1891. Given that evolution acts through 
natural selection on progeny, he proposed that ageing was beneficial as it removed 
older, worn-out individuals from the population. This would allow their progeny 
greater resources and would facilitate natural selection (Kirkwood and Holliday, 
1979). However, this argument is circular: it presupposes what it purports to explain, 
namely ageing within a population.  
In 1952, Medawar proposed an alternative theory of ageing. He had the 
important insight that the force of natural selection would weaken with age, even if 
age-related morality did not exist (Kirkwood and Holliday, 1979). Even in a non-
ageing population, cumulative adult mortality from extrinsic hazard will increase with 
time. This will lead to a decline in reproductive probability, and thus weaken the force 
of natural selection (Williams, 1957).  
Williams built on this insight. He proposed that ageing results from the action 
of pleiotropic genes. If the genes conferred a beneficial effect when the organism was 
young, such as increased fecundity, then they would be selected for. Due to the 
reduced selection pressure on post-reproductive organisms, these genes would still be 
selected for even if they then conferred a deleterious effect on the older organism. 
	   14 
Williams proposed that ageing may result from these antagonistically pleiotropic 
genes, where ageing was the deleterious flip side of a fit, fecund youth. Consequently, 
Williams predicted that animals which are subject to high levels of extrinsic hazard 
(such as predation) should have reduced longevity, even in the absence of that 
extrinsic hazard (Williams, 1957).  
Another theory, proposed by Kirkwood in 1977, is the disposable soma theory of 
ageing which posits a resource trade-off between somatic maintenance and 
reproduction (Kirkwood, 1977). As discussed above, selection pressure lessens with 
age. Somatic cells need only be maintained long enough to attain a fit reproductive 
maturity; after a certain duration the risk of extrinsic hazard-mediated morality 
increases, and outweighs the cost of maintaining replicative fidelity. However, 
investing resources in germ-line cells’ replicative machinery lessens the possibility of 
damaging mutations arising in progeny and so increases their odds of survival. 
Consequently, this hypothesis predicts that soma are “disposable”: only the minimal 
viable level of resources are devoted to their maintenance, consequently increasing 
their risk of error catastrophe and causing them to age (Kirkwood and Holliday, 
1979). However, the disposable soma theory makes certain assumptions. One 
assumption is that mechanisms capable of tissue specific resource allocation have 
evolved; another is that ageing is brought about by error catastrophe, or other kinds of 
molecular damage.  
These theories provide a theoretical framework that allows us to explain the 
evolution of ageing. They imply that ageing is not likely to be programmed in the 
sense of being selected for; rather ageing most probably arises from the selection of 
other beneficial traits.  
 
1.3 Mechanistic theories of ageing 
Inanimate objects such as cars and buildings deteriorate over time, and it is 
tempting to liken our own ageing to this process. However, as discussed above, 
organismal ageing can be understood as a non-mandatory, genetically controlled 
process. Consequently, biological mechanisms which cause us to age must exist. 
There are several proposed mechanisms of ageing, of which some are merely 
mechanistic, some attempt to integrate evolutionary theory and some which explain 
ageing only in specific organisms. Here I shall describe only proposed theories which 
are capable of explaining ageing in the model organism used in this thesis, 
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Caenorhabditis elegans; for example, I will not discuss theories of cellular 
senescence, as these do not apply to C. elegans’ post-mitotic adult soma. 
The molecular damage theory of ageing was originally proposed as the free 
radical theory of ageing by Harman in 1956. He noted that irradiation induced ageing 
in living beings, possibly through the creation of free radicals. Free radicals are atoms 
or molecules made highly reactive by the presence of at least one unpaired electron. 
Free radicals had been demonstrated to be present in living cells (Commoner et al., 
1954) and so Harman proposed that they could react with cellular constituents, 
leading to damage: “in this manner, functional efficiency and reproductive ability of 
the cell could eventually be impaired,” (Harman, 1956). This theory gained wider 
acceptance with the discovery of anti-oxidant enzymes and in vivo hydrogen peroxide 
(H2O2) (Muller et al., 2007), and changed to encompass other reactive oxygen species 
(ROS) capable of causing oxidative damage within cells. ROS are produced as by 
products from multiple biological processes, arising most notably from mitochondrial 
respiration. In its current form, the oxidative damage theory of ageing posits that 
ageing occurs due to an accumulation of cellular damage, caused either by an increase 
in ROS-mediated damage or by a decrease in cellular antioxidant defenses. This 
theory has been extensively tested in model organisms. Investigations have looked 
both for evidence that increased oxidative damage levels correlate with age and that 
manipulating levels of oxidative damage lead to changes in the rate of ageing (Gems 
and Doonan, 2009).  
Many different cellular constituents can be damaged by ROS attack. Proteins, 
lipids and DNA can all be oxidatively damaged, and so multiple studies in a variety of 
organisms have examined whether these types of damage increased with age (Bokov 
et al., 2004). Many studies confirm that oxidative damage does increase with 
advanced age, irrespective of type of damage being measured. For example, a by-
product of oxidative damage in DNA is 8-oxo-2-deoxyguanosine (oxo8dG). Hamilton 
and colleagues measured oxo8dG in different tissues of multiple rodent strains and 
discovered significant age-related increases in all tissues sampled (Hamilton et al., 
2001). Other such examples have been seen in damaged lipids and proteins (Muller et 
al., 2007).   
Experiments seeking to manipulate levels of oxidative damage have attempted to 
either increase or decrease endogenous levels of ROS in order to see if ageing is 
accelerated or retarded respectively. Levels of oxidative damage can be reduced by 
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reducing ROS levels or by increasing endogenous antioxidant defenses. One of the 
most widely used interventions has been the manipulation of the antioxidant enzymes 
superoxide dismutase (SOD) and catalase. SODs convert the ROS superoxide (O2-) 
into hydrogen peroxide (H2O2). H2O2 can subsequently be converted to water and 
oxygen by the enzyme catalase (Keaney et al., 2004).  
Experimental manipulation of these enzymes was first carried out in Drosophila. 
Flies that had been selectively bred for their increased longevity were found to have 
increased SOD and catalase activity levels (Arking, 1987). Thus, there was great 
interest in discovering whether increasing enzyme activity levels could increase 
lifespan. Overexpression of Sod1 (which encodes the cytoplasmic SOD) through the 
use of the constitutive β-actin promotor gave very different data: some groups 
reported an increase in lifespan (Sohal et al., 1995); others a decrease (Seto et al., 
1990). Sod1 null flies show an unambiguously shortened lifespan, of ~20% of 
wildtype (Reveillaud et al., 1994). However, a Sod1 mutant with partially rescued 
wildtype Sod1 expression of 5% had a normal lifespan (Mockett et al., 1999). As 
Muller and co-authors point out in their extensive 2007 review on this topic: “[it is] 
difficult to explain how 5% of normal Sod1 activity (i.e. a 95% knockdown) is 
sufficient for completely normal lifespan, yet Sod1 levels 150% of normal…actually 
result in an extension of lifespan” (Muller et al., 2007). There is similar contention 
between contradictory interventionist experiments with SOD and catalase in mice and 
worms (the latter discussed in more detail below) (Muller et al., 2007).  
Another difficulty with the oxidative damage theory is the fact that mechanisms 
that control ROS induced damage have been identified. For example, yeast cells 
differentially partition carbonylated (oxidatively damaged) proteins when dividing 
(Liu et al., 2010), and the levels of carbonyls decrease during the differentiation of 
embryonic stem cells (Dang et al., 2009). Thus, if oxidative damage does cause 
ageing, but can be ameliorated, why have greater, more precise antioxidant defenses 
evolved? This can be understood in the light of the disposable soma theory, which 
could argue that such effective antioxidant defenses may be energetically costly. 
However, it may be equally well understood if one assumes that ageing does not 
result from oxidative damage and so the selection pressure driving the evolution of 
better antioxidant defenses is absent.  
Thus, despite correlative data showing an increase in oxidative damage with age, 
the consensus of  intervention studies is that the role of oxidative damage as a cause 
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of ageing has not been sufficiently demonstrated to be considered a public, or 
conserved, mechanism of ageing across species (Muller et al., 2007). As a 
consequence, other theories of ageing which do not invoke molecular damage as a 
causative mechanism of ageing are being considered. The hyperfunction or bloated 
soma theory of ageing argues that ageing does not arise from molecular damage but 
by quasi-programmed hyperfunction (Blagosklonny, 2006). Proposed by 
Blagosklonny, here a quasi-programme is defined as “an unintended continuation of 
the developmental programme” (Blagosklonny, 2007). Blagosklonny illustrates quasi-
programme concept using an analogy between development and running a bath. The 
programme for running a bath which leaves your bathtub full becomes a quasi-
progamme for flooding your bathroom if the water is not turned off (Blagosklonny, 
2007).  
The hyperfunction theory can be understood in the light of antagonistic 
pleiotropy. Phenotypic plasticity has evolved in response to differing environments, 
and, in particular, resource levels. Growth pathways such as the insulin/IGF-1 
signaling (IIS) and target of rapamycin (TOR) pathways are induced by nutrient 
availability, and stimulate somatic growth. Thus biosynthesis rates will increase in 
response to nutrient availability in younger organisms but will result in 
hyperfunctional pathologies in later life. In contrast, low nutrient availability would 
be predicted not to induce these biosynthetic pathways thus reducing pathology in old 
age (Blagosklonny, 2008). Thus, the hyperfunction theory of ageing could also 
explain the mechanism by which dietary restriction extends lifespan.  
There are multiple examples of age-related pathologies of excessive growth or 
stimulation, among which the most salient are cancer, diabetes and obesity, all of 
which increase in an age-dependent manner (Blagosklonny, 2006), and a recent paper 
has shown correlative evidence for age-related hyperfunction in C. elegans ageing 
(Figure 1.1) (Gems and de la Guardia, 2012). This theory has only been proposed 
recently and so much experimental work needs to be done in order to test its 
predictions. However, it is an exciting theory as it offers an alternative mechanism of 
ageing to that of molecular damage. 
It is clear that the mechanisms of ageing are far from being conclusively 
answered and work therefore continues on model organisms. The nematode worm C. 
elegans is a widely used in genetic research, and I will now discuss its use as a model 
organism for ageing research. 
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Figure 1.1: Evidence of hypertrophy during ageing in C. elegans. This figure shows six 
examples of age-dependent changes in C. elegans physiology which involve hypertrophy. 
Figure reproduced from Gems and de la Guardia, 2012.  
 
1.4 C. elegans as a model organism 
 
1.4.1 Introduction to C. elegans 
C. elegans was first proposed as a model by Sidney Brenner in 1974 due to the 
ease of using it for genetic screens (Brenner, 1974). It has subsequently become one 
of the most widely used scientific model organisms due to its rapid lifecycle, small 
size and the ease of maintaining laboratory stocks. C. elegans was the first 
multicelluar organism to have its genome sequenced (1998) and now rejoices in a 
wealth of dedicated interactive tools to aid further discoveries, such as WormBase, 
WormBook and WormAtlas.  
C. elegans is a small, transparent nematode worm which grows to an adult length 
of approximately 1.5mm (Riddle et al., 1997) (Figure 1.2). The animals are found in 
microbe rich habitats, such as decaying plant matter (Felix and Braendle, 2010). In 
the laboratory, C. elegans can easily be maintained on Petri dishes seeded with a 
bacterial lawn of Escherichia coli as a food source. A single unmated animal can 
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produce up to 350 progeny in a lifetime, surpassing even the progeny production of a 
bacteriophage (Riddle et al., 1997). Furthermore, stocks can be maintained almost 
indefinitely by freezing, both providing biological records and safeguarding against 
the strain divergence which comes from long laboratory cultivation (Riddle et al., 
1997).  
 
 
Figure 1.2: C. elegans hermaphrodite anatomy. (A) shows a micrograph of an adult  
C. elegans hermaphrodite using Nomarski microscopy and (B) shows a schematic drawing of 
the same. The scale bar is 0.1mm, images reproduced from WormAtlas 
(www.wormatlas.org). 
 
C. elegans are diploid and have two sexes: male and hermaphrodite (Herman, 
2005). Hermaphrodites have five pairs of autosomes and two sex chromosomes (XX), 
whereas males share the same autosomes but lack a sex chromosome (XO). Almost 
all gametes produced by hermaphrodites have a single X chromosome and thus 
hermaphrodites most frequently produce hermaphroditic progeny through self-
fertilization (Herman, 2005). Males can spontaneously arise from hermaphroditic 
selfing due to X chromosome loss, but this is rare, occurring at a rate of ~0.1% 
(Riddle et al., 1997). Hermaphrodites mated with males produce an even sex ratio, but 
this is immediately disorted when hermaphrodite progeny begin to self. Consequently, 
unless maintained for parity, most populations’ sex ratios are skewed towards a clonal 
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culture of hermaphrodites which provides a useful tool for the generation of isogenic 
populations and subsequent genetic analysis.  
 
Figure 1.3: C. elegans lifecycle at 22°C. Developmental time shown in blue. Figure taken 
from WormAtlas (www.wormatlas.org).  
 
  C. elegans have a short, temperature dependent lifecycle (Figure 1.3), with a 
mean lifespan of 19 days when maintained at 20°C. When fully fed, the animals pass 
through a short developmental period with four larval cuticle molts (L1-L4, Figure 
1.2) (Felix and Braendle, 2010). However, under stressful conditions, C. elegans 
larvae can undergo developmental arrest and enter an alternative, non feeding L3 
stage known as ‘dauer’ (taken from the German, meaning ‘to endure’). Strikingly, this 
appears to be a non-ageing state (Klass and Hirsh, 1976). When conditions improve, 
larvae can exit the dauer state and re-enter the developmental lifecycle, ageing 
normally irrespective of the duration in the dauer state (Klass and Hirsh, 1976). 
 
1.4.2. C. elegans anatomy  
The adult hermaphrodite C. elegans is comprised of 959 somatic cells, with an 
entirely documented developmental lineage (Sulston et al., 1983). The animals are 
pseudocoelomates, having a simple body structure of two concentric tubes separated 
by a fluid filled space; their shape is maintained by this hydrostatic pressure (Riddle 
et al., 1997). C. elegans anatomy can be subdivided into the body wall, which 
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comprises the cuticle, hypodermis, excretory system, neurons and muscles, and the 
inner system comprised of the  alimentary and reproductive systems. The cuticle is a 
flexible and durable external surface which acts to protect the animals from 
environmental hazard. It also maintains the animals’ body shape and enables motility 
by acting as an external skeleton (WormAtlas, 2002-2012). The nervous system 
consists of 302 cells, of which 282 neurons make up the somatic nervous system and 
20 others comprise the pharyngeal nervous system (WormAtlas, 2002-2012). C. 
elegans have both striated and non-straited muscles, of which the former is used for 
motility and the latter for feeding. The alimentary canal, consisting of the pharynx, 
intestine, rectum and anus, is the main organ of C. elegans, and acts not only to 
intake, digest and excrete nutrients but also has liver-like metabolic properties (Figure 
1.1).  
 
Figure 1.4: Male C. elegans anatomy and reproductive system. (A), schematic of male 
anatomy and B, micrograph of the male using Nomarski microscopy; scale bar 0.1mm. (C-E), 
the male reproductive system. (C) shows the male gonad, (D) the enlarged male tale, used as 
a copulatory apparatus, (E) the tail developing as an L3 larva. Images reproduced from 
WormAtlas (www.wormatlas.org).   
 
In the hermaphrodite, the reproductive system consists of the gonad, germline and 
vulva. Two U shaped gonad arms pass through spermathecae and connect to the 
uterus. Germ cells develop into oocytes in the ovaries and are fertilized by the 
spermathecae en route to the uterus. Fertilized eggs are released through the vulva.  
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Male anatomy differs somewhat to that of the hermaphrodite. From L2 onnwards, 
larvae develop an altered, thicker tail which eventually develops into a copulatory 
apparatus. The male reproductive system consists of a single gonad arm, a seminal 
vesicle and vas deferens (Figure 1.4) (WormAtlas, 2002-2012). 
 
1.4.3. C. elegans genetics 
 
1.4.3.1. C. elegans as a genetic model organism 
C. elegans was originally selected as a model partly due to the ease with which it 
could be genetically manipulated and studied. With the complete sequencing of C. 
elegans’ ~100Mb genome in 1998 (C.S.C. et al., 1998), and its subsequent annotation, 
even more genetic tools are now available to the worm researcher (Hodgkin).  
One of the most useful tools for genetic analysis in C. elegans is the ease of 
mutation generation; multiple different techniques work reliably in the worm, 
including exposure to ionizing radiation and the chemical mutagen ethyl methane 
sulfonate (EMS) (Hodgkin, 2005). As the animals are diploid hermaphrodites, lethal 
mutations can be carried in heterozygotes without killing the animal, and 
hermaphroditic self fertilization allows production of homozygotes even if the 
mutation greatly reduces reproductive fitness. The ease with which mutations can be 
generated and mapped has lead to the creation of a central stock center, the 
Caenorhabditis Genetics Center (CGC, 2012). The CGC maintains a multitude of 
frozen strains which can be thawed and easily mailed worldwide. Deletion mutations 
not yet available can be custom made by one of two consortiums in either Japan 
(NBR, 2012) or in Northern America (CKC, 2012). 
C. elegans is entirely transparent, allowing detailed microscopy of development 
and the visualization of fluorescent reporter genes’ expression to be observed in vivo. 
These fluorescence reporters, and other genetic material can be introduced relatively 
easily, e.g. by microinjection (Evans, 2005) (Figure 1.5). Microinjection uses a very 
fine needle to inject genetic material directly into the distal arm of the gonad (Figure 
1.4). Once injected, the animal is allowed to recover and is placed alone on an plate. 
After self-fertilization, some of the F1 progeny of the injected animal will carry the 
introduced genetic material. Injected genetic material can also be integrated into the 
genome via irradiation, where the radiation damages the DNA and causes 
chromosomal breaks. The extra-chromosomal array can subsequently be integrated 
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into the genome via ligation using the endogenous DNA repair mechanisms (Evans, 
2005). 
 
Figure 1.5: Microinjection of the C. elegans gonad showing optimal positioning of the needle 
in the distal arm of the germline. Reproduced from WormBook (Evans, 2005). 
 
 1.4.3.2. C. elegans genetic nomenclature  
The C. elegans research community has developed worm-specific gene 
nomenclature, outlined as follows (WormBase, 2012): 
A gene name consists of three or four italicized lower case letters, a hyphen and 
number, e.g. unc-30. This name can be followed by non-italicized Roman numerals to 
indicate which linkage group the gene is found on; here unc-30 IV. For genes 
discovered by mutation-induced phenotype, the phenotype can be referenced in the 
gene name; here uncoordinated. For those genes described by sequence similarity, the 
gene name will refer to the predicted genetic product, e.g. sod-1 for superoxide 
dismutase. Genes which have homology to genes in other species are given names 
which correspond, such as rnt-1 for the C. elegans homolog of the Drosophila gene 
runt. Genes which have similar mutant phenotypes are given the same three letter 
code and a number, as seen in unc-1 to unc-132. 
Every mutation (allele) has a unique code designation of one or two italicized 
letters and a number, which follow the gene name, e.g. glo-1(zu437). The letters refer 
to the laboratory group which first isolated the allele, and the reference codes are 
registered with the CGC: for example, David Gems’ group code is wu. The 
numbering arises from the lab of origin. Transgenes are also named according to lab 
designation but the prefixes “Ex” or “Is” are added to indicate if the transgene sits on 
an extrachromosomal array or is integrated into the genome respectively. The 
transgenes are numbered, and the gene name is contained within square brackets. 
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Thus an injected extrachromosomal array expressing a rol-6(su1006) mutation made 
in the Gems lab is designated wuEx166 [rol-6(su1006)].   
Strains are given non-italicized names consisting of two to three uppercase letters 
followed by a number. The letters refer to the lab where the strain originated, but are 
distinct from the mutation prefixes; for example the Gems lab has the strain prefix 
GA. The lab strain prefixes are also registered with the CGC.  
C. elegans proteins are given the same letter-number designation as the gene that 
encodes them, but are written in non-italicized capitals to differentiate between the 
two. Thus the gene daf-16 encodes the protein DAF-16.   
I will use this nomenclature throughout this thesis.  
 
1.5 The study of C. elegans in ageing research 
As mentioned above, C. elegans have an alternative, non-ageing third larval stage 
called dauer, which they enter in to in response to stressful environments such as high 
temperatures, crowded conditions or low availability of food. First described in 1975 
(Cassada and Russell, 1975), the genetics and biochemistry of dauer formation has 
provided insights into longevity regulation in C. elegans. Dauers are smaller and 
thinner than L3 larvae (Figure 1.6). They develop a specialized, thicker and re-
enforced cuticle which protects the larvae from environmental hazards and 
desiccation. Their pharynx is remodeled, shrunken (WormAtlas, 2002-2012) and does 
not pump (Cassada and Russell, 1975).  
    
Figure 1.6: Micrographs of the larval stages of C. elegans. Images viewed with Nomarski 
microscopy, including the dauer stage, which is smaller and thinner. Scale bar is 0.1mm. 
Reproduced from WormAtlas (www.wormatlas.org).  
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36 genes controlling dauer formation (daf genes) have been identified to date. 
Mutations in Daf genes fall into two classes, constitutive (Daf-c) or defective (Daf-d), 
where dauers occur in normal, non-stressful environments or do not form in response 
to normal triggers, respectively. Some Daf-c mutants are temperature sensitive, and 
only form dauers at permissive temperatures. Multiple Daf genes that play important 
roles in determining C. elegans longevity have been identified, including daf-2 and 
daf-16.  
 
1.5.1. The insulin signaling pathway in C. elegans 
The daf-2 gene is a temperature dependent Daf-c mutant. In 1993, Kenyon and 
colleagues discovered that if daf-2(sa189), daf-2(e1370) and daf-2(sa193) mutants 
were shifted to their non-permissive temperature at the L4 stage, the lifespan of the 
daf-2 mutants increased by 230% (Kenyon et al., 1993). Moreover, the animals 
displayed an extended youthspan: when N2 animals were dead or immobile, daf-2 
animals still moved actively on their plates. The activity of the gene daf-16 had been 
shown to be required for daf-2 constitutive dauer formation. Thus, Kenyon and 
colleagues tested to see if daf-16 mutants affected the longevity phenotype of the daf-
2 mutants. daf-16(m26) completely suppressed the lifespan extension of daf-2(e1370) 
mutants (Kenyon et al., 1993). These findings contributed to previous research that 
had tried to identify long lived mutants in C. elegans. A screen in 1983 by Klass had 
identified eight long lived strains (Klass, 1983). Of these, one was later identified to 
be a mutation in the gene age-1, later identified by Friedman and Johnson as the 
catalytic subunit of phosphoinositide 3-kinase (PI3K) (Friedman and Johnson, 1988). 
It has subsequently been discovered that these three genes all act within the 
insulin/IGF-1 signalling (IIS) pathway. daf-2 encodes an insulin/IGF-1 receptor 
which lies upstream of the phosphatidylinositol 3-kinase (Kenyon, 2010). daf-16 was 
found to encode a forkhead transcription factor (FOXO class) (Lin et al., 1997; Ogg et 
al., 1997) which acts downstream of daf-2 and age-1 (see Figure 1.7). When the daf-2 
receptor is activated by ligand binding, it initiates a downstream signaling cascade 
which results in the phosphorylation of DAF-16 by AKT kinases (Paradis and 
Ruvkun, 1998). When phosphorylated, DAF-16 is unable to enter the nucleus (Lee et 
al., 2001; Lin et al., 1997)  However, when either daf-2 or age-1 functions are 
impaired by mutation, DAF-16 is phosphorylated and can enter the nucleus, 
stimulating or inhibiting gene transcription which results in the increased longevity 
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described above. Thus one of the most important questions in ageing research has 
become: what genes are affected by daf-16? Current opinion points to daf-16 being a 
“master regulator” of many different gene sets, including upregulation sets of genes 
involved in stress response, antimicrobial defense and metabolism (Murphy et al., 
2003; Schuster et al., 2010).  
Many other genes have been shown to be present in, or interact with, the IIS 
pathway, and it remains a frontier of biogerontology research in C. elegans. However, 
it is important to note that since the discovery of this pathway in C. elegans, 
homologs in other model organisms have been discovered where mutation also leads 
to significant lifespan increases. For example, mutations in the Drosophila, 
insulin/IGF-1 receptor InR increased lifespan by ~80% (Tatar et al., 2001), as do 
mutations in the downstream insulin receptor substrate chico (Clancy et al., 2001). 
 
Figure 1.7: Simplified schematic showing the insulin/IGF-1 signaling pathway in C. 
elegans. Disruption of ligand binding to the DAF-2 receptor prevents DAF-16 phosphorylation 
and allows it to enter the nucleus, inducing upregulation of genes required for longevity. 
Please note: many different interactions that have been discovered are not shown for the 
sake of simplicity. Image reproduced from Carter et al., 2002. 
 
In mice, which possess separate insulin and IGF-1 receptors, heterozygous knockouts 
of the IGF-1 receptor has been shown to extend lifespan ~30% longer than wildtype   
	   27 
(Holzenberger et al., 2003). Loss of the insulin receptor in adipose tissue extends the 
lifespan of mice by ~18% (Bluher et al., 2003). Multiple other examples of conserved 
(“public”) mechanisms of ageing across model organisms have been discovered 
(Kenyon, 2005). Moreover, a study of Ashkenazi Jews demonstrated a correlation 
between increased longevity and mutations in the IGF1R gene, which encodes the 
IGF-1 receptor. These mutations were shown to lead to a partial loss of function, 
implying that IIS pathway alteration may increase human longevity (Suh et al., 2008).  
 
 
1.5.2. Oxidative damage theory of ageing in C. elegans  
As discussed above, it remains unclear whether ROS-mediated oxidative damage 
limits longevity (Muller et al., 2007). Work using C. elegans as a model has both 
supported and challenged the oxidative damage theory of ageing.  
There is ample evidence consistent with the possibility that oxidative damage 
affects C. elegans lifespan. Long lived C. elegans IIS mutants have been shown to be 
resistant to oxidative stress (Larsen, 1993) and  researchers have successfully used 
resistance to a ROS generating compound as a selective mechanism to identify long 
lived C. elegans strains (de Castro et al., 2004). A mutation in the mitochondrial 
respiratory chain has been shown to make mutants hypersensitive to high oxygen 
environs: the mev-1(kn1) mutation in succinate dehydrogenase cytochrome b 
decreases lifespan by ~35% (Ishii et al., 1998). Conversely, C. elegans grown in low 
levels of oxygen have been shown to have an increase in lifespan (Honda et al., 
1993). Multiple other mutations affecting respiration have been shown to increase 
lifespan, but whilst it has been suggested that this effect occurs due to decreasing 
levels of ROS, this has not been directly examined (Kenyon, 2005).  
However more recent work has challenged the role of ROS and oxidative damage 
in C. elegans ageing (Gems and Doonan, 2009; Kenyon, 2010). Firstly, evidence in C. 
elegans has emerged that high levels of ROS may in fact increase longevity. The 
organic compound juglone produces superoxide anion radicals . However, when C. 
elegans were exposed to 40µM juglone, it was found that exposure actually 
significantly increased their lifespan by a mean of 15 days (Heidler et al., 2010). 
Another experiment demonstrated that 2-deoxy-glucose, which has shown to increase 
longevity in C. elegans both stimulated the longevity increasing AMP kinase and 
raised ROS levels. However longevity was suppressed when the 2-deoxy-glucose was 
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supplemented with antioxidants, implying that increased longevity was not due to 
AMP kinase activity but instead from increased ROS levels (Schulz et al., 2007).  
Other intervention experiments have also raised doubt about oxidative damage in 
C. elegans. As outlined above, a widely used test is the overexpression or mutation of 
antioxidant enzymes. Antioxidant manipulations have also been tested in C. elegans 
by using SOD and catalase mimetic compounds and mutations to increase in vivo 
antioxidant activity. Several trials, both using the EUK-8 and EUK-134 mimetics, 
reported contradictory results. One group found a 44% increase in mean lifespan 
(Lithgow et al., 2005; Melov et al., 2000) whereas four other groups found no effect 
on C. elegans lifespan (Keaney and Gems, 2003; Keaney et al., 2004; Kim et al., 
2008; Uchiyama et al., 2005). Furthermore, high doses of EUK-8 and EUK-134 
actually decreased longevity in a dose dependent manner (Keaney et al., 2004; Kim et 
al., 2008). 
Genetic manipulation of endogenous antioxidants does not appear to increase 
longevity. Most eukaryotes possess three SOD isoforms. One is expressed in the 
mitochondrial matrix, another in the cystol and another in the extracellular matrix.  
C. elegans is unusual in having two isoforms in each compartment (Doonan et al., 
2008). Systematically deleting or inhibiting gene expression of the mitochondrial 
isoforms showed no change in lifespan (Doonan et al., 2008; Yang et al., 2007). A 
small reduction in lifespan was seen in some studies when the cytosolic isoform was 
deleted or its expression knocked down (Doonan et al., 2008; Yang et al., 2007) but 
another study saw no change in longevity (Van Raamsdonk and Hekimi, 2010).  
Thus, whilst it is possible that ROS plays a role in ageing, taken together, this 
and other data does not conclusively support oxidative damage as a significant cause 
of ageing in C. elegans.  
 
1.6 Lipofuscin accumulation: evidence for a role of oxidative damage in C. 
elegans ageing? 
A frequent difficulty in oxidative damage ageing research is that claims of altered 
oxidative damage are not always empirically demonstrated. An example is the 
discovery of the mev-1(kn1) mutation affecting the C. elegans succinate 
dehydrogenase cytochrome b, located in complex II of the mitochondrial respiratory 
chain (Ishii et al., 1998). mev-1(kn1) showed decreased lifespan at elevated oxygen 
levels and Ishii and colleagues claimed that mev-1 “governs the rate of ageing by 
	   29 
modulating the cellular response to oxidative stress”. However no evidence was 
presented demonstrating that the mev-1(kn1) mutation increased oxidative stress or 
damage (Ishii et al., 1998). Instead, both were assumed.  
Other investigations into the oxidative damage theory of ageing in C. elegans 
have had similar difficulties. The oxidative damage theory predicts that oxidatively 
damaged cellular constituents should accumulate over time. One product of oxidative 
damage found in ageing postmitotic mammalian tissues is lipofuscin. This substance 
is a heterogenous, cross-linked aggregate of oxidatively damaged lipids and proteins 
that accumulates in an age-dependent fashion (Brunk and Terman, 2002a; Jung et al., 
2007). Discussed in more detail in the introduction to Chapter 3, C. elegans contains 
lysosome related organelles, or “gut granules”, in its intestinal cells (Chitwood 1950). 
These organelles contain an autofluorescent substance which has been proposed to be 
lipofuscin (Davis et al., 1982; Gerstbrein et al., 2005; Klass, 1977). This 
autofluorescent material has similar spectral properties to lipofuscin and its levels 
have been shown to increase in an age dependent manner in C. elegans cohorts (Davis 
et al., 1982; Garigan et al., 2002; Gerstbrein et al., 2005). Despite not being 
biochemically identified as lipofuscin, nor shown to increase with increased levels of 
oxidative damage, this pigment has been identified as lipofuscin in over 50 original 
research papers and used as a biomarker of ageing. Please see Appendix 1 for 
examples of C. elegans blue fluorescence being used in this manner. 
Biomarkers of ageing are defined as “measureable parameters that predict 
individual longevity better than chronological age” (Baker and Sprott, 1988). 
Biomarkers of ageing are an important tool in biogerontology as they allow 
researchers to distinguish between interventions that affect longevity by altering the 
risk of death and those which actually affect the rate of ageing. In two otherwise 
identical populations of organisms, one may be more likely to die from extrinsic 
hazard than the other. The cumulative survivorship of these populations cannot 
distinguish between death from age and death from extrinsic hazard. In an elegant 
study, Mair and colleagues demonstrated how to experimentally separate these two 
parameters to distinguish whether dietary restriction extended lifespan through 
reduced risk or through altered ageing rate (Mair et al., 2003). In order to understand 
the mechanisms of ageing through model organism experimentation, it is important to 
distinguish between these two causes. A reliable biomarker of ageing would be one 
way of doing this.  
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Extrinsic hazard would not affect the expression of a valid biomarker of 
ageing and so experimental interventions could be assessed for their alteration of the 
ageing rate, not just cumulative mortality. One of the most interesting questions in C. 
elegans biogerontology is how genetically identical animals exhibit such variability in 
their longevity. Pincus and colleagues studied individually cultured C. elegans in 
order to understand this (Pincus et al., 2011b). They identified several biomarkers of 
ageing in C. elegans which could be used to predict a substantial degree of variation 
in lifespan between individuals. For example, the expression of microRNA miR-71 
alone explained 47% of future longevity. Other physiological biomarkers of ageing 
have been identified in C. elegans. Amongst other traits, elderly worms show 
decreased motility, an increased levels of mislocalized yolk in the body cavity, 
reduced levels of pharyngeal pumping and a surfeit of bacteria within the intestine 
(Garigan et al., 2002). C. elegans autofluorescence has been assumed to be another 
biomarker of ageing, particularly because of its equation with lipofuscin, and I will 
discuss this problem in further detail in the introduction to Chapter 3.  
 
1.7 Aims 
C. elegans is an important model that has been extensively used in biogerontology 
to understand the mechanisms of ageing. As discussed above, one of the most 
important theories of ageing is the oxidative damage theory, and this has been tested 
extensively in C. elegans. However, despite the large amount of work done on this 
topic, ambiguities remain. My initial aims were to investigate the intestinal 
autofluorescence in C. elegans in order to verify its identify as the age pigment 
lipofuscin. This would serve two functions. Firstly, if true, it would be an important 
piece of evidence for the oxidative damage theory of ageing. Secondly, it would 
validate its use as a biomarker in ageing studies. However, earlier work done by an 
undergraduate summer student, Sally-Anne Edwards, in the Gems lab had suggested 
that levels of autofluorescence remained unchanged during life, and instead only 
increased at death.  
As I shall demonstrate in the Chapter 3, I successfully confirmed her observations 
and showed that C. elegans emit a burst of blue fluorescence when they die. My 
supervisor David Gems allowed me to continue to work on this fascinating discovery, 
despite my showing its irrelevance to ageing. In Chapter 4, I describe how this 
fluorescence is generated by a type of necrotic cell death only previously observed in 
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neurodegeneration, and I outline how systemic necrosis contributes to C. elegans 
organismal death. In Chapter 5 we use NMR based comparative metabolomics to 
identify the blue fluorescent material as a product of the kynurenine pathway. 
Detailed background to both of these topics are given in the relevant introductions.  
In order to successfully understand this phenomenon it was necessary to 
collaborate with other labs, as we lacked necessary expertise in several areas. 
Consequently, this thesis includes some results which I did not personally obtain. In 
all cases, data generated by others is clearly attributed as such, and I have summarized 
their contributions on the next page (Table 1.1). I also supervised several students 
over the course of my PhD and their results, where relevant, have also been included 
and attributed. The project swiftly outgrew both me and my PhD, but at all times I 
remained involved in the work being done elsewhere in the world. Only with my 
collaborators’ help could we ever have begun to understand the biology of death in C. 
elegans.   
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Name Data obtained Page 
Filipe Cabreiro Hyperoxia oxyblot 64 
   
Caroline Araiz FAC oxyblot  64 
 hsp-4::GFP and blue fluorescence measurements 64 
   
Alexander Davidson DF measurements in larvae, males and other species 68 
   
Zachary Pincus Independent verification of fluorescence patterns 70 
   
   
Grahame Fischer Images of curtailed DF wave in inx-16  93 
 Acridine orange staining 97 
   
Erik Allman and in vivo calcium measurements  95-96 
Keith Nehrke in vivo pH measurements 98 
   
Manolis Vlachos 
and Nektarios 
Tavernarakis 
Some lifespan data  99 
   
Alexandre 
Benedetto 
Osmotic stress data 100 
   
Parag Mahanti and 2D NMR and DANS data  116 
Frank Schroeder Identification and verification of AA derivatives 117 
   
Filip Matthijssens 
and 
Bart Braeckman 
Measurement of L-Trp changes at death 119 
   
Abraham Mandel TDO RNAi fluorescence measurements 120 
 TDO RNAi lifespan data 
 
121 
Table 1.1: Data presented in this paper which has been contributed by others.  
Data is also accredited as it appears in the text.  
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2. MATERIALS AND METHODS 
 
2.1 C. elegans maintenance and methodology 
  
2.1.1. Stock maintenance 
Unless otherwise stated, all C. elegans strains were maintained on 60mm Petri 
dishes containing nematode growth medium (NGM), seeded with OP50 Escherichia 
coli (E. coli) bacteria as a food source. OP50 bacteria are uracil auxotrophs, limiting 
its growth on the NGM agar. Consequently, C. elegans strains are transferred several 
times a week to freshly seeded plates to avoid starvation or contamination (see 
below).  
Depending on what type of population was required, different stock 
maintenance methods were used: 
(i) Individual animal were transferred using a flame-sterilized thin platinum
 wire (‘worm pick’). This is known as picking.  
(ii) Large numbers of a worms were transferred by using a flame-sterilized 
scalpel to cut a chunk of NGM agar from an old plate, and transfer it to a 
freshly seeded one. This is known as chunking. 
Picking is used to generate a precise population, as individual numbers and stages of 
worms could be precisely picked. Chunking is used to maintain a growing population 
of mixed stage animals. The transfer frequency depended on what experiments were 
being undertaken, the strains being used and the growing temperature. N2 (wild type) 
were sub-cultured every 3-4 days.    
 
2.1.2. Decontamination and population synchronization 
 Given that NGM agar is specifically designed to provide an excellent growth 
environment for E. coli bacteria, it is unsurprising that growing populations of worms 
are frequently contaminated with bacterial, fungal and yeast growths. Small fungal 
contaminants can be excluded by chunking worms found away from the growth and 
then serially transferring them from new plates. However, aggressive fungal, bacterial 
and yeast contaminants require a different approach. Animals were treated with an 
alkaline hypochlorite solution which killed and dissolved the contaminated animals 
whilst leaving their chitin-encased eggs intact. This technique could also be used for 
large-scale synchronization of populations.  
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2.1.2.1. Alkaline hypochlorite treatment (egg prep) 
 The protocol for alkaline hypochlorite treatment is as follows: 
First, make the alkaline hypochlorite (bleach) solution, which is 7:8 sodium 
hypochlorite: 4M NaOH. Then, using M9 bugger, wash gravid adults from plates and 
into an 1.5ml eppendorf. Allow worms to settle by gravity, then aspirate excess liquid 
until only 200µl remains. Add 150µl bleach solution and invert the eppendorf for no 
more than 4 minutes. (It is important to note that the reaction is heat-dependent, and 
so the eppendorf should be held only by the lid whilst inverting.) The reaction is 
stopped by addition of M9 to 1.5mls. Vortex and centrifuge at 6000rpm for 30 
seconds. Aspirate off all but 200µl of liquid, make up to 1.5ml with M9 and re-
suspend the pellet by shaking vigorously. Vortex, centrifuge and repeat twice more. 
After the third repetition, aspirate off most of the excess M9, and then transfer the 
pellet to freshly seeded plates under sterile conditions.  
 
2.1.2.2. Egg lays 
 Another method for population synchronization is to use an egg lay. This is a 
non-invasive and non-stressful procedure. Here, several gravid worms are transferred 
to a fresh plate for a given amount of time to lay eggs. The number of worms 
transferred and their duration on the new plate depends on size of the desired final 
population.  
 
2.1.3. Lifespan measurements 
 An animal’s lifespan will most likely be influenced by its genotype and the 
environmental conditions. Thus to see if a given genetic manipulation alters lifespan, 
the environment needs to be kept as constant as possible. Animals were age 
synchronized via one of the two methods mentioned above, and 25 worms were 
placed on four seeded plates (NGM or IPTG, depending on whether RNAi was being 
used). Animals were then scored for viability every other day. 10µM 5-fluoro-2’-
deoxyuridine (FUDR) was sometimes applied topically on this plate to stop progeny 
development (Gandhi et al., 1980). If so, FUDR was applied after plates had been 
seeded with OP50 and allowed to grow for two days. When trials used FUDR, 
animals were placed on FUDR seeded plates as L4s; L4 = day 0 and age was 
described in terms of days of adulthood.   
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 Animals were scored for survival every other day. An animal was deemed 
dead if it made no movement in response to gentle prodding with a worm pick. Any 
animals which displayed signs of non-ageing related pathology, such as uterine 
rupture or internal hatching of embryos (bagging), were censored. Animals which 
burrowed into the agar, or dried from desiccation after climbing on the plate wall 
were also censored.   
 
2.1.4. Stress assays 
 
 2.1.4.1. Thermotolerance 
 Animals were assessed for thermotolerance by exposing them to high 
temperatures and then examining their survival over time. One day prior to the 
beginning of the experiment, unseeded NGM plates were placed in a 35°C incubator. 
40 animals per strain, 20 per plate, were then transferred to the pre-heated plates. 
Survival was scored every two hours, again with animals classified as dead if they 
failed to respond to gentle prodding. However, in this assay animals were not 
censored if they displayed signs of pathology, as this was deemed to be induced by 
the stressor.  
 
 2.1.4.2. Osmotic stress assay 
 Animals were assessed with resistance to osmotic stress by exposing them to 
increased levels of sodium chloride. Standard NGM plates were made (see section 
2.5.4.) except to a final concentration of NaCl of 500mM NaCl. They were seeded 
with OP50 E. coli and synchronized one day old hermaphrodites were placed on 
them. These animals were scored for survival after one day. This assay was performed 
by Alexandre Benedetto.  
 
2.1.5. Acridine orange staining 
 Animals were stained as previously described (Hermann et al., 2005; Kostich 
et al., 2000). 500µl of 0.5mg/ml Acridine Orange (Invitrogen, Molecular Probes) was 
added topically to OP50 seeded NGM plates, which were then left to dry in darkness. 
Young adult N2 animals were transferred to the stained plates, which were covered in 
tin foil to protect against light, for 1 hr. The animals were then collected, washed 
twice with S-buffer and left to recover on an unstained OP50 plate for 1 hr. 
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Fluorescence was measured via microscopy as described below, under a FITC filter 
(λex/λem 460-500nm/512-542nm) with a 195ms exposure time. This assay was 
performed by Grahame Fischer.  
 
2.1.6. Methods of killing  
Different killing assays affected the rate of death fluorescence formation and 
were used accordingly. Pick killing was used to observe DF dynamics in individual 
animals over a shorter time scale. Acute exposure to tert-butylhydroperoxide (t-
BOOH) was used for individual animals to capture DF dynamics with a better 
temporal resolution. Freeze-thaw assays were used for cohorts of worms to determine 
if levels of DF were altered by genotype, and for acquisition of whole spectrum 
excitation/emission scans. 
 
Pick killing: Individual animals’ fluorescence was measured on NGM plates, 
as above. Animals were killed by application of a heated platinum wire onto the agar, 
adjacent to the animal.  
 
Exposure to tert-butylhydroperoxide: Worms were exposed to 0.726M (or 
7%) t-BOOH, diluted in M9, for 5 minutes.  Following exposure, worms were moved 
to a 2% agarose pad for time lapse imaging. Worms were imaged at 100x 
magnification, on a Nikon Eclipse TE2000-U inverted fluorescence microscope 
quipped with an excitation monochromator (Polychrome IV, TILL Photonics) and a 
high-speed monochromatic camera (Sensi-Cam, Cooke). Fluorescence emissions 
were monitored at 460-nm after 4 ms excitation at 360 nm. Images were captured 
every 10 secs. Image capture and quantitative measurements were performed using 
the TILLvisION software package (TILL Photonics).  Traces were plotted in 
Microsoft Excel. This was used by Erik Allman and Keith Nehrke for in vivo calcium 
and pH analysis.  
 
Freeze-thaw: 60 young adult animals were individually picked into a V-
shaped microtitre (Greiner) well containing 100µl of M9 buffer. 50µl of 0.2% 
levamisole was added to settle the worms. Fluorescence was measured in a plate 
reader (InfiniteM200, Tecan) using λex/λem 340/400-450nm. The microtitre plate was 
then placed at -80°C for 15 mins to freeze. Plates were then thawed, and fluorescence 
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re-measured; death fluorescence was defined as the difference between the alive and 
dead fluorescence readings. All data shown was based on three biological replicates.  
 
2.2 Microscopy 
 
2.2.1. Microscopy hardware and software 
 
2.2.1.1. Microscopy hardware 
All readings were taken using Leica DMRXA2 microscope (Leica 
Microsystems) and a Hamamatsu C10600 – 10B Orca R2 camera (28 MHz digital 
CCD camera, cooled, absorption spectra: min 300 nm, max 1050 nm; PerkinElmer). 
UV light was produced by a 100 W mercury lamp (HBO ebq 100 isolated; Leica 
Microsystems) in conjuction with a DAPI cube (Set 4900 Chroma Technology Corp, 
λex: 350/50nm, λem: 460/50nm). The shutter (LEP Mac 5000 4 channel shutter driver; 
PerkinElmer) was connected to the bright field source. The computer controlling the 
system is an iMac (2.66GHz Intel Core 2 Duo, 4GB memory; Apple). The 
microscope is connected to the computer through an EasySync USB to RS232 cable 
adaptor (UC232R-10, EasySync). Multiple filter cubes were fitted to the Leica 
microscope to allow for the visualization of many spectra (please see Table 2.1) 
 
 
 
 
 
 
 
 
Table 2.1: Spectral ranges of filter cubes fitted to Leica DMXRA2. 
 
2.2.1.2. Microscopy software 
 The iMac runs OS X 1.5.6. (Leopard, Apple). The microscope system is 
automated by Volocity 5.2 for Macs (Improvision, PerkinElmer). Volocity has 
Cube name 
 
Excitation 
filter 
Range 
(nm) Emission 
Range 
(nm) 
Rhodamine 546/12 540-552 600/40 580-620 
DAPI 350/50 325-375 460/50 435-485 
GFP 470/40 450-490 525/50 500-550 
FITC 480/40 460-500 527/30 512-542 
Laser safe 440/10 435-445 475 >475 
dsRed 545/30 515-575 620/60 590-650 
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four different components, which can be assembled together. Volocity Acquisition 
and Volocity Quantitation were used; Acquisition captures images and they can be 
analyzed within Quantitation without need for export. 
 
2.2.2. Image acquisition 
 Using an integrated software system, multiple images could be automatically 
acquired and merged to create multi-channel stop motion photography films. Here I 
describe how to set up automatic multi-channel image acquisition, and then discuss 
the specific protocols used in my experiments.  
 
2.2.2.1. Automatic image acquisition 
 Acquisition protocols are made up of multiple ‘lightpaths’. A lightpath is a 
command to take an image under specific conditions, such as a specific exposure time 
or using a particular filter cube. Filter cubes are chosen depending on the fluorophore 
of interest. As blue intestinal fluorescence was the most studied fluorophore in this 
work, a DAPI filter cube, spectra above, was used most frequently. Image intensity 
depends on exposure time: longer exposure times will lead to brighter images, but 
will come at the sacrifice of speed of acquisition, and may potentially also lead to 
photobleaching by overexposure. Other options are available to increase the intensity 
of the signal being received: both contrast enhancement and increasing gain will boost 
the fluorophore signal. However this technique sharpens images by decreasing the 
information received; images look clearer but are less informative. Thus when 
measuring fluorescence levels, all artificial means of image enhancement should be 
avoided. Many of these options can be applied to the image after acquisition to give a 
clean image for display.  
In order to set up a lightpath, one selects a free lightpath option (see Figure 
2.1), right clicks and holds. This brings up the light path properties which has an array 
of options (Figure 2.2). When an option box is ticked, the light path will always take 
note of the settings in that option and apply them to the protocol. For example, if 
“exposure” is selected, the lightpath will take the current exposure time (e.g. 500 ms) 
as the default exposure time. Thereafter, selecting that lightpath will automatically set 
the exposure time to 500 ms. Shutters can also be controlled in lightpaths too. When 
viewing fluorescence, the brightfield shutter must be closed or the signal will be 
overwhelmed by intensity. Also, importantly, the fluorescence shutter must be open! 
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When programming lightpaths false colour can also be used to allow visualization of 
multiple fluorophores simultaneously. False image colouring can be selected by 
entering the wavelength of light emitted in the “color” option.  
 
Figure 2.1: Volocity acquisition control. Volocity Acquisition software makes automatic 
control of multiple microscope functions possible.  
 
Figure 2.2: Volocity acquisition lightpath configuration. Lightpaths are configured through 
the selection of different modules. 
 
Once all adjustments have been made, the lightpath must be named, described 
and saved. When all necessary lightpaths have been made, they can be combined by 
using the image acquisition set-up (Figure 2.3). This set-up has multiple further 
options.  
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Figure 2.3: Volocity image acquisition set-up. Lightpaths can be combined with other 
options in order to produce complex acquisition routines, such as time-lapse photography.  
 
The number of time points can be specified in the image acquisition set-up. 
Images can be acquired for one timepoint (i.e. only once), as often as possible to 
create stop-motion photography, or a certain number of times per unit of time, e.g. 
once a minute. They will be captured until told to stop or for a certain period of time.  
It is also possible to specify the use of ‘auto-focus’ in the image acquisition 
set-up. Auto-focus can be used to ensure that the most important fluorophore is 
always in focus and is an excellent way of correcting against image shift when taking 
long term exposures. For example, during 24 hour imaging on NGM plates the agar 
slightly dries and loses volume, with the result that the initial plane of focus is set too 
high. Auto-focus can be used to follow the strongest fluorescent signal, thereby 
adjusting the focal plane.  
 Finally, the image acquisition set-up has the option to implement pseudo-
confocal microscopy. Confocal microscopy uses point illumination so that only detail 
very close to the focus plane is picked up. The illumination (generally using a laser) 
moves up and down the sample until points over the whole sample have been picked 
up. These points are then computer combined, leading to a 3D-rendered object which 
can be digitally manipulated. Pseudo-confocal takes advantage of the microscope’s 
automation: the microscope can be programmed to take Z slices through the sample, 
which is then built up into a rendered object. Z slices are pictures of focal planes, 
generally beginning from slightly above the sample and working through it until 
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slightly beneath. In the acquisition protocol one can specify how many Z slices one 
wants, and which lightpaths they should be taken on. This is pseudo-confocal as it is 
not as accurate or detailed as confocal, but does allow better resolution of points for 
e.g. co-localization observations.  
 Once all of these options have been selected, the images will all automatically 
be acquired in the lightpath sequence specified. The images will be merged as they 
are acquired. However, in the merged option, it is still possible to increase or decrease 
one spectra’s intensity for closer examination of individual images. As each image 
has been acquired separately they can also be exported individually. 
 
2.2.2.2. Life-long acquisition protocol 
 Preliminary trials were done in order to ascertain the best protocol for the life-
long acquisition protocols. Fluorescence exposure time was difficult to determine: in 
order to make intensity data obtained throughout the duration of the experiment 
comparable, the same exposure time had to be used throughout. However, as 
fluorescence levels were not expected to be constant, the selected exposure time 
needed to be long enough to pick up low levels of fluorescence, but not so low as to 
cause image saturation if exposed to high levels of fluorescence.  
 The exposure time of 500ms was obtained by finding the auto-exposure time 
for several different individuals at different stages (L4, early adult, late adult). These 
estimates were manually adjusted to guard against over-exposure in the event of 
increasing fluorescence. Daily autofluorescence was measured as follows: 
Animals were kept on NGM plates at all times, and cooled on ice for 10 to 15 
minutes prior to imaging. Immediately before imaging each plate was wiped down 
with a paper towel to prevent the microscope from dripping condensation. Plates were 
placed under 5x magnification. 2 images were captured and merged. 
Channel 1: Brightfield. Exposure time = 158ms, Fluorescence cube = 
DAPI, Bright field shutter = Open, Fluorescence shutter = Closed. 
Channel 2: DAPI. Exposure time = 500ms, Fluorescence cube = DAPI, 
Bright field shutter = Closed, Fluorescence shutter = Open.  
Shutters are managed for balanced protection and speed. When making 
overnight observations, measurements are taken 1 timepoint per 15 minutes. When 
taking images for detailed stop motion photography, measurements are taken to be as 
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fast as possible (i.e. acquisition of as many images as physically possible given the 
constraints of shutter opening speed). 
 
2.2.3. Daily photography protocol 
 This protocol has also been described in Results 3.2.2. Strains were grown up 
under standard conditions. At the L4 stage, 30 – 40 animals were picked onto OP50 
seeded NGM plates containing 15µM FuDR to prevent progeny development. 
Animals were scored daily on two counts: firstly, for their movement phenotype and 
subsequently for their fluorescence values.  
 Movement phenotype scoring was adapted from Herndon et al 2002, where an 
animal was placed into one of three movement categories depending on its movement 
characteristics. Preliminary trials showed that a single category could contain very 
different motility levels, and so three more categories were introduced to give a total 
of six classes:  
A class: Animals spontaneously move quickly and fluidly in a clear sinusoidal 
pattern. 
A/B class: Worms move spontaneously but do so more slowly than A, or in 
non-sinusoidal (uncoordinated) manner. 
B class: Worms move only after gently touch with a platinum wire; movement 
is slow, uncoordinated or very brief. 
B/C class: Worms move very slowly and briefly in an uncoordinated manner 
in response to manual stimulation. 
C class: Worms cannot move away after touch. 
Terminal C class: Worms are entirely paralyzed except for very slight head 
movement in response to touch. 
Terminal C class animals were found to be the most likely to die within the next 24 
hours, which had important implications for how their fluorescence values were 
measured. 
 Different exposure times were used when observing different spectra: 
 Blue fluorescence (DAPI cube): 0.5s 
 Green fluorescence (GFP): 1s 
 Red fluorescence (dsRed): 1.5s  
 When animals were classified as Terminal C class, they were filmed using 
stop motion photography for 12 – 24 hours. This allowed us to observe any changes 
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in fluorescence immediately prior to, during and after the animal’s death. This 
protocol is summarized in Figure 3.7.  
 
2.2.4. Fluorescence quantification 
 Levels of fluorescence were quantified in Volocity Quantitation. Merged 
DAPI and brightfield images were used. The brightfield outline of each worm was 
traced manually using an Intuos 4 graphics tablet (Wacom). The mean pixel density 
for the fluorescence layer of the image was then exported to Excel (Microsoft Office). 
The same outline was then moved away from the worm to get a background DAPI 
reading which was again exported to Excel. The background reading was manually 
subtracted from the worm reading to give the final fluorescence value, in order to 
discount any fluorescence variation arising from changes to ambient light or 
fluctuating mercury bulb intensity.  
The fluorescence values were then plotted against time, where time was 
defined as the number of hours prior to death (0). When plotting measurements taken 
for stop motion photography, time was calculated in fractions of days in order to 
present the data on the same scale.  
  
2.2.5. Microscope slide preparation 
 High magnification microscopy was required in order to visualize cellular and 
sub-cellular DF localization. In order to use magnifications of 20x or higher, animals 
were placed on glass microscope slides. A 2% agarose solution was prepared, either 
fresh or made molten by microwaving, and 50µl was placed on the glass slide. This 
was then compressed with another slide and left for several minutes to harden. The 
secondary slide was removed, and 2-10µl of 0.2% levamisole was dropped onto the 
agarose pad. Worms were picked into drop of levamisole, and a cover slip was 
carefully lowered over them, using tweezers to ensure careful placement. Care needed 
to be taken when using slides to observe DF, as if animals were left for more than ~30 
min they began to die from dessciation and consequently generate death fluorescence.    
 
2.3 RNA interference by dsRNA ingestion  
RNA interference (RNAi) is the phenomenon whereby the introduction of a 
sequence of double stranded RNA (dsRNA) to a cell leads to targeted gene expression 
knockdown of the identical endogenous sequence.   
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 2.3.1. Mechanism of action 
 When dsRNA is taken into a cell, it is cleaved into small interfering RNAs 
(siRNAs) by the enzyme Dicer. Upon being cleaved into siRNAs, they separate into 
single strands and bind to the RNA-induced silencing complex (RISC). Once bound, 
they base-pair to homologous endogenous mRNAs. An enzyme within RISC then 
cleaves the bound mRNA, causing it to become degraded (Montgomery, 2006): thus 
whilst genes continue to be expressed, their expression is knocked down (Figure 2.4). 
The RISC mechanism is believed to have evolved in response to retroviruses and 
other genetic invasions (Ketting et al., 1999). Subsequently this phenomenon has been 
co-opted by researchers as a convenient technique for gene function analysis, 
especially in C. elegans where an easy feeding protocol and multiple clone libraries 
exist.    
Figure 2.4: Diagram illustrating the basic mechanisms by which RNAi mediates gene 
expression knockdown. Illustration reproduced from www.nobelprize.org.  
 
2.3.2. Protocol 
 RNAi in C. elegans can be induced by feeding the animals HT115 E. coli 
bacteria containing a fragment of the gene of interest cloned into the L4440 plasmid. 
The L4440 vector contains T7 promoters flanking the insert site, and produces T7 
polymerase in response to IPTG exposure. The promoters sit in opposite orientation, 
allowing transcription from both ends of the fragment. T7 polymerase mediated 
transcription produces dsRNA of the gene of interest. HT115 bacteria carrying the 
empty L4440 plasmid were always used as a control in any experiment using RNAi.  
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 In all experiments, feeding clones were already made and present in an RNAi 
library (The Ahringer library), kindly donated by our UCL colleague Stephen Nurrish 
(Kamath and Ahringer, 2003). Clones were obtained from frozen stock, and re-grown 
in the presence of the antibiotics ampicillin and teracycline. The plasmids were 
purified using the QiaSpin MINIprep kit (Qiagen) and sequenced at the Wolfson 
Institute for Biomedical Research, using the custom primers JJM130 and JJM131 (see 
section 2.5.3). 
 Once the sequence identity has been confirmed, HT115 bacteria are seeded 
onto IPTG plates and animals feed on the growing bacteria. Animals were generally 
raised from hatching on this bacteria, via egg lay or egg prep. The first animals raised 
on the RNAi are the F1 generation; their progeny (F2) were then used in experiments 
to counter any maternal rescue effects of maternal protein. If the RNAi inhibited 
development or growth, animals were placed on it as L4s.  
 
2.4 Metabolomics 
 
2.4.1 High performance liquid chromatography (HPLC) 
 
2.4.1.1 HPLC background 
In 1970 Csaba Horváth described the innovation of using high pressure to 
generate flow in packed columns, giving much greater resolution than previously 
described chromatography techniques (Waters, 2012). Now, high performance liquid 
chromatography (HPLC) is the most widely used chromatographic technique and is 
used in ~60% of separation experimentation worldwide (Lough and Wainer, 1996). 
 HPLC is used to isolate substances from a heterogenous compound; a typical 
set-up is illustrated in Figure 2.5. Compounds are separated from samples according 
to their relative polarities or charges. Briefly, samples are dissolved in a solvents, 
where the solvent depends on the sample type and compound to be isolated. When the 
sample is dissolved in solvent it is known  as the mobile phase. The mobile phase is 
pumped at high pressure through a column filled of packing material (the ‘stationary 
phase’) (Figure 2.5). The packing material again will be determined by what 
compounds are being identified. For example, if the mobile phase is polar, the 
stationary phase will be non-polar. The extent of the relative attractions will 
determine how fast a compound moves through the column (Figure 2.6). Thus polar 
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compounds in a polar mobile phase will be repelled by the non-polar column and so 
move fast through the stationary phase. In contrast, non-polar compounds will be 
attracted to the stationary phase and so move slowly through it. Thus the compounds 
within a solvent are separated by polarity. HPLC differs from standard 
chromatography by the use of a pump which moves the mobile phase through the 
stationary phase. The pump allows the stationary phase column to be tightly packed 
without using a very column or losing any resolving powers as expected for non-
pressurized chromatography (Waters, 2012).  
Figure 2.5: Schematic of typical HPLC system set-up. Image repdroduced from 
http://www.waters.com/waters/nav.htm?cid=10049055&locale=en_US; accessed 22.8.2012.  
 
Figure 2.6: Samples in HPLC are differentiated by relative attraction. Here, if the solid 
phase is polar, the yellow compound is the least polar of the three compounds and so moves 
fastest through the solid phase. Image source as in Figure 2.2. 
 
As the compounds exit the column, moving at separate speeds, they will pass 
through a detector. The detector used again depends on what compounds are under 
scrutiny: for example, when looking at fluorescence compounds, a fluorimeter can be 
used to detect intensity at specific wavelengths. The intensity peaks are then plotted 
on a chromatagram (intensity against time the sample was eluted) (Figure 2.5). If 
required, peaks can be fractionated by collecting samples at specific times, and so the 
samples can be physically separated for further analysis.       
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 We aimed to use HPLC as a first step to biochemically identify the death 
fluorescence fluorophore. In order to do this we hoped to identify the compound(s) of 
characteristic fluorescence present in the wild type samples that were absent or 
reduced in the glo-1(zu437) background.  
 
2.4.1.2 Sample preparation 
 Whole worm sonicates were prepared in dH2O from large mixed stage 
populations grown on OP50 seeded NGM plates. Sonication was performed in 
repeated cycles of 1 min followed by a 30 sec pause for cooling in a ‘Bioruptor’ water 
bath sonicator (Diagenode) until samples were homogenously clouded. Samples were 
spun down at 4°C at 14,000rpm for 15 minutes, and the supernatant extracted. Cold 
100% ethanol was added in a 1:9 sample:ethanol ratio and left at -20°C overnight. 
Samples were spun down again as above. The remaining supernatant was taken as the 
blue fluorescence sample. Samples were then evaporated in vacuum at room 
temperature, resuspended in 500 µL methanol, centrifuged and 1-30 µL aliquots were 
used for HPLC-MS analysis.  
 
 2.4.1.3. Protocol 
 HPLC was performed using an Agilent 1100 Series HPLC system equipped 
with a Varian Pursuit XRs-3-C18 column (4.6 x 250 mm, 5 µm particle diameter) 
connected to a Quattro II spectrometer (Micromass/Waters) A water (containing 0.1% 
acetic acid) – acetonitrile (also containing 0.1% acetic acid) solvent gradient was used 
at a flow rate of 0.7 ml/min, starting with an acetonitrile content of 5% for 15 min 
which was increased to 35% over a period of 20 min and subsequently to 95% over a 
period of 5 min and continued at 95% for 6 min (for graphical summary please see 
Figure 2.7). Metabolite extracts were analyzed by positive and negative electrospray 
ionization-MS. High resolution HPLC-MS was performed using a Waters 
nanoACQUITY UPLC System equipped with a Waters Acquity UPLC HSS C-18 
column (2.1 x 100 mm, 1.8 µm particle diameter) connected to a Xevo G2 QTof Mass 
Spectrometer. 
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Figure 2.7: Diagram of HPLC protocol overlaid over data seen from N2 sample. The 
solvent front of B is shown diagrammatically to show the elution of the putative death 
fluorescence peaks at ~5 minutes in the polar solvent front. 
 
2.4.2. NMR and DANS 
Please note, both NMR and DANS were performed by Parag Mahanti and Frank 
Schroeder.   
 
 2.4.1.1. NMR and DANS background 
Nuclear magnetic resonance spectroscopy (NMR) is a technique which allows 
molecular identification of species based on the magnetic resonance of their nuclei. 
Magnetic resonance arises from the quantum mechanical property of ‘spin’. ‘Spin’ is 
the angular momentum specific to most nuclei (Evans, 1995). This momentum 
endows the nuclei with magnetic field, and so when the magnetic nuclei are exposed 
to a magnetic field this magnetism is converted to energy (Evans, 1995). These 
energies give nuclei characteristic signatures (spectra) which can be read, allowing 
subsequent molecular identification of the species in question. More information 
about the species can be obtained by using different types of magnetic field (fixed or 
continuous wave), or by obtaining the NMR signal as a function of frequency. Multi 
dimensional NMR uses magnetic pulses of different frequencies and durations in a 
particular order (pulse sequences) over time to extract multiple types of information 
from the molecular species.  
DANS (Differential Analysis of 2D NMR Spectra) is a two dimensional 
analysis of metabolomes derived from different genotypic backgrounds (Schroeder et 
al., 2007). Here multidimensional 2D NMR spectra are produced from the sample of 
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interest and a control. Using graphical analysis, the two spectra produced can be 
overlaid to clearly isolate signals derived from the sample of interest. This method 
results in silencing of signals common to both spectra, irrespective of the relative 
abundances of shared and unique signals. This method accelerates the identification 
of genome-specific compounds because it does not require extensive chromatographic 
fractionation. In traditional structural elucidation schemes, chromatographic 
fractionation is a major cause of compound loss due to degradation or decomposition, 
and so can significantly hamper the speed of identification (Forseth and Schroeder, 
2011a). Several recent examples have demonstrated the utility of a specific type of 2D 
NMR spectrum (double quantum filtered correlation spectroscopy, or dqfCOSY) for 
compound identification via DANS (Forseth and Schroeder, 2011b). This technique 
has led to the successful identification of differentially expressed metabolites in C. 
elegans (Hu and Sherman, 2009; Pungaliya et al., 2009). Given that glo-1 animals do 
not possess endogenous blue fluorescence, we decided to try and use DANS to 
identify metabolites differentially expressed between N2 and glo-1.    
 
 2.4.1.2. Sample preparation and protocol 
 N2 and glo-1 samples were prepared as previously described to acquire the 
blue fluorescence containing supernatant (Section 2.4.1.2.). Samples were then 
evaporated in vacuum at room temperature and then the residues were dissolved in 
200-600 µL of methanol-d4.  
NMR spectra were recorded on a Varian INOVA 600 NMR (600 MHz for 1H, 
151 MHz for 13C) and INOVA 400 NMR (400 MHz for 1H, 100 MHz for 13C) 
instruments. Non-gradient phase-cycled dqfCOSY spectra were acquired using the 
following parameters: 0.6 s acquisition time, 500-900 complex increments, 8-32 scans 
per increment. Gradient and non-gradient HSQC[AD], HMQC, and HMBC[AD] 
spectra were acquired with these parameters: 0.25 s acquisition time, 300-600 
increments, 8-32 scans per increment. 1H,13C-HMBC spectra were optimized for 
JH,C = 6 Hz. Susceptibility-matched NMR tubes (Shigemi) were used for sample 
amounts smaller than 2 mg. NMR spectra were processed using Varian VNMR, 
MestreLabs MestReC and Mnova software packages. 
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2.5 Reagents 
 
2.5.1. C. elegans strains used 
 N2 was the wild type (WT) strain in all experiments and the terms are used 
interchangeably. N2 was obtained from the Caenorhabditis Genetic Center (CGC). 
Most mutant strains were also obtained from the CGC, those that were not are 
acknowledged here or in the text.  
 
Necrosis:  
ZB1028 crt-1(bz29) V,  
CB540 unc-68(e540) V,  
JT73 itr-1(sa73) IV,  
CB4027 tra-3(e1107);eIs2137 IV,  
CB189 unc-32(e189) III,  
RB938 vha-12(ok821) X,  
RB2035 asp-4(ok2693) X,  
PJ1 cad-1(j1) II.  
Apoptosis:  
MT1522 ced-3(n717) IV,  
MT4770 ced-9(n1950) III,  
MT2547 ced-4(n1162) III.  
Calcium measurements:  
KWN190 pha-1(e2123ts) III, him-5(e1490) V;rnyEx109 [pKT67 (Pnhx-
2::D3cpv); pCL1 (pha-1(+)],  
KWN26 pha-1(e2123ts) III;him-5(e1490) V;rnyEx006 [pIA5nhx-2 (Pnhx-
2::pHluorin); pCL1(pha-1(+)],  
pH measurements:  
KWN385 inx-16(ox144) I;pha-1(e2123ts) III;him-5(e1490) V rnyEx006 
[pIA5nhx-2 (Pnhx-2::pHluorin); pCL1 (pha-1(+)].  
Other:  
BA671 spe-9(hc88) I,  
GH10 glo-1(zu437) X, obtained from the Hermann lab 
EG144: inx-16(ox144);  
GA91: ftn-1(ok3625) V;  
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GA1200 mdl-1(tm311) X,  
GA200 wuEx41[rol-6(su1006)]. 
 
2.5.2. Reagents 
 
Freezing medium 
Dissolve 20 ml 1 M NaCl, 10 ml 1M KH2PO4 (pH 6.0), 60 ml 100% glycerol 
in purified H2O, make up solution to 1 L with purified H2O, autoclave and add 
0.6 ml 0.1 M MgSO4. 
Luria-Bertani (LB) buffer 
Dissolve 10 g tryptone, 5 g yeast extract, 10g NaCl in purified H2O, make up 
solution to 1 L with purified H2O, adjust pH to 7.5 with NaOH and autoclave. 
M9 solution 
Dissolve 7 g Na2HPO4.2H2O, 3 g KH2PO4, 5 g NaCl, 0.25 g MgSO4.7H2O in 
purified H2O, make solution up to 1 L with purified H2O, and autoclave for 
sterility. 
Nematode growth media (NGM) 
Dissolve 3 g NaCl, 20 g agar and 2.5 g peptone in H2O, make up solution to 1 
L with purified H2O and autoclave. Then add 1 ml 1 M Ca Cl2, 1 ml 1 M 
MgSO4, 1 ml 5 mg/ml cholesterol (in ethanol) and 25 ml 1M KH2PO4. 
NGM Isopropyl-ß-D-1-thiogalactopyranoside (IPTG) agar 
Dissolve 3 g NaCl, 20 g agar and 2.5 g peptone in H2O, make up solution to 1 
L with purified H2O and autoclave. Then add 1 ml 1 M CaCl2, 1 ml 1 M 
MgSO4, 1 ml 5 mg/ml cholesterol, 25 ml 1M KH2PO4, 400 µl 50 mg/ml 
carbenicillin and 1 ml 1M IPTG. 
OP50 growth solution 
Dissolve 5 g tryptone, 2.5 g yeast extract in H2O, make up solution to 1 L with 
purified H2O and autoclave. 
Phosphate Buffered Saline (PBS) 
Dilute 10 x PBS (100 ml + 900 ml purified H2O) and add 1 ml Tween-20. 
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2.5.3. Primers 
These primers were used to identify RNAi cultures by sequencing in a pL4440 
vector (see section 2.3), and were originally generated by Josh McElwee (past Gems 
lab member).  
 
 JJM130 GGGAAGGGCGATCGGTGCGGGCC 
 JJM131 GCGCAGCGAGTCAGTGAGCGAGG 
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3. ENDOGENOUS C. ELEGANS BLUE FLUORESCENCE  
INCREASES WITH DEATH, NOT AGE 
 
3.1 Introduction to C. elegans autofluorescence 
C. elegans contains autofluorescent puncta within its intestinal cells (Clokey 
and Jacobson, 1986; Hermann et al., 2005) which have been likened to lipofuscin-
containing lysosomes. Here I introduce the age pigment lipofuscin, C. elegans 
inetsinal autofluorescence, and discuss why the two have been equated. I then 
examine potential problems with this equation, and how I aim to test it.  
 
3.1.1. Lipofuscin in mammalian cells 
Post-mitotic mammalian cells, such as neurons and muscle fibres, accumulate 
a yellow-brown, autofluorescent pigment with increasing age (Brunk and Terman, 
2002a). This pigment was first discovered in 1842 by Hannover, and it was dubbed 
lipofuscin by Hueck in 1912 (derived from the Greek lipo for fat and the Latin fuscus 
for dark) (Brunk and Terman, 2002a). Despite being described in the 1800’s, 
lipofuscin’s formation and composition have only been the subject of investigation 
relatively recently.  
 Lipofuscin is defined as a heterogenous, cross-linked aggregate of oxidatively 
damaged lipids and proteins that accumulates in an age-dependent fashion in post-
mitotic mammalian cells (Brunk and Terman, 2002b; Jung et al., 2007; Terman and 
Brunk, 1998). Damaged cytosolic proteins and lipids are predominantly degraded by 
the proteasome (Coux et al., 1996). However, proteins and lipids that have been 
severely oxidatively damaged are highly reactive, and so are more likely to form 
intra- and intermolecular cross links causing aggregation (lipofuscin) (Jung et al., 
2007). The ability of the proteasome to degrade damaged molecules appears to be 
greatly compromised by this cross-linkage, and there is evidence to suggest that 
lipofuscin can inhibit the proteosome (Friguet and Szweda, 1997; Shringarpure et al., 
2000). Consequently, lipofuscin is taken up into the lysosomes by autophagy (Kurz et 
al., 2007). However, as a consequence of the extensive cross-linkage within lipofuscin 
it is not degradable by proteolytic lysosomal enzymes (Brunk et al., 1992). Therefore 
lipofuscin accumulates within lysosomes and the cytosol. In dividing cells, lipofuscin 
concentration can be diluted through division, but in post-mitotic cells lipofuscin 
accumulates with age (Brunk and Terman, 2002a). Lipofuscin levels have been found 
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to correlate negatively with the age of post mitotic cells, and consequently are 
frequently used as a biomarker of ageing (Sitte et al., 2000; Taylor and Davies, 1987). 
Lipofuscin generated in a non-age-dependent manner is known as ‘ceroid’, and is 
implicated in multiple juvenile diseases (Mole, 2011).  
 Lipofuscin composition is dependent on the cell type of origin, and so is 
highly variable, preventing the development of an antibody (Jung et al., 2007). 
Consequently lipofuscin is therefore most readily identified by its endogenous 
autofluorescence, although there is disagreement about its exact spectral signature. 
Lipofuscin excited by UV light in vitro emits blue fluorescence, most likely reflecting 
Schiff base formation between carbonyl and amino groups (Chio and Tappel, 1969; 
Fletcher et al., 1973). Schiff bases are functional groups with a carbon-nitrogen 
double bond attached to a hydrocarbon or aromatic ring group (Davis et al., 1982). 
However UV excitation of lipofuscin in vivo gives a peak at 540 – 640nm, or orange-
yellow fluorescence (Eldred et al., 1982). Blue fluorescence has also been observed in 
vivo, but it has been suggested that this may be due to instrumental bias (Eldred et al., 
1982). Moreover, multiple excitatory wavelengths produce a variety of fluorescent 
emissions depending on filter type (Brunk and Terman, 2002a). These discrepancies 
in reported spectra may well be due to the heterogeneous nature of the material, but it 
does compromise accurate identification of lipofuscin in model organisms such as the 
nematode C. elegans. 
 
3.1.2. C. elegans contain autofluorescent lysosome-related organelles (LROs) 
 The Rhabditidae family of nematode worms, of which C. elegans is a 
member, contain cytoplasmic ‘rhabditin granules’ within their gut cells (Chitwood 
and Chitwood, 1950) (Figure 3.1). These granules are formed early in C. elegans 
development, being first visible in the embryo at four to six hours after fertilization 
(Laufer et al., 1980). These granules are denser than the surrounding tissue and so 
cause light to be refracted, or bent, around them, making them appear bright under 
polarized microscopy (Nill, 2006). They also contain autofluorescent material, of 
which the predominant spectral signature is held to be UV-excited blue fluorescence 
λex/λem 340/430nm (but see below) (Gerstbrein et al., 2005). These autofluorescent, 
granules are thought to correspond to C. elegans intestine-specific lysosome related 
organelles (LROs) (Hermann et al., 2005).   
	   55 
               
Figure 3.1: C. elegans contain punctate blue fluorescence in their intestinal cells (white 
arrow heads show puncta). Bar = 50µm. 
 
The exact nature of lysosomes in C. elegans is somewhat unclear. In 1987, 
Clokey and Jacobson proposed that the autofluorescent puncta were lysosome-like 
organelles, as they were acidic (demonstrated by staining with the lysosomotropic dye 
acridine orange) and were capable of endocytosis (Clokey and Jacobson, 1986). 
Mammalian cells contain a structurally distinct family of lysosome associated 
membrane proteins (LAMPs), which are found in endosomal-lysosomal 
compartments (Kostich et al., 2000). The closest C. elegans homolog is encoded by 
lmp-1, which contains the consensus lysosomal targeting motif on the C-terminus 
found on all mammalian LAMPs (Kostich et al., 2000). LMP-1 antibodies stain 
granules within C. elegans intestinal cells in a similar pattern to that observed for 
autofluorescent, acidic granules. However, co-localization of the two patterns was not 
demonstrated (Kostich et al., 2000). 
 In 2005, a class of mutant was discovered which lacked these autofluorescent 
puncta. These Glo mutants (Gut granule LOss) did not show staining with either of 
the lysomotropic dyes acridine orange or Lysotracker red (Figure 3.2) (Hermann et 
al., 2005). However, LMP-1::GFP puncta were still present in glo-1 mutant animals, 
potentially indicating that LMP-1 associated granules are in a different class to the 
autofluorescent puncta. glo-1 encodes a putative Rab GTPase, whose protein 
sequence is very similar to those of Drosophila and Dictyostelium Rabs (45 and 47% 
conserved identity respectively) (Hermann et al., 2005). 
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Figure 3.2: Glo mutants lack intestinal autofluorescence (image reproduced from 
Hermann et al 2005). 
 
These Rabs have been implicated in biogenesis of the specialized lysosome-
like pigment-containing organelle melanosomes (Hermann et al., 2005). Thus, it has 
been suggested that the autofluorecent puncta observed in C. elegans intestinal cells 
might be melanosomes (Raposo and Marks, 2007). However, an alternative 
explanation – widely accepted in the ageing field - may be that the gut granules 
contain autofluorescent lipofuscin. 
   
3.1.3. Equation of C. elegans autofluorescence and lipofuscin 
C. elegans intestinal autofluorescent material was initially characterized 
through in vitro aqueous and chloroform-methanol extraction, showing a spectral 
signature of λex/λem 320-365/450-480nm (Davis et al., 1982; Klass, 1977).  
                         
Figure 3.3: C. elegans blue fluorescence increases with age in vitro. Figures show blue 
fluorescence contained in aqueous extractions (marked “B”) taken from cohorts of 4 and 12 
day old wildtype worms. Figure reproduced from Davis et al, 1982. 
 
	   57 
This blue fluorescent pigment was shown to increase in older samples, and, 
based on spectral similarities to the Schiff bases found within lipofuscin, it was 
suggested that the material could represent C. elegans lipofuscin (Figure 3.3) (Davis 
et al., 1982; Klass, 1977). However, it was also noted that both reduced NAD and 
anthranilic acid have similar blue spectral signatures, and thus that further analysis 
would be required to confirm the biochemical composition of the autofluorescence 
(Davis et al., 1982). 
Subsequent studies examined C. elegans autofluorescence in vivo in ageing 
animals. These studies followed the fluorescence levels of either individual or 
populations of animals, and investigated a variety of fluorescent signatures. 
Observation of wild type worm populations on day 2, 5 and 10 of adulthood identified 
an age-related increase in UV-excited green fluorescence (525nm bandpass filter), 
whose appearance was delayed in long lived daf-2 animals (Garigan et al., 2002). 
Another study also examined the spectral signature of a population of animals in vivo. 
Gerstbrein and colleagues scanned a large excitation/emission range, but only found 
significant age-related increases in UV-excited blue fluorescence, with an excitation 
maximum of 430nm (Figure 3.4) (Gerstbrein et al., 2005). Finally, an in vivo study 
monitoring individual animals found significant age related increases in levels of red 
fluorescence (λex/λem515-573/590-650) (Pincus et al., 2011a). 
                                       
Figure 3.4: C. elegans blue fluorescence increases with age in vivo. The levels of 
fluorescence attributed to the amino acid tryptophan residues (left) remains constant, as 
compared to the blue fluorescence (right) which is shown increasing with age in cohorts of 
animals. Figure reproduced from Gerstbrein et al 2005. 
 
Thus, these data suggest that autofluorescence in C. elegans increases in an 
age-dependent manner. On the basis of these studies, and those mentioned above 
showing autofluorescent puncta to be acidic lysosome-like organelles, it is now 
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widely held that C. elegans autofluorescence is lipofuscin (Adachi et al., 1998; Fisher 
and Lithgow, 2006; Fujii et al., 1998; Ishii et al., 1998; Masse et al., 2008). Thus, 
despite there being no direct evidence that C. elegans autofluorescence is lipofuscin, a 
literature search revealed over 50 papers (please see Appendix 1) citing one or more 
of the above papers as evidence that C. elegans autofluorescence being lipofuscin.   
 
3.1.4. Challenges to the assumption that C. elegans autofluorescence is lipofuscin
 The assumption that C. elegans autofluorescence is equivalent to lipofuscin 
has not been verified. One difficulty is that cohort studies do not take into account 
heterogeneity in fluorescence levels between individual worms1. This issue was raised 
by a previous study (Gerstbrein et al., 2005), as follows. Aging worms can be classed 
according to their degree of motility: class A animals move normally, class B animals 
move more slowly, and class C animals do not move away when touched, and are 
near to death (Herndon et al., 2002). Notably, blue fluorescence levels did not 
different between class A and B, and only increased in class C worms (Figure 3.5) 
(Gerstbrein et al., 2005).  
                                    
Figure 3.5: In vivo measurements of C. elegans cohorts show that blue fluorescence only 
increases significantly when animals are “C” stage, or close to death, rather than increasing 
gradually with age. Figure taken from Gerstbrein et al 2005. 
 
This suggests that blue fluorescence levels in worms increase only as they 
approach death. Average fluorescence levels from cohorts could therefore mask 
individual heterogeneity (Figure 3.6). Another difficulty regarding the assumption of 
autofluorescence as lipofuscin is the lack of tested predictions. Mammalian lipofuscin 
is a product of oxidative damage (Brunk and Terman, 2002a). When human foreskin 
                                                
1 Please note that we began this investigation prior to the publication of the 2011 Pincus et al study 
which individual animals were used.   
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fibroblast cultures were exposed to 40% normobaric hyperoxia (40% O2) they 
accumulated significantly more lipofuscin than those under atmospheric conditions 
(Terman and Brunk, 1998). One attempt to test this in C. elegans yielded somewhat 
inconclusive data, which implied that increased oxidative damage leads to increased 
autofluorescence levels, but did not demonstrate a significant effect (Hosokawa et al., 
1994).
 
Figure 3.6: Cohort fluorescence levels may mask population heterogeneity. (a) 
Individuals a-f are plotted showing changing intensity peaks through time. Individual a shows 
peak intensity at time 2, and then no more fluorescence, whereas individual f shows steady 
fluorescence until peak intensity at time 4. However, as shown in (b), when cumulative 
population data is presented, the illusions of fluorescence gradually increasing over time 
appears. 
 
Finally, the existence of single gene mutations that entirely abrogate (Glo) or 
alter (Flu) intestinal autofluorescence argues against it resulting from cumulative 
oxidative damage (Hermann et al., 2005). The Flu class of mutants contain single 
gene mutations which alter the spectral signature of the intestinal autofluorescence; 
for example, the mutation flu-1 results in purple-blue fluorescence in response to UV 
excitation and flu-2 animals show green (Siddiqui and Von Ehrenstein, 1980). For 
more detail, please see Chapter 5.  
 Taken together, these issues challenge the assumption that C. elegans 
autofluorescence is equivalent to mammalian lipofuscin. As outlined in the 
introduction, a valid biomarker of biological ageing would be a useful tool in 
biogerontology. Biomarkers of ageing are better than mortality as a measure of 
ageing, as morality is influenced by both extrinsic hazards as well as intrinsic risks of 
death. It is therefore important to rigorously test this assumption before its use in 
research. Consequently, the initial aims of this project were to test some of the 
predictions generated by the hypothesis that C. elegans autofluorescence could be 
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lipofuscin. Firstly, if the autofluorescence is lipofuscin, then increasing oxidative 
damage levels should increase autofluorescence. Secondly, individual animals should 
show gradually increasing levels of autofluorescence with age.  
 
3.2 Results 
 
3.2.1. Creating a microscopy system capable of monitoring individual animals 
over time 
As outlined above, in order to avoid artefacts caused by looking at aggregate 
fluorescence data in population cohorts, it was necessary to follow individual animals 
as they age. Preliminary data obtained by Sally-Anne Edwards indicated that there 
was no increase in fluorescence during life, but instead showed an increased 
fluorescence at death. The preliminary data for this study was acquired in a slow, 
manual manner. Images were collected on a Leica DMXRA2 microscope. Brightfield 
and fluorescence filters were manually moved into position, their respective light 
sources were manually turned on and off and two images were taken separately, and 
manually overlaid. The autofluorescence was then analysed on OpenLab software 
(Improvision) by drawing an outline of the worm on the bright field image, and then 
superimposing that outline onto the fluorescent image. This value was measured, and 
a subsequent value was taken from the background in order to normalize the data. The 
final fluorescence value was then calculated as the mean pixel density measured from 
the fluorescent image.  
This method was sufficient to observe that the increase in autofluorescence was 
correlated with death (see below). In order to determine the dynamics of fluorescence 
increase at death, it was necessary to upgrade to a system capable of time-lapse image 
capture. Thus, the microscope system required upgrading to one that was capable of 
automatic control. The new system was upgraded as follows: 
• The computer controlling the microscope was upgraded to a new 
iMac computer (Apple) which was capable of supporting updated software, 
and had greater processing power, giving faster control. 
• OpenLab was upgraded to Volocity (Improvision) which made it 
possible to create automatic acquisition protocols known as ‘lightpaths’ 
(please see Section 2.2) that were capable of controlling the microscope 
automatically from the computer. 
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• A bright field shutter was acquired. This shutter fits over the bright 
field bulb, allowing computer control of illumination. This in turn allows 
acquisition of multiple images almost simultaneously, and so makes time-
lapse photography possible. Previously only manual control of bright field 
illumination was possible. 
• A new DAPI filter cube was acquired. The previous filter cube 
produced very faint fluorescence; when removed, it was found to be covered 
with a dark residue that could not be cleaned off. The replacement filter cube 
(detailed in Section 2.2.2.1.) required lower exposure times for brighter 
images, further increasing the overall efficiency of the system. 
This new system made possible the creation of automated programmes, capable of 
controlling most of the aspects of microscopy hardware. The system is integrated with 
control software, which can automatically alter aspects of image acquisition. In order 
to examine large numbers of individual animals on a daily basis (see below), fast 
throughput was especially important. That the new system increased speed and 
reproducibility of image acquisition can be seen in the time taken in acquiring a 
merged brightfield and epifluorescent image: ~5 seconds under the old system, 0.6 
seconds for the new. Thus we were confident that this setup would be sufficient to 
accurately observe small changes in C. elegans autofluorescence over time.  
 
3.2.2. Developing a protocol to monitor individual animals over time 
Previous studies looking at C. elegans autofluorescence in vivo monitored age-
matched cohorts of animals (Garigan et al., 2002; Gerstbrein et al., 2005), a method 
which, as discussed previously, may generate misleading data. At the time of 
experimentation, there was no protocol for following individual animals in this way, 
and so we had to develop one. This protocol is outlined briefly here, and discussed in 
more depth in Materials and Methods. 
 Strains were grown up under standard conditions. At the L4 stage, 30 – 40 
animals were picked onto OP50 seeded NGM plates containing 15µM FuDR to 
prevent progeny development. Animals were scored daily on two counts: firstly, for 
their movement phenotype and subsequently for their fluorescence values.  
 Movement phenotype scoring was adapted from Herndon et al 2002, where an 
animal was placed into one of three movement categories depending on its agility. 
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Preliminary trials showed that a single category could contain very different motility 
levels, and so three more categories were introduced to give a total of six classes:  
A class: Animals move quickly and fluidly in a clear sinusoidal pattern, 
without the need for manual stimulation.  
A/B class: Worms move without manual stimulation but do so more slowly 
than A, or in non-sinusoidal (uncoordinated) manner. 
B class: Worms are manually stimulated to move by touching gently with a 
platinum wire; movement is slow, uncoordinated or very brief. 
B/C class: Worms move very slowly and briefly in an uncoordinated manner 
in response to manual stimulation. 
C class: Worms cannot move away from manual stimulation. 
Terminal C class: Worms are entirely paralyzed except for very slight head 
movement in response to manual stimulation. 
Terminal C class animals were found to be the most likely to die within the next 24 
hours, which had important implications for how their fluorescence values were 
measured. 
 Animals’ fluorescence values were determined by fluorescent microscopy. In 
order to measure the same animal’s fluorescence values daily, it was necessary to do 
so without harming them. As such, animals remained in situ on NGM plates, and were 
not mounted onto glass slides. They were placed on ice for 10 – 15 minutes in order 
to induce stillness for the measurements.  
Animals were initially measured only for their blue fluorescence levels, 
characterized by Gerstbrein et al at approximately λex/λem 340/430nm. A DAPI filter 
set was used for these readings. Preliminary trials established an exposure time of 
500ms as being sufficient to see intestinal fluorescence, and this was held constant 
throughout the trial to make all data points comparable.  
Daily observations acquired two images in quick succession: brightfield and 
then blue fluorescence. These two images were automatically overlaid, and the 
brightfield outline of the animal was traced by hand using a graphics tablet, thus 
supplying the mean fluorescence pixel density for the animal. The worm outline was 
moved to right of the worm image and a background pixel density reading was taken. 
The final fluorescent value was obtained by subtracting the background from the 
outline reading. Plotting these pixel densities over time showed each animal’s lifelong 
fluorescence readings. 
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 When animals were classified as Terminal C class, they were filmed using 
stop motion photography for 12 – 24 hours. This allowed us to observe any changes 
in fluorescence immediately prior to, during and after the animal’s death. This 
protocol is summarized in Figure 3.7.  
  
 
 
 
 
 
 
 
Figure 3.7: Schematic illustrating protocol for observing individual animal 
fluorescence over time. Animals are individually plated and photographed in situ until they 
reach the “Terminal C” stage of mobility. They are then filmed until after death.  
 
3.2.3. Blue fluorescence does not increase with increased oxidative damage 
To probe whether the blue fluorescent material in C. elegans LROs is 
lipofuscin, we asked whether oxidative stress increases fluorescence levels. First, we 
subjected young adult C. elegans to normobaric hyperoxia (90% partial pressure O2), 
and measured levels of protein oxidation, and blue fluorescence. Protein oxidation 
was measured via oxyblot, which detects protein carbonyls that have been formed 
through oxidative damage, and has previously been used in C. elegans (Van 
Raamsdonk and Hekimi, 2010; Yang et al., 2007). Blue fluorescence levels were 
measured using the microscopy set-up described above. This work was carried out in 
collaboration with Filipe Cabreiro and Caroline Araiz.  
Hyperoxia resulted in a 29% increase in oxidative damage (protein carbonyl 
levels) relative to normoxia controls, but did not increase blue fluorescence (Figure 
3.8). By contrast, in mammalian cells, 40% O2 significantly increased lipofuscin 
levels (Terman and Brunk, 1998). We then exposed animals to 15mM ferric 
ammonium citrate (FAC), which have been shown to increase oxidative damage in C. 
elegans (Valentini et al., 2012). Again, this treatment significantly increased levels of 
protein damage, but blue fluorescence levels showed no significant changes (Figure 
3.9).  
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Figure 3.8: Exposure to hyperoxia increases levels of protein carbonyls, but not blue 
fluorescence. (a) Blue fluorescence levels do not increase under hyperoxia. (b) Quantified 
oxyblots show that hyperoxia (90% oxygen) increases protein carbonyl levels compared to 
atmospheric levels (20% oxygen). Graphs show mean of 3 biological replicates, ± SEM. 
Asterisks indicate significant differences, where * p < 0.05 and ** p < 0.01, Student’s t test.  
 
 
Figure 3.9: Exposure to free iron (FAC) increases levels of protein carbonyls, but not 
blue fluorescence. (a) Blue fluorescence levels do not increase after exposure to 15mM 
FAC. (b) Quantified oxyblots show that 15mM FAC increases protein carbonyl levels 
compared to control. Graphs show mean of 3 biological replicates, ± SEM, Student’s t test. 
 
 
Figure 3.10: Blue fluorescence does not increase with heat-shock induced increased 
unfolded protein response (UPR) activity, as indicated by increased levels of hsp-4::GFP. 
Graphs show mean of 3 biological replicates ± SEM, Student’s t test.  
	   65 
 
Finally, we attempted to measure a different type of damage. Increased 
expression of hsp-4::GFP is a marker for the unfolded protein response, symptomatic 
of protein damage (Urano et al., 2002). Heat shock significantly increased levels of 
hsp-4::GFP expression but again blue fluorescence levels showed no increase (Figure 
3.10). These results imply that C. elegans intestinal fluorescence is not the product of 
oxidative damage, and so may not be lipofuscin. 
 
3.2.4. Blue fluorescence increases with death, not age 
In mammalian cells, lipofuscin is not degradable by proteolytic enzymes, and 
so accumulates in the lysosomes with age. Thus if C. elegans intestinal fluorescence 
is lipofuscin, it should increase gradually with age. As outlined above, previous 
studies have described increased mean fluorescence levels with age in C. elegans 
cohorts (Garigan et al., 2002; Gerstbrein et al., 2005) but there is concern that 
population heterogeneity may mask individuals’ fluorescence levels. To test this, the 
fluorescence levels of individually cultured, wild-type C. elegans in situ on NGM 
agar plates were examined at intervals throughout life (DAPI filter; λex/λem 
350/460nm). The fluorescence levels of animals identified as Terminal C were 
measured during the subsequent 12–24 hrs using time-lapse photography in order to 
capture fluorescence changes during death. 
     
Figure 3.11: Blue fluorescence increases death, not age. Graph showing individual 
worm’s levels of blue fluorescence viewed in situ on NGM plates; there is no change during 
life but then a large, significant increase in fluorescence at death (for individuals a – e, days 7, 
10, 11, 12 and 14 respectively).   
 
Over the course of adulthood until a short time prior to death, blue 
fluorescence levels in individual animals did not increase significantly (Figure 3.11). 
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However, a striking and rapid increase in fluorescence levels occurred in class C 
animals, which coincided with complete cessation of movement (i.e. with death) 
(Figure 3.12, Movie 1; for movies please see DVD appendix inside back cover). This 
burst of fluorescence entailed an average increase in fluorescence of ~400% above 
basal levels (Figure 3.12). This fluorescence developed very quickly as the animals 
approached death, typically starting to rise two hours prior to the cessation of 
movement, and then fading during the first six hours after death (Figure 3.12, Figure 
3.13). 
 
Figure 3.12: Blue fluorescence increases with death, not age. Mean levels of 
fluorescence normalized to time of death of 47 individual animals. Time 0 = time of death. 
Shaded area ± SD. The burst of fluorescence has a duration of approximately six hours from 
beginning until fading (see inset).  
 
 
Figure 3.13: Representative image showing fluorescence change during death from old 
age. Time is hours, where 0 marks a complete cessation of movement, defined as death. The 
fluorescence is initially punctate (i), then increases in intensity in the anterior intestine (ii-iii), 
engulfs the intestine (v) and finally fades in a diffuse distribution (vi).  
 
The fluorescence also showed a marked alteration in its distribution. Living 
animals show punctate gut granule fluorescence (Figure 3.1, Figure 3.13 i). However, 
as death approached, fluorescence engulfed entire cells one after another, until the 
whole intestine glowed emitted a bright blue glow (Figure 3.13 i - iv, Movie 1). 
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Thereafter, fluorescence spread to other tissues in the animal, except the pharynx and 
gonad. After death, the fluorescence intensity returned to pre-death levels, but did not 
regain its punctate distribution (Figure 3.13 v).  Taken together with our earlier result 
showing that increased oxidative damaged does not increase blue fluorescence levels, 
our data strongly argues against C. elegans blue fluorescence being lipofuscin. It 
suggests that earlier results could reflect error resulting from summing data from 
population cohorts. Finally, it suggests that increased levels of blue fluorescence may 
serve as a novel biomarker of death in C. elegans. 
 
3.2.5. A burst of blue fluorescence marks death in C. elegans and other 
nematodes, irrespective of age or cause 
In order to investigate whether increased levels of blue fluorescence act as a 
universal biomarker of death in C. elegans, we examined fluorescence changes in 
young animals dying from injury. Young adult animals were killed with a hot pick, by 
freeze-thaw, dessication or immersion in acetic acid (pH3) (please see section 2.1.6). 
Significant increases in blue fluorescence were observed in each case (Figure 3.14, 
Movies 2 and 3). 
            
Figure 3.14: Blue fluorescence increases when young adult hermaphrodites die from 
injury. (a) Young adults generate death fluorescence when killed by exposure to acetic acid 
or freeze-thaw stress, as measured in a plate reader; please see section 2.1.6 for 
methodology. Graphs show percentage increase in fluorescence at death, normalized to 
living fluorescence ± SD, Student’s t-test. (c) Representative image of young adult 
hermaphrodite killed by application of a hot pick to adjacent agar.   
 
We then tested to see if males and L4 hermaphrodite larvae generated a burst 
of fluorescence at death. Significant increases in blue fluorescence were also observed 
when adult males and L4 hermaphrodite larvae were killed by heat (Figure 3.15). A 
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burst of blue fluorescence was also observed after heat killing in two other nematode 
species, Caenorhabditis briggsae and Pristionchus pacificus (Figure 3.15), and so 
may be widespread among nematode species (this data obtained by my student, 
Alexander Davidson).  
  
            
 
Figure 3.15: Blue fluorescence increases at death in C. elegans and other species. 
Blue fluorescence increases when L4 larvae and young adult males die from injury. (a) L4 
larvae and young adult male C. elegans show death fluorescence when they die, as do  
C. briggsae and P. pacificus. Graphs show living and dead fluorescence, ± SD, Student’s T 
test.  (b-d) Representative images of a dead young male C. elegans (b), C. briggsae (c) and 
P. pacificus (d) killed by exposure to heat. 
 
Thus, bursts of fluorescence accompany death whether caused by old age or 
mortal injury in C. elegans and other nematodes. This being so, this death-associated 
burst of blue fluorescence will hereafter be referred to as death fluorescence.  
The discovery of death fluorescence confirms that blue fluorescence within C. 
elegans intestinal cells is unlikely to be lipofuscin. Previous reports of increases with 
age can most likely be attributed to population heterogeneity masking the effect of 
individuals’ death fluorescence increases. Whether lipofuscin exists in C. elegans 
therefore remains an open question. However, the discovery of death fluorescence 
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provides a novel endogenous marker of death in C. elegans which could be useful, 
e.g. for lifespan measurements.  
 
3.2.6. Red and green fluorescence increase with both age and death 
As detailed above, multiple different fluorescent signatures have been 
described in C. elegans (Garigan et al., 2002; Gerstbrein et al., 2005; Pincus et al., 
2011a). We were interested to see whether or not the reported increases in these 
spectra would be reproducible in individuals. Individuals were observed daily as 
previously described, but three fluorescent images were taken, using the DAPI, GFP 
(green, λex/λem 470/525nm) and dsRed (λex/λem 545/620nm) filters to examine green 
and red fluorescence levels along with blue. Green and red fluorescence in C. elegans 
appear much dimmer than blue fluorescence using mercury bulb illumination. 
Consequently, longer exposure times were required to visualize the fluorescence well 
enough to detect changes. This was problematic, as excessive exposure to UV light 
both harms the animal and can cause photobleaching of fluorescence. Preliminary 
experimentation found that 1 and 3 second exposure times for green and red 
fluorescence respectively was sufficient to visualize the fluorescence.  
Levels of red and green fluorescence were both extremely low, with a high 
degree of variation. Both did not appear to show any increase in life, and appeared to 
increase only after death; not prior to death, as seen in death fluorescence (Figure 
3.16). However the levels of fluorescence seen were so low, it was not possible to 
draw confident conclusions about the nature of red and green fluorescence in C. 
elegans.   
 
Figure 3.16: Red and green fluorescence increase only after death. Red and green 
fluorescence in C. elegans appear to increase only after death, and not during life, or prior to 
death in the manner of blue fluorescence.  
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Figure 3.17: Independent experimentation showing that blue fluorescence increases at 
death, whereas green and red fluorescence increase with age. (a) Average levels of 
fluorescence normalized to time of death, viewed under red, blue and green filter sets, 
showing different rates of fluorescence increase with time. n = 43 individual animals. Shaded 
area = ± 1 standard deviation. Each plot is scaled on separate arbitrary units as absolute-
terms comparisons are not possible. Note that rates of fluorescence accumulation and spatial 
distribution of the blue, red and green fluorescence differ, consistent with the presence of 
distinct fluorophores. (b and c) Typical prior to death and during death images of an animal in 
each fluorescence band, showing altered spatial distribution of the fluorescence. Data and 
figure from Zachary Pincus, Yale University.  
 
Consequently we repeated the experiments using a more sensitive fluorescence 
detection system. This data was obtained by Zachary Pincus (Yale University), using 
the methodology as described (Pincus et al., 2011a). Fluorescence was measured 
using DAPI (blue, λex/λem 350/460nm ), GFP (green, λex/λem 470/525nm) and TRITC 
(red, λex/λem 546/600nm) filter sets. Blue fluorescence measurements allowed 
verification that blue fluorescence does not increase prior to death (Figure 3.17).  
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Again, no significant age-increase in blue fluorescence was seen (though weak 
but non-significant increases were seen late in life) (Table 3.1). Green and red 
fluorescence did increase significantly with age (Table 3.1), and all three forms of 
fluorescence increased during death (Figure 3.17, Table 3.1). 
  
Student’s t test p value Blue Green Red 
Is the pre-death slope significantly greater than 0? 0.0768 2.86e-14 2.35e-27 
Do pre- and post-death slopes differ significantly? 5.93e-12 5.94e-13 1.56e-06 
Do pre- and peak death fluorescence maxima 
differ significantly? 1.02e-13 3.36e-19 1.82e-16 
Table 3.1 Multiple types of fluorescence increase with death in C. elegans. Both green 
and red fluorescence increase significantly with age, but blue fluorescence does not. Table 
also shows a significant increase in all types of fluorescence at death, with peak death 
fluorescence significantly higher than at any time seen during life.  
 
These results confirm that the increase in the blue fluorescence in C. elegans 
in aging population cohorts is predominantly a function not of aging but of death. The 
fact that red and green fluorescence increase with both age and death suggest that C. 
elegans may contain multiple fluorophores. However, it does show that red or green 
intestinal fluorescence could be used as markers of ageing in C. elegans, provided that 
death-related increases were controlled for by studying individuals, not populations.  
 
3.2.7. Living fluorescence increases gradually with time in slide-mounted animals  
 Based on population heterogeneity, it is easy to understand how in vivo 
measurements of population cohorts could mask death fluorescence and show instead 
a gradual increase in blue fluorescence with age. However, another possibility is that 
in worms mounted on microscope slides, there is an age-related increase in blue 
fluorescence. To test this, we measured the levels of fluorescence in living animals on 
slides in age-matched cohorts at days 2, 5, 7, 9 and 15 of adulthood.  
 In order to see if increased duration mounted on slides leads to brighter 
fluorescence, the animals were measured immediately after being placed on slides and 
subsequently 20 minutes later (Figure 3.18). We found that initial measurements of 
fluorescence in living animals mounted on slides significantly increased in intensity 
with age from day 7 of adulthood. However we found that leaving animals on slides 
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did not increase fluorescence. These findings suggest the possibility that mounting 
worms onto slides damages them, and such damage leads to DF development. One 
possible cause of stress is physical pressure of the cover slip.  
    
Figure 3.18: Blue fluorescence does increase with age in slide-mounted animals. There 
is a significant increase over time in fluorescence measured immediately after mounting. 
Remaining on slides for a further 20 minutes does not increase fluorescence. All values are 
normalized to 0 minutes, day 2 (shown in grey). Data mean of 27 individual animals, ±S.D, 
student’s t test.  
 
3.2.8. Death fluorescence spreads in a characteristic pattern 
As death fluorescence (DF) is generated as a result of death, examining its 
spatiotemporal spread may reveal the dynamics of death in C. elegans. We examined 
time-lapse films of worms dying of old age to further characterize the origins of DF. 
63% of animals showed significantly higher fluorescence in the anterior intestine for 
the start or entire duration of the burst, with a secondary focal point occurring near the 
vulva. Fluorescence levels increased with time, and in 69% of animals, the anterior 
and central intestine showed the greatest increase over the time observed. Mean data 
show an anterior-posterior wave of fluorescence spreading down the length of the 
intestine (Figure 3.19). This fluorescent wave occurred irrespective of the time scale 
of the burst, which varied between 2-6 hours. Our observations suggest that the origin 
of DF occurs in the anterior intestine. To probe this, we attempted to generate a 
posterior to anterior wave by placing a hot wire adjacent to either the tail or the head 
of young adults. In those with a hot pick applied to the head, the fluorescence rose in 
the anterior intestine and spread as expected (Figure 3.20). Those with a hot pick 
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applied to the tail showed an initial rise in fluorescence intensity, but this was 
restricted to the posterior 25% of the intestine (Figure 3.20). This intensity neither 
spread nor faded within 15 minutes of observation. Furthermore, these animals 
remained alive when assayed 24 hours later.  
These observations imply that the wave of fluorescence can only be initiated in the 
anterior intestine, and must travel from anterior to posterior. Given that DF 
consistently originates in the anterior intestine, this area may represent an organismal 
weak point in C. elegans, where a local crisis in homeostasis can lead to organismal 
death. 
 
Figure 3.19: Fluorescence increases in an anterior to posterior wave. Figure shows 
mean fluorescence intensity (values normalized to highest value in each individual) at 5 
points along the intestinal length of animals dying from age, n = 29. As time of DF spread 
varies between animals, the duration of each observation was divided into 5 equal points for 
measurement. 
  
Figure 3.20: DF spreads only when anterior cells are killed. Applying a hot pick directly 
adjacent to anterior, but not posterior, intestinal cells leads to a spread of DF.  
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3.3 Discussion 
 
3.3.1 Lipofuscin and the oxidative damage theory of ageing in C. elegans 
C. elegans is widely used to study ageing. In recent years the idea that 
molecular damage is a cause of ageing in C. elegans has come into question (Gems 
and de la Guardia, 2012; Van Raamsdonk and Hekimi, 2010). As detailed above, blue 
intestinal fluorescence in C. elegans has been thought to be equivalent to mammalian 
lipofuscin. It has thus been taken as another piece of evidence in favour of the 
oxidative damage theory of ageing. However, this equation was based predominately 
on spectral similarities, and potentially misleading cohort studies (Gerstbrein et al., 
2005; Klass, 1977). In these respects, the equation of intestinal fluorescence with 
lipofuscin somewhat resembles the correlative data showing increasing ROS levels 
with age; both theories have encountered difficulties when experimental manipulation 
tested their predictions. 
We tested the prediction that manipulating levels of oxidative damage should 
alter the level of intestinal fluorescence in C. elegans, and found that it had no effect. 
We thereafter showed that blue fluorescence increases only with death, and not with 
age – and that a rise in fluorescence can be induced by killing young adult animals. It 
therefore seems very unlikely that this fluorescent material is lipofuscin; indeed, 
Chapter 5 discusses the biochemical identification of the fluorophore, and it is not 
lipofuscin.   
This finding does not disprove the existence of lipofuscin in C. elegans, but its 
existence is an open question. We confirmed previous findings showing that both red 
and green fluorescence increase with age, but also show that both also increase with 
death. Without detailed molecular analysis it is impossible to ascertain if these species 
arise anew with death, or just increases their rate of formation. It is possible, 
therefore, that one of these species may be lipofuscin. However, as our work 
demonstrates, this hypothesis should be tested, biochemically if possible, before being 
equated with lipofuscin. Until then, our findings remove a significant piece of 
evidence for the role of molecular damage in C. elegans ageing.  
 
3.3.2. The loss of a biomarker of ageing 
As outlined in the introduction, biomarkers of ageing are important research 
tools for gerontologists. An accurate biomarker of ageing will respond to 
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experimental intervention, confirming that any alteration in lifespan is due to the 
manipulation of ageing and not due to altered risk of death. Lipofuscin has been 
shown to be a valid biomarker of ageing, as it increases in senescent post-mitotic 
mammalian cells It has now been shown that C. elegans blue fluorescence is unlikely 
to be lipofuscin. Moreover, our data shows that blue fluorescence cannot be used as a 
biomarker of ageing in situ, as it increases at death and not with age (although see 
below with reference to mounted animals).  
Blue fluorescence was largely thought to be a valid biomarker of ageing based 
on cohort studies. As demonstrated above, these can give false conclusions if 
population heterogeneity is not taken into account, and, the false impression that 
fluorescence gradually increases with age. Longitudinal study of individual worms 
reveals the death-related increase. By contrast, red fluorescence does rise with age 
(Pincus et al., 2011a). Red fluorescence however does also increase with death, albeit 
to a smaller extent than blue fluorescence. Therefore red fluorescence could be used 
as a biomarker of ageing, but only using individually cultivated worms.  
However, population heterogeneity cannot explain other results showing that 
blue fluorescence increases with age. Studies observing age-matched cohorts of slide-
mounted worms (Garigan et al., 2002) or biochemical isolates of blue fluorescence 
increasing in an age-dependent manner (Davis et al., 1982; Houthoofd et al., 2002; 
Klass, 1977). Findings presented here show that worms mounted on microscope pads 
show age-dependent increases in blue fluorescence. An experiment is currently being 
run (September 2012) by Abraham Mandel to further test this finding. An animal’s 
fluorescence is measured in situ on NGM plates and subsequently re-measured  after 
mounting onto a microscope slide. This experiment will hopefully confirm whether 
slide mounting does lead to increased generation of DF. As animals age they become 
frailer. We suggest that as a result, older animals are more vulnerable to the 
mechanical stress caused by mounting, and so generate increased fluorescence. 
Another observation that requires explanation is that extracts from older worm 
cohorts show higher levels of fluorescence than those from younger animals (Davis et 
al., 1982; Houthoofd et al., 2002; Klass, 1977). One might expect that killing young 
and old worm cohorts would result in similar levels of death fluorescence. One 
possibility is that this reflects the importance of the development of death 
fluorescence. Data presented in Chapter 4 demonstrates that the formation of DF is an 
active, enzymatic process probably requiring ATP. Potentially this is because older 
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cohorts of animals have a greater proportion of dying individuals. All in vitro 
measurements of blue fluorescence used samples of worms which had been snap 
frozen using liquid nitrogen (Davis et al., 1982; Houthoofd et al., 2002; Klass, 1977). 
We suggest that snap freezing prevented the further development of DF; hence the 
higher levels of DF in extracts of old worms. One way of testing this theory would be 
to snap freeze two samples from the same age matched cohort of animals. One could 
then be thawed at an ambient temperature and incubated. Both samples should then be 
homogenized and blue fluorescence levels measured. Here, thawing and incubation 
should allow development of death fluorescence and greater levels of blue 
fluorescence in the extracts.  
 
3.2.3 The gain of a biomarker of death 
 C. elegans is widely used to study ageing. Most ageing studies are conducted 
by seeing if genetic or environmental manipulation alters the animals’ lifespan. 
Measuring lifespan in C. elegans is time consuming. Animals are assessed by their 
mobility: in early life, they move spontaneously, but as they age manual stimulation is 
needed to trigger movement. There has been some attempt to automate this process 
through the use of C. elegans microfluidic devices which rely on the uptake of the 
vital dye, Sytox green (Gill et al., 2003; Rohde et al., 2007). Both methods can be 
problematic. Manual stimulation is tedious, time consuming and subject to bias. 
Automation relies on dye uptake, which may be unreliable and uneven, affecting 
reliability. 
 Death fluorescence could be used as an endogenous biomarker of death. 
Microfluidic devices used in conjunction with a UV emitting light source and camera 
could effectively monitor large populations of individual worms from birth to death. 
This automation could provide multiple benefits. Firstly, as the animals would be 
tracked individually, it would guard against false conclusions borne of aggregate 
cohort data. Secondly, having individual data may findings which would be obscured 
from cohort measurements. Most importantly, it could hugely free up one of the most 
valuable resources of any C. elegans researcher: time. A collaboration between a 
member of the Institute for Healthy Ageing, Eugene Schuster and David Holmes, 
London Centre for Nanotechnology, is currently underway to build a prototype model 
of this automated system, using death fluorescence as a biomarker of death, and will 
hopefully be complete by the end of 2012.  
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3.2.4. Trying to understand death fluorescence 
 The discovery of death fluorescence may have answered multiple questions 
about the nature of lipofuscin and fluorescence in C. elegans, but stimulated many 
more. The most pressing questions, addressed in the following two chapters, were: 
“what is death fluorescence?” and “how is it generated at death?”. Thus the project 
became devoted to attempting to answer these questions. In so doing, my 
investigations became more a study of death than of ageing. I am grateful to my 
supervisor, David Gems, for allowing me to pursue these fascinating tangents.  
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4. DEATH FLUORESCENCE IS PRODUCED BY NECROTIC CELL DEATH 
 
4.1 Introduction to necrosis 
The idea of necrotic cell death as a programmed, or quasi-progammed, 
cascade is a recent one, and not yet universally accepted. Here I discuss the definition 
of necrotic cell death, outline how it has become to be understood as a conserved 
cascade, and explain the implications these findings have for the understanding of 
death of C. elegans.  
 
4.1.1. Cell death classification 
 Cell death was first classified into two distinct types in 1972: controlled 
(apoptotic) or uncontrolled (necrotic) (Kerr et al., 1972). The name apoptosis was 
coined to describe cells that died in response to physiological stimuli. It was taken 
from the Greek word describing the way in which leaves fall from trees, emphasizing 
it as a non-catastrophic form of cell loss (Kerr et al., 1972). Apoptosis was described 
in contrast to necrosis: a more widely observed type of cell death which appeared “to 
be invariably caused by noxious stimuli, and is probably the result of an irreversible 
disturbance of cellular homoeostatic mechanisms” (Kerr et al., 1972).  
This categorization was based on morphological differences between types of 
cell death. Scattered apoptotic cells were shown to condense into small spherical 
cytoplasmic fragments (apoptotic bodies), and were then degraded by phagocytosis. 
Necrotic cells did not condense, retained their original shape, and were not degraded. 
Thus, apoptosis appeared as a physiologically controlled means of cell death, and 
necrosis remained characterized solely by its absence of apoptotic-like features (Kerr 
et al., 1972).   
As a consequence of these categorizations, much work was done on the 
mechanisms of apoptotic cell death. Necrotic cell death was more commonly regarded 
as “an accidental uncontrolled form of cell death” (Kroemer et al., 2009). However, 
evidence is now accumulating that suggests necrosis may be biochemically regulated 
in a manner similar to apoptosis.  
 In 2009, The Nomenclature Committee on Cell Death (NCCD) published its 
second set of recommendations for cell death nomenclature (Kroemer et al., 2009). 
Apoptosis has multiple characteristic morphological and biochemical features which 
can be used for identification, such as chromatin condensation, reduction in cell 
	   79 
volume, nuclear fragmentation, phagocytic engulfment, and activation of the Bcl-2 
and caspase protein families (Kroemer et al., 2009). Necrosis was defined as 
exhibiting cytoplasmic and organelle swelling, plasma membrane rupture, and a 
localized inflammatory response (Kroemer et al., 2009). However, the committee 
noted that this definition was predominantly a “negative” definition of apoptosis: 
necrosis was mainly defined by the absence of apoptotic hallmarks. 
Aside from the lack of necrosis-specific biochemical and morphological 
hallmarks, cell death classification is made more complex due to multiple examples of 
cells showing partial or mixed characteristics (Kroemer et al., 2009; Zong and 
Thompson, 2006). For example, it was found that caspase inhibition during 
interdigital cell death in mice did not prevent the cells from dying. Instead, the dead 
cells exhibited necrosis-like features, but showed no phagocytosis or inflammatory 
response (Chautan et al., 1999). Compounding the difficulty in identification, certain 
physiological stimuli appear to induce either apoptosis or necrosis, depending on the 
severity of the insult (Zong and Thompson, 2006). For example, human promonocytic 
cells (cell arising from monocytes) were treated with either 0.2mM or 2mM 
concentrations of hydrogen peroxide. Both concentrations proved cytotoxic, but those 
treated with the lower dose entered apoptosis whereas those treated with the higher 
dose entered necrosis (Troyano et al., 2003).  
 Nonetheless, there is now a growing body of literature suggesting that necrosis 
may also be a type of programmed cell death  (Golstein and Kroemer, 2007; Luke and 
Silverman, 2011; McCall, 2010; Zong and Thompson, 2006). The mechanisms by 
which necrosis operates are not fully understood. However, examples in the literature 
frequently describe similar hallmarks, despite often originating from different tissues 
and organisms. Consequently, it is possible to sketch a general picture of necrosis. 
From this, it is clear is that similar mechanisms of cell death can be repeatedly seen in 
multiple dissimilar examples, strongly supporting the idea of necrosis as a 
programmed mechanism of cell death.  
 
4.1.2. Calcium is required for necrosis 
Calcium (Ca2+) has long been associated with cytotoxicity, dating back to 
observations of calcium deposits in necrotic tissue in 1965 (Sattler and Tymianski, 
2000). The mechanisms by which raised intracellular calcium levels lead to cell death 
are not fully understood, but it is increasingly recognized to be a major component of 
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necrotic cell death (Mattson, 2007; Mattson and Magnus, 2006; Yamashima et al., 
1996; Zong and Thompson, 2006). Multiple insults can trigger raised intracellular 
calcium levels. In mammalian neuronal models, the most commonly studied model 
system, calcium induced cytotoxicity has been documented in response to excessive 
glutamate stimulation (excitoxicity) (Fryer et al., 1999), ischemia (Xiong et al., 2004) 
and anoxia (Aarts et al., 2003). 
Intracellular Ca2+ homeostasis is required for normal cell function. Under 
normal conditions, extracellular Ca2+ concentration is ~1.2mM, and intracellular Ca2+ 
concentration is ~0.1µM (Zong and Thompson, 2006). Increasing intracellular  
calcium levels can lead to necrotic cell death.  
Most intracellular Ca2+ is stored within the endoplasmic reticulum (ER). Thus 
Ca2+ can enter the cell both from the extracellular matrix and from the ER stores. 
Extracellular Ca2+ can cross into a cell via multiple receptors. In neurons, 
neurotransmitter receptors that act by binding excitatory amino acids such as α-
amino-3-hydroxy-5-methylisoxazole-4-propionate (AMPA) and N-methyl-D-
aspartate (NMDA) to their receptor channels, or by indirectly activating voltage-
dependent Ca2+ channels (VDCCs) cause a rise in intracellular [Ca2+] from 
extracellular sources (Mattson, 2007). When increase in intracellular calcium 
mediated by these excitatory neurotransmitters leads to neuronal death it is known as 
excitotoxic cell death.  
In non-neuronal cells, there three types of receptors control extracellular 
Ca2+influx: 
• VDCCs, as above, control Ca2+ flow via proton gradient potentials 
across the plasma membrane.  
• Entry channels, which are activated by ER Ca2+ release  
• Acid sensing ion channels (ASICs) which are epithelial sodium 
channels (Zong and Thompson, 2006).  
In all cells, calcium elimination is maintained by a Na+/ Ca2+ exchanger and a plasma 
membrane Ca2+ pump (Ca2+-ATPase) (Zong and Thompson, 2006).  
Multiple receptor channels control the ER Ca2+ stores. The 
sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA) controls Ca2+ uptake from the 
cytosol. ER Ca2+ release is controlled by the inositol triphosphate (IP3), phosphatidyl-
inositol bisphosphate (PIP2) and ryanodine receptor channels.  In neurons, glutamate 
receptors coupled to the GTP-binding proteing Gq11 stimulates IP3 channel opening, 
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and so glutamate binding further increases intracellular [Ca2+] and raises the risk of 
excitotoxic death (Mattson, 2007). Furthermore, release of Ca2+ by the ER leads to an 
increase in active transport of extracellular Ca2+ into the cell (Zong and Thompson, 
2006), creating a positive feedback loop.  
That calcium influx leads to cytotoxicity and cell death has been well 
documented. For example, inhibition or genetic manipulation of gap junction protein 
subunits in mammalian neurons greatly reduces the extent of neurodegeneration in the 
brain after exposure to ischemia (Wang et al., 2010; Wang et al., 2012).  Gap 
junctions allow direct cell-to-cell transmission of calcium; thus these data implies that 
calcium influx can lead directly to cell death. However, the mechanisms which 
underlie this cytotoxicity are less well understood. Experiments examining the basis 
of calcium-associated neurotoxicity have shown that, contrary to early theory, 
calcium influx in and of itself is not necessarily toxic (Tymianski et al., 1993). Instead 
toxicity appears to be a function mediated by the specific receptor(s) leading to the 
influx. For example, levels of calcium within the cytosol that lead to cytotoxicity 
when mediated by the NMDA receptor were not toxic when mediated by VDCCs 
(Tymianski et al., 1993). This implies that toxicity is instead a function of a post-
synaptic specific receptor-associated process (Sattler and Tymianski, 2000), and so 
under a degree of cellular control, rather than simply being catastrophically toxic. The  
calpain-cathepsin hypothesis, which has been comprehensively tested in mammalian 
neurons by Yamashima and colleagues, provides an explanation of these toxicity 
mechanisms (Yamashima, 2004).  
 
4.1.3. The calpain-cathepsin hypothesis 
The calpain-cathepsin cascade (Figure 4.1) was first characterized in 
mammalian CA1 hippocampal neurons that died from exposure to ischemia 
(Yamashima et al., 1996). Ischemia-mediated neurodegeneration in CA1 hippocampal 
neurons had long puzzled researchers. CA1 hippocampal neurons were exceptionally 
sensitive to ischemia, but when exposed to ischemic shock, survived for 2 to 3 days 
before suddenly dying (Kirino and Sano, 1984). Glutamate had been shown to 
accumulate after transient ischemia, and so it was thought that glutamate-bound 
NMDA receptors induced the Ca2+ influx that led to cell death. However, it was 
subsequently shown that NMDA receptors were present in all hippocampal neurons 
(Moriyoshi et al., 1991): Ca2+ influx into the CA1 cells could not be the sole 
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mechanism of toxicity. Experimentation then demonstrated that ischemia triggers 
increased intracellular levels of Ca2+ via IP3 and PIP2-mediated Ca2+ release from the 
ER stores in CA1 neurons (Ishida et al., 1992). Thus, this release of Ca2+ was thought 
to act as a second messenger, triggering other interactions which eventually led to cell 
death (Henzi and MacDermott, 1992). 
     
Figure 4.1: Schematic of the calpain-cathepsin hypothesis.  
 
The first major interaction to be discovered was the activation of the calcium-
dependent cysteine proteases, calpains. Calpains are a family of cytoplasmic proteases 
with both ubiquitous and tissue specific forms. They have multiple substrates, 
including cytoskeletal and membrane proteins, which they act on in a non-reversible 
manner (Saido et al., 1994). There are two ubiquitous forms, µ- and m-calpains, 
named after the molarity of Ca2+ required for their activation (Saido et al., 1994). The 
high levels of Ca2+ required for activation in vitro was surprising; even µ-calpains 
required more than 10-6 M Ca2+ for activation, significantly higher than cytosolic Ca2+ 
concentrations (~10-7 M). However, when cells are exposed to ischemia, IP3 and 
PIP2-mediated release of Ca2+ is thought to raise the cytosolic concentrations 
sufficiently high for activation of µ-calpains (Yamashima et al., 1996). Antibody 
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studies of the proteolyzed µ-calpain substrate fodrin revealed that the proteases were 
activated in response to ischemia (Saido et al., 1994).  
Yamashima and co-workers then developed antibodies which responded to 
activate or inactive forms of µ-calpain (1996). The hippocampus of primates exposed 
to 20 minutes of ischemia were removed and Western blots were performed. In CA1 
hippocampal neurons, µ-calpain was shown to be activated, whereas in all other 
hippocampal neurons it remain in its inactive state (the converse being true when the 
cells were probed with an antibody specific to calpains). Immunoelectron microscopy 
was used to confirm this result in CA1 cells exposed to hypoxia-hypoglycaemia in 
vitro. This technique also revealed that post-ischemia, activated µ-calpain localized 
specifically to lysosomal membranes, causing lysosomal membrane disruption 
(Yamashima et al., 1996). These findings recapitulated previously discovered but 
overlooked results showing lyosomal lysis in both gerbils and rat ischemic death, 
suggesting a conserved mechanism of action (Yamashima et al., 1996).   
Disruption of the lysosomal membrane could lead to lysosomal lysis and the 
subsequent spilling of lysosomal contents into the cytosol. Lysosomes’ main function 
is degradative (Repnik et al., 2012), and so they contain a multitude of destructive 
enzymes, including cathepsins proteases (Yamashima and Oikawa, 2009). 
Yamashima and colleagues noted that cathepsin B, a cysteine cathepsin, was found to 
be significantly increased in aged rat neurons. They assumed that common 
mechanisms may underlie both age-related neurodegeneration and injury induced 
neurodegeneration (Yamashima et al., 1996). Consequently they examined what role, 
if any, lysosomal lysis and cathepsin release may play in cell death. 
Yamashima and co-workers discovered that cathepsin B activity levels 
increased steadily in primate hippocampi after exposure to ischemia (Yamashima et 
al., 1996). They also found that inhibition of cathepsin B with the specific inhibitor 
CA-074 was sufficient to inhibit CA1 neuronal death. Subsequent studies have shown 
that inhibition of multiple cathepsins is sufficient to ameliorate cell death in many 
different models, e.g. Bivik et al., 2007; Hwang et al., 2008; Johansson et al., 2003. 
Lysosomal cathepsins have very broad specificities, as would be expected from 
primarily degradative enzymes, and are low pH dependent (Repnik et al., 2012). 
Release of lysosomal contents would most likey lead to cellular acidosis, allowing 
lysosomal cathepsin activity within the cytosol, consequently causing widespread 
degradation (Repnik et al., 2012).  
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Thus, the calpain-cathepsin hypothesis outlines a deadly cascade. Calcium 
influx and release from the ER leads to the activation of calcium-dependent calpains. 
These calpains act preferentially upon the lysosomal membrane, causing to lysosomal 
membrane permeabilization, which in turn leads to cytosolic acidosis and the 
destructive release of lysosomal cathepsin proteases (Figure 4.1). This model was 
initially identified and tested in the CA1 subset of hippocampal neurons, but has been 
shown to be conserved in multiple other types of neurodegeneration – including in C. 
elegans’ mechanosensory neurons. 
 
4.1.4. Necrosis in C. elegans 
Necrosis has been studied in C. elegans models of neurodegeneration. 
Multiple gain-of-function mutations in C. elegans neuronal ion channels have been 
found to replicate excitotoxic, necrosis-like neuronal death (Chalfie and Wolinsky, 
1990; Driscoll and Chalfie, 1991). Of these, the best studied is mutant degenerin Na+ 
channel MEC-4(d). MEC-4 encodes a subunit of the mechanosensory channel within 
C. elegans touch neurons (Hong and Driscoll 1994). The mutation mec-4(u231 or d) 
leads to substitutions near the MEC-4 channel pore of amino acids with large side 
chains (Adams et al., 1998). These substitutions cause a change in the channel 
conformation, leading to it becoming constitutively open and causing excess ion 
influx which leads to cytotoxicity (Adams et al., 1998; Hong and Driscoll, 1994). 
mec-4(d) cell death does not require the cell’s apoptotic machinery for execution, 
making it a distinct form of cell death (Chung et al., 2000). As mec-4(d) generated 
cell death is mediated by ion influx and leads to cell swelling it has been classified as 
necrotic cell death (Xu et al., 2001).   
An initial screen for mechanisms of mec-4(d) induced toxicity employed mec-
4(d) expressed ectopically in the ventral cord neurons under control of the unc-8 
promoter (Xu et al., 2001). This screen identified multiple genes whose mutation 
ameliorated mec-4(d) induced neuron death via control of ER Ca2+ storage and 
release. Mutations in crt-1, a calreticulin homolog, unc-68, a ryanodine receptor, and 
itr-3, an IP3 homolog, all protected neurons against necrotic death (Xu et al., 2001). 
These findings clearly have strong similarities with the Yamashima and colleagues’ 
discoveries of ER calcium-mediated mammalian neuron toxicity as discussed above.  
A subsequent study also looked for genes which inhibited mec-4(d) induced 
neurodegeneration (Syntichaki et al., 2002). Here, C. elegans mutations in multiple 
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different proteases were specifically examined based on the similarities to the necrosis 
cascade outlined above. Syntichaki and colleagues discovered mutations in genes 
encoding calcium regulated calpain homologs clp-1 and tra-3, and the cathepsin 
homologs asp-3 and asp-4 (Syntichaki 2002). These findings recapitulated prior 
developments in the understanding of mammalian neurotoxicity.  
The same group then published data showing that vacuolar H+-ATPases (V-
ATPases) were required for mec-4(d) neurodegeneration (Syntichaki et al., 2005). 
RNAi-mediated knockdown of vha-2, vha-10 and vha-12 gene expression all 
suppressed neurodegeneration, as did mutations in spe-5, unc-32 and vha-12.  All of 
the affected genes encoded components of the V-ATPase (Syntichaki et al., 2005). 
The V-ATPase is required for lysosomal acidosis. Consequently, this data 
demonstrates that acidified lysosomes are required for necrotic cell death in C. 
elegans. By examining double mutants with mutations in both ER calcium release as 
well as in the V-ATPase, they also showed that acidosis is required downstream of 
raised cytosolic calcium levels in order to lead to cell death. Thus, this data supports 
the calpain-cathepsin cascade hypothesis and demonstrates a high degree of 
conservation across species.  
The majority of work studying necrosis has been in neuronal cell death, in 
both mammalian and C. elegans models. However, there is C. elegans data suggesting 
that necrosis is not solely a mechanism of neurodegeneration. In 2007, Luke and 
colleagues discovered a mutation in spr-6 (Serine PRotease inhibitors), which 
encodes an extracellular serpin. Serpins are a family of proteins which act to regulate 
proteolytic enzymes (Luke et al., 2007). Worms carrying the srp-6 mutation displayed 
the previously undiscovered phenotype Osl  (Osmotic Stress Lethal). When both 
adult and larval srp-6 mutants were exposed to water, they died violently in under a 
minute (Figure 4.2) (Luke et al., 2007). Microscopic examination of the corpses 
revealed that their cells had lost plasma membrane integrity, and appeared expanded 
and rounded, as would be expected in necrotic cells. Consequently, the authors 
examined whether mutations in components of the necrotic cascade could protect 
against srp-6 mediated Osl death. Double mutants contained srp-6 and any mutation 
protecting against necrosis, e.g. calpain mutation clp-5 protected against Osl (Luke et 
al., 2007). Interestingly, srp-6; glo-1 double mutants were also protected against Osl, 
further confirming that gut granules are indeed lysosome like organelles, and 
demonstrating their contribution to necrosis.  
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Figure 4.2: srp-6 animals die when exposed to water. (A) shows survival of srp-6(+) and 
srp-6(ok319) animals after 30 minutes exposure to water; (B) shows representative images of 
the same. Image reproduced from Luke 2007.  
 
These findings are of particular interest. Firstly they add to the body of proof 
that the necrotic calpain-cathepsin cascade exists and is conserved in C. elegans. Far 
more importantly, they imply that this cascade is not solely confined to the neurons 
and instead may contribute to organismal death. As described in the following results 
section, we confirm these conclusions and demonstrate that necrosis does indeed 
contribute to organismal death in C. elegans.  
  
4.2 Results 
  
4.2.1. Death fluorescence requires low pH or energy for generation 
After the discovery of death fluorescence, we were interested in determining 
how it is generated at death. When young animals were being tested for DF 
generation, it was noted that worms killed with CH3COOH (pH 3) showed much 
higher levels of DF than other methods of killing. Consequently, we tested to see if 
DF generation was pH dependent. A range of pH solutions (pH 3 to pH 11) were 
made using either CH3COOH, NaOH or M9 salt solution (pH 7). The worms were 
placed in these solutions in a microtitre well, and left to acclimatize for ten minutes to 
ensure that the solution pH did not kill them. The animals were then killed by freeze-
thaw (Please see section 2.1.6.), and the DF measured by plate reader. In initial trials, 
sodium azide was added to anaesthetize the animals. Once anaesthetized, animals 
sank to the bottom of the well, giving a clearer signal for the plate reader. Previous 
trials using non-anaesthetized animals had generated a ~500% increase in 
fluorescence at death (c.f. Figure 3.15). However, unexpectedly, anaesthetized 
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animals only generated comparable levels of DF when incubated in pH 3 or 4 (Figure 
4.3), seemingly contradictory data.  
 
Figure 4.3: Death fluorescence of animals in a pH range killed by freeze-thaw, using 
sodium azide as an anaesthetic. Previously, when no sodium azide was used, animals 
showed ~500% increase in fluorescence at death (death fluorescence), see Figure 3.15. Here 
only animals killed at low-pH killed exhibit similar levels of death fluorescence.  
 
Animals were then incubated for longer, thus sinking to the bottom of the well 
by gravity without the need for sodium azide anaesthetization. They were again killed 
by freeze-thaw. Using this protocol DF was seen at all pH values (Figure 4.4).  
 
Figure 4.4: DF is generated at all pH values when animals are killed without sodium 
azide anaesthetization. Data is mean of three biological replicates, error bars are ± SD. 
 
These findings show that sodium azide blocks DF generation , except at low 
pH. Sodium azide inhibits  complex IV in the mitochondrial electron transport chain 
(Biswas et al., 1997). Thus, sodium azide inhibits respiration and ATP generation.  
Taken together these results imply two things. Firstly, that the generation of 
DF is an energetically costly process, which could imply that its formation is 
enzymatic. However, even when respiration was inhibited, DF was still generated if 
animals were incubated in low pH solutions. This result suggests that the process 
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leading to DF formation involves acidosis, and that generation of acidosis requires 
energy.  
An alternative possibility is that the DF fluorophore is brighter at low PH. To 
test this we asked whether altering the pH of a solution after DF generation affected 
its intensity. Aliquots of pH 3 or 11 were added to killed animals in M9 solution, and 
the change in fluorescence measured by plate reader. Both lowered fluorescence by 
similar amounts, presumably by diluting the solution, (Figure 4.5). Thus, acidity is 
required in order to generate DF.  
 
 
 
 
 
 
 
 
 
Figure 4.5: Addition of CH3COOH (pH 3) or NaOH (pH 11) to an M9 solution containing DF-
generating dead animals lowered fluorescence by similar amounts, indicating a dilution effect.  
 
Thus our data implies that the development of DF is an energetically costly 
process which requires acidosis: i.e. an active process occurring during organismal 
death. The calpain-cathepsin hypothesis of necrosis, discussed above, is an enzymatic 
cascade which generates acidosis via lysosomal lysis and leads to cell death. We 
hypothesized that this conserved cascade, which has been shown to occur in C. 
elegans, may be involved in the generation of death fluorescence.  
 
4.2.2. Death fluorescence is reduced in necrosis mutants 
 To investigate whether the necrosis cascade is required for the generation of 
death fluorescence, we used mutants to test whether inhibition of components of the 
necrosis pathway (Figure 4.1) suppresses DF. 60 young adult animals were picked 
into a microtitre well containing M9 salt solution, and were anaethetized with 0.2 % 
levamisole (which does not suppress DF development). Their living fluorescence was 
measured in a plate reader at ex/em λ340/λ400-450nm. The animals were then killed by 
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freeze thaw, and their death fluorescence measured at the same wavelengths. The 
living fluorescence was then subtracted from the death fluorescence to get the final 
value. Each experiment had an N2 control, and strains were tested one at a time to 
minimize any stress caused by prolonged M9 immersion.  
 We first tested the effect of inhibiting Ca2+ release from endoplasmic 
reticulum (ER) stores. Mutations in the ryanodine and inositol-1,4,5-triphosphate 
receptors, and the ER Ca2+ binding protein calreticulin all suppress mec-4(d)-induced 
necrotic cell death in C. elegans, and the necrosis-dependent hypo-osmotic stress 
lethal (Osl) phenotype induced by srp-6 RNAi (Luke et al., 2007; Xu et al., 2001). 
Each mutation, unc-68(e540), itr-1(sa73) and crt-1(bz29), respectively, greatly and 
significantly reduced DF (Figure 4.6). 
                               
Figure 4.6: Inhibition of mechanisms of intracellular calcium influx reduces DF. Graphs 
show relative increase of fluorescence at death of 60 young adult animals of each strain, 
killed by freeze-thaw. Data of crt-1 and unc-68 are mean ± SD of three biological replicates, 
itr-1 is mean of four replicates, ***p < 0.001, student’s t-test.  
 
During cellular necrosis, increased intracellular Ca2+ concentration can 
activate calpains (Ca2+ dependent cysteine proteases). The calpain TRA-3 is required 
for neuronal necrotic cell death in C. elegans (Syntichaki et al., 2002), and we found 
that the tra-3(e1107) mutation reduced DF levels (Figure 4.7). 
 The necrosis cascade (Figure 4.1) requires lysosomal lysis for cytosolic 
acidification and release of aspartyl proteases (cathepsins). In C. elegans, the vacuolar 
proton-translocating ATPase (V-ATPase), which mediates lysosomal acidification, is 
required for neuronal death in larvae (Syntichaki et al., 2005). We therefore tested 
two V-ATPase mutants, vha-12(ok821) and unc-32(e189). Both mutations block mec-
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4(d)–induced neurodegeneration (Syntichaki et al., 2005), and both also reduced DF 
(Figure 4.7). 
                      
Figure 4.7: Inhibition of calpains and lysosomal acidification reduces DF. Graphs show 
relative increase of fluorescence at death of 60 young adult animals of each strain, killed by 
freeze-thaw. Data are mean ± SD of three biological replicates., ** p < 0.01, student’s t-test.  
 
Finally, we asked whether aspartyl proteases (cathepsins) promote DF. cad-
1(j1) mutant animals have 10-20% of wild type cathepsin D activity (Jacobson et al., 
1988), and cad-1 is required for mec-4(d)–induced neurodegeneration (Syntichaki and 
Tavernarakis, 2002). asp-4 encodes an aspartyl protease which is required for 
neuronal necrotic cell death (Syntichaki et al., 2005). Again, both cad-1(j1) and asp-
4(ok2693) greatly reduced DF (Figure 4.8). 
                                                     
                                      
Figure 4.8: Inhibition of cathepsins reduces DF. Graphs show relative increase of 
fluorescence at death of 60 young adult animals of each strain, killed by freeze-thaw. Data 
are mean ± SD of three biological replicates, * p < 0.05, student’s t-test.  
 
 These findings strongly suggest that the necrotic cascade promotes the 
formation of DF at death. We were interested to see whether DF could be generated 
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by necrosis alone, or if other mechanisms of cell death, such as apoptosis, also 
promoted its formation. ced-3, ced-4 and ced-9 are required for apoptosis in C. 
elegans (Ellis et al., 1991). To test whether apoptotic cell death machinery contributes 
to DF, we examined dying ced-3(n717), ced-4(n1162) and ced-9(n1950) mutants. 
ced-9 mutants showed no decrease in DF, ced-4 mutants only a slight decrease and 
ced-3 actually showed an increase in DF (Figure S4A) (Figure 4.9).  
                                       
Figure 4.9: Inhibition of apoptosis does not generally reduce DF. Graphs show 
relative increase of fluorescence at death of 60 young adult animals of each strain, killed by 
freeze-thaw. Data are mean ± SD of three biological replicates.  
 
In order to confirm that lowered DF is indeed a function of impaired necrosis 
and does not simply result from mutation, we tested a random selection of other 
mutants. Mutations in the genes ftn-1, mdl-1 and rol-6 (ferritin, the MAD-like 
transcription factor and a cuticular collagen, respectively) were tested, but showed 
wild-type levels of DF (Figure 4.10).  
 
Figure 4.10: Diverse non-necrosis associated mutations do not reduce DF (negative 
control). Graphs show relative increase of fluorescence at death of 60 young adult animals of 
each strain, killed by freeze-thaw. Data are mean ± SD of three biological replicates.  
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4.2.3. Death fluorescence propagation requires calcium signalling 
 As discussed above, necrosis is heavily dependent on calcium for initiation 
and for propagation (Wang et al., 2010; Yamashima and Oikawa, 2009). Given that 
death fluorescence results from necrosis, we were curious to see if the characteristic 
spread of death fluorescence is calcium-dependent.  
 
4.2.3.1. inx-16 mutants have aberrant DF patterns 
Gap junctions are channels that form between cells, allowing direct cell-to-cell 
contact and so diffusion of ions and molecules between cells (Bennett and Zukin, 
2004). The conserved protein family which make up gap junction components are 
known as “pannexins”, and the invertebrate proteins are known as “innexins” (Peters 
et al., 2007). In C. elegans, gap junctions exist between intestinal cells. inx-16 
encodes an intestinal innexin subunit; Figure 4.11 shows its GFP tagged intestinal 
expression pattern.  
 
Figure 4.11: Expression of a functional translational fusion protein INX-16:GFP. 
Note the distribution of GFP at cell-to-cell contacts within the intestine. Image reproduced 
from Peters et al 2007.  
 
          
Figure 4.12: inx-16(ok144) disrupts the calcium propagated defection wave. (A) shows a 
wild-type calcium defection wave, and (B) a failed calcium defecation wave in an inx-
16(ox144) mutant background. Images reproduced from Peters et al 2007. 
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In C. elegans, defecation is controlled by means of rhythmic Ca2+ propagation 
through the intestine (Figure 4.12 A). The mutation inx-16(eg144) was shown to 
disrupt this propagation, leading to a failed Ca2+ wave and constipation (Figure 4.12 
B).   
We were struck by the similarity of these waves of Ca2+ propagation to the 
systemic spread of death fluorescence. Neuronal death from ischemia had been shown 
to be inhibited when gap junctions are genetically or chemically inhibited (Wang et 
al., 2010; Wang et al., 2012). Consequently, if DF spread via Ca2+ propagation, we 
hypothesized that we might observe a curtailed DF wave in inx-16 mutants.  
We measured inx-16 mutants’ DF in the plate reader and found that the 
mutation dramatically reduced DF levels; mutants showed only ~10% of the DF in N2 
animals (Figure 4.13a). We then attempted to see if the wave of DF failed to 
propagate in these animals (this data obtained by my student, Graham Fischer). The 
different strains were blinded to protect against bias and then killed on an agar plate 
using a hot pick. The subsequent wave of DF was then monitored by microscopy. We 
found that inx-16 animals developed increased DF in their anterior intestine; however, 
it did not spread past that point nor did it increase in intensity (Figure 4.13b, Movies 3 
and 4).  
  
Figure 4.13: inx-16(ox144) mutants show decreased death fluorescence.  
(a) inx-16(ox144) mutants show reduced death fluorescence compared to N2. Data are mean 
± SD of three biological replicates, normalized to N2. (b) representative image of inx-16 and 
N2 animals at one and six minutes after placing a hot pick near the anterior intestine. inx-16 
mutants display reduced fluorescence which does not spread.  
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This finding was very exciting. Firstly, it confirmed that DF does indeed 
require Ca2+ propagation via gap junctions to spread. Secondly, it demonstrated that a 
mechanism, which had only previously been documented in ischemic neurons, 
facilitated the spread of necrosis through an organism. Given that DF occurs in all 
types of death studied, both age and injury induced, it suggests that a cascade of 
necrosis may contribute to organismal death in C. elegans.   
 
4.2.3.2. In vivo calcium measurements 
In order to verify that a wave of Ca2+ influx is required for the wave of DF 
seen as animals die, we collaborated with Keith Nehrke and Erik Allman from the 
University of Rochester. They had developed a microscopy set up which allowed 
intestinal calcium levels to be visualized in vivo and in real-time using individual, 
living, mobile animals (Miesenbock et al., 1998; Nehrke, 2003). All data referring to 
visualized calcium was obtained by Keith and Erik.  
Transgenic worms expressing the Ca2+-sensitive fluorescent reporter d3cpv 
within intestinal cells were killed by acute exposure to 0.5M tert-butylhydroperoxide 
(t-BOOH). This method of killing was employed to give the best time course 
resolution required for in vivo Ca2+ and pH imaging (see below). During death, 
changes in Ca2+ levels were determined through single excitation (λ435), dual emission 
(λ480/λ535) fluorescence ratio imaging. As the animals died, there was a marked 
increase in intestinal Ca2+ levels (Figure 4.14). Comparison of Ca2+ fluorescence 
levels in the anterior and posterior ends of the intestine show that the rise in Ca2+ 
originates in the anterior intestine and only occurs in the posterior intestine after a 
time lag (Figure 4.14, Movie 5). This is consistent with an anterior to posterior wave 
of Ca2+ influx during death, as observed in DF propagation. 
Next we asked if this rise in Ca2+ levels precedes or follows DF. Mosaic 
animals that express the construct within a subset of the intestinal cells allow for 
simultaneous visualization of DF and changing Ca2+ levels. Cells that express the 
Ca2+ indicator display a clear calcium signal that occurs due to fluorescence 
resonance energy transfer (FRET) between the donor and acceptor fluorophore.  
Adjacent cells lacking the indicator display an increase in the acceptor (λ530) 
emissions, which does not correspond to a decrease in the donor (λ470) emissions, and 
as such is not caused by FRET. Using wild-type animals as negative controls, they 
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confirmed that DF can be visualized at an ex/em of λ435/λ530, and concluded that 
fluorescence arising in adjacent, non-indicator containing cells must be DF. 
              
Figure 4.14:  Measurements of in vivo Ca2+ levels using the Pnhx-2::d3cpv Ca2+ reporter 
show a rise in Ca2+ levels in C. elegans at death. Ca2+was measured in anterior and 
posterior regions of interest (ROIs). An anterior to posterior wave of Ca2+increase is 
demonstrated as the lag in calcium appearance in the anterior ROI (black) compared to the 
posterior ROI (red). Data is mean of 27 individual animals, error bars ± SD.  
 
This fluorescence rise lagged behind the appearance of the Ca2+ peak, 
indicating that the wave of Ca2+ precedes that of death fluorescence (Figure 4.15). 
                                
Figure 4.15: Animals expressing the Pnhx-2::d3cpv Ca2+ reporter mosaically 
demonstrate that a rise in Ca2+levels precedes DF. Calcium trace taken from intestinal 
anterior; DF measured in adjacent, non-reporter expressing cells. Data shown is 
representative trace.  
 
Finally Ca2+ was measured in the inx-16(ox144) mutants as they died (Figure 
4.16).  As was observed for DF, there was an increase in Ca2+ levels in the anterior 
intestine that was not propagated to the posterior intestine. Thus, Ca2+ signalling is 
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required for, and precedes, the spread of DF. This implies that during death an 
anterior to posterior wave of Ca2+ influx drives a wave of necrosis that leads to death 
fluorescence, confirming our previous results.  
                               
Figure 4.16: The spread of both Ca2+ and DF is curtailed in an inx-16(ox144) mutant 
background. The d3cpv Ca2+reporter expressed in an inx-16 background confirms that 
calcium begins to rise in an anterior intestine ROI at death, but does not spread to the 
posterior intestine ROI, a pattern previously observed with DF. Data is mean of 12 individual 
animals, error bars ± SD. 
 
4.2.4. Death fluorescence occurs concurrently with low pH spread 
 The calpain-cathepsin model predicts that calpain-induced lysosomal lysis will 
lead to cytoplasmic acidosis and the release and activation of cathepsins. We therefore 
were interested to see if these features also accompanied DF.  
 
4.2.4.1. Acridine orange staining 
 If death fluorescence is generated by necrotic cell death, then it should be 
accompanied by lysosomal lysis. To test this, we stained worms with the 
lysosomotropic dye acridine orange (AO), which stains C. elegans LROs (Jacobson et 
al., 1988). AO can pass freely through plasma membranes in its unprotonated form. In 
acidic environments, it becomes protonated and fluoresces orange when excited with 
UV light. Once protonated AO can no longer pass through membranes and so is 
confined inside the organelle. We reasoned that if LROs lyse during DF generation, 
we should see altered AO distribution (this data obtained by Grahame Fischer).  
Wild-type worms stained with AO showed punctate orange fluorescence 
within intestinal cells, which co-localized with blue fluorescence (Figure 4.18), as 
previously observed (Clokey and Jacobson, 1986). Stained animals were then killed 
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with a hot platinum pick. This resulted in a loss of punctate AO staining, which 
coincided with DF (Figure 4.17, Movie 6). Once protonated, AO cannot leave a 
membrane-bound organelle, and so this result suggests that loss of lysosomal 
membrane integrity coincides with DF. The calpain-cathepsin cascade requires 
lysosomal lysis for the release of cathepsins and cytoplasmic acidosis: consequently, 
this result adds to the evidence that DF is generated by this necrotic cascade. 
However, insufficiently many animals were successfully stained to quantitatively 
measure this effect and so this data can only be treated as anecdotal. More data would 
be required in order to demonstrate the occurrence of lysosomal lysis at death.  
 
Figure 4.17: AO become diffuse at death. Initially, AO co-localizes with blue fluorescent 
LRO within the intestine in a living wild type young adult. However, AO staining becomes 
diffuse with death. As protonated (fluorescent) AO cannot cross membranes, this indicates 
that the lysosomal membranes become permeable as DF is generated. 
 
4.2.4.2. In vivo pH measurements 
According to our working model, cytosolic acidosis is part of the necrotic 
cascade leading to the generation of DF. We therefore asked whether a decrease in 
cytosolic pH (cytosolic acidosis) accompanies DF. For this, we used a pH-sensitive 
reporter, Pnhx-2::pHluorin (Miesenbock et al., 1998; Nehrke, 2003) which indicates 
intracellular intestinal pH in vivo. This work was again carried out by Keith Nehrke 
and Erik Allman. In live animals, the intestinal cytosol was at approximately pH 7.4 
(Figure 4.18). Upon killing, the pH dropped to 6.6 (Figure 4.18, Movie 7).  
We also examined the organismal dynamics of this death-associated cytosolic 
acidosis. Comparison of region of interests (ROIs) in the anterior and posterior 
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intestine revealed a lag in the appearance of low pH in the posterior intestine (Figure 
4.19). This supports the view that during death, intestinal cytosolic acidosis occurs in 
an anterior to posterior wave. This is the same propagation pattern observed in both 
calcium spread and DF. The findings that both lysosomal lysis and cytosolic acidosis 
occur in intestinal cells at death provide further evidence that death fluorescence is 
generated by the necrotic pathway. 
 
                             
Figure 4.18: Acidosis occurs as animals die. Measurement of pH in vivo using an intestinal 
Pnhx-2::pHluorin reporter during death shows a drop of pH from ~7.35 to ~6.6. pH was 
measured in an anterior intestine ROI and death was induced using t-BOOH exposure. Data 
mean of 18 individual animals, error bars ± SD. 
  
Figure 4.19: Death induced acidosis spreads in an anterior to posterior wave . 
Measurement of pH in vivo using an intestinal Pnhx-2::pHluorin reporter during death shows 
that pH drops from anterior to posterior during death. pH was measured in an anterior and 
posterior intestinal ROIs and death was induced using t-BOOH exposure. Data mean of 18 
individual animals, error bars ± SD. 
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4.2.5. Necrosis mutants are not long lived, but are stress resistant 
Our data strongly implies that death fluorescence requires the activity of the 
necrotic cell death pathway for generation at death. Inhibiting components of this 
pathway via mutation leads to a decrease in the levels of death fluorescence 
generated. It also implies the occurrence of a cascade of necrotic cell death. An 
interesting possibility is that this cascade actually contributes to organismal death. To 
test this, we asked whether inhibiting necrosis postponed death, leading to increased 
longevity. In collaboration with the Tavernarakis lab in Crete University, we 
measured the lifespans of multiple strains carrying necrosis mutations. All strains 
were backcrossed a minimum of three times to guard against genetic background 
effects. However, we found that most necrosis mutants had either wild-type longevity, 
or were short lived (Figure 4.20).  
 
 
Figure 4.20: Necrosis mutants have normal or shortened lifespans. Lifespans carried out 
at 20°C, on OP50 NGM seeded plates for mutants and HT115 IPTG seeded plates for RNAi-
mediated knockdown. Data is mean of  two to three biological replicates, with a minimum of 
100 worms per replicate per strain.  
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The sole exception is inx-16(ox144) which showed a 22% increase in mean lifespan. 
However, these mutants are very slow growing and have a starved appearance, 
suggesting that this strain may experience dietary restriction. Thus their increased 
longevity may be attributable to this, rather than reduced necrotic pathway activity.  
This result was initially puzzling to us, as we had expected to observe that a 
decrease in necrotic pathway activity would confer some degree of protection against 
death. However, aging causes death by a number of processes acting in parallel, likely 
including systemic necrosis (given that it destroys a major organ within C. elegans). 
Here there are potential parallels in human aging: estimations of the likely upper 
limits of human longevity have calculated that removal of a major age-related disease 
(e.g. cardiovascular disease, cancer) would cause only small increases in lifespan 
(Olshansky et al., 1990). This is because multiple pathologies act in parallel to 
increase age-related mortality. 
Next, we tested whether reduced necrotic pathway activity protected against 
stress induced death. Animals were killed using lethal thermal and osmotic stress, the 
latter assay being performed by Alexandre Benedetto. We found that necrosis mutants 
were significantly more resistant to death induced by theses stressors than wild type 
animals (Figure 4.21, Table 4.1). Furthermore, it was previously shown that necrosis 
mutants are resistant to death induced by bacterial pathogens than wild type (Wong et 
al., 2007). Taken together, these data provide clear evidence that necrosis does 
accelerate stress or injury induced organismal death in C. elegans.  
 
 Figure 4.21: Necrosis mutants are significantly more stress resistant than WT.  
Necrosis mutants are significantly more resistant to thermal (a) and osmotic (b) stress than 
N2. Data mean of three biological repeats, 40 animals per replicate; (b) error bars ± SD.  
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Table 4.1: Necrosis mutants are significantly more thermotolerant than N2, log-rank. 
 
4.3 Discussion 
 
3.3.1. DF requires the necrotic cascade for generation 
 Necrosis is increasingly acknowledged as a form of programmed cell death 
(Yamashima, 2012). The mechanisms of necrotic cell death are yet to be fully 
elucidated, but extensive work in model systems supports a testable theory in the 
calpain-cathepsin hypothesis (Yamashima and Oikawa, 2009). Originally discovered 
in mammalian ischemia models, the calpain-cathepsin cascade was discovered to be 
conserved in C. elegans neurodegeneration (Driscoll and Chalfie, 1991; Syntichaki et 
al., 2005; Syntichaki et al., 2002; Xu et al., 2001). More recently, it has been shown 
that these elements are required for organismal death in the srp-6-dependent Osl 
phenotype (Luke et al., 2007). We have now shown that a functional necrotic cascade 
is also required for the generation of death fluorescence. When aspects of this cascade 
are inhibited, death fluorescence is significantly reduced.  
Another hallmark of this cascade is lysosomal lysis, leading to cytosolic 
acidosis and the release of cathepsins. Using AO staining and in vivo pH 
measurement, we showed that lysosome lysis causes cytosolic acidosis concurrently 
with the appearance of DF. Finally, Ca2+ has been extensively documented to cause 
necrotic cell death in many different model systems. Using in vivo Ca2+ reporters and 
genetic manipulation of intestinal gap junctions, we demonstrated that DF requires 
Ca2+ propagation to spread in this its characteristic anterior-posterior wave (Figure 
3.23). Taking all of these results into account, we can conclude that death 
fluorescence requires the necrotic calpain-cathepsin cascade for generation.  
This result has several interesting implications. Firstly, it is the second 
example of necrosis being involved in whole organism death, as originally hinted at 
Strain Mean survival time 
(hours) 
% N2 mean  
survival  time  
p vs N2 
N2 (control) 7.7 - - 
glo-1 8.7 113% <0.0001 
inx-16 10.2 132.4% <0.0001 
cad-1 8.4 109% <0.001 
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by Luke and colleagues (2007). Secondly, DF allows us to visually examine the 
spatiotemporal dynamics of death in C. elegans. Finally, it adds to the growing body 
of evidence that necrosis can be considered as a programmed (or quasi programmed, 
see below) cascade of cell death. 
 
3.3.2. Systemic necrosis contributes to organismal death in C. elegans 
 As discussed above, necrosis has predominantly been studied in neuronal 
models. Whilst being an excellent model system, this means of study has the 
disadvantage of specificity: neuronal mechanisms may not be conserved in other 
tissues or across species. Notably, the calpain-cathepsin model has been shown to 
hold across different species in neuronal cell death. Results presented here imply that 
the means of initiation and propagation of necrotic cell death is conserved in a manner 
which contributes to organismal death.  
 Wang and colleagues demonstrated that the extent of ischemia-induced 
neuronal cell death could be ameliorated via genetic and biochemical inhibition of 
gap junctions (Wang et al., 2010; Wang et al., 2012). We have shown that genetic 
knockout of intestinal gap junction subunit INX-16 also inhibits the spread of DF. 
inx-16 animals were consistently most resistant to stress-induced death, strongly 
suggesting that inhibition of Ca2+ influx gives the best protection against necrosis, as 
would be predicted from multiple models of necrotic cell death.  
 These data also imply that systemic necrosis is a mechanism of organismal 
death in C. elegans. In humans, organismal death often occurs in a cascade of 
systemic failures resulting from an initial crisis, such as a stroke or heart failure. It 
was previously unknown whether equivalent death-inducing crises occur in C. 
elegans. The existence of DF makes it possible to visualize the spatio-temporal 
dynamics of death, thereby providing information about its initiation and propagation. 
DF typically originates in the int1 quartet of anterior intestinal cells. From 
here the wave of DF is propagated backwards down the intestine. Similarly, the 
increase in calcium level and drop in pH show an anterior to posterior pattern of 
change during death. This pattern implies that the int1 cells play a pivotal role in 
initiating organismal death. The reason for the special vulnerability of the int1 cells 
remains unclear. One possibility is that these cells are more susceptible to increased  
Ca2+ levels or a signal that increases Ca2+ levels. This is supported by the observations 
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that the Ca2+-mediated defecation cycle also appears to be initiated in the anterior 
intestine (Nehrke et al., 2008). 
Consequently, we can present a tentative model for the mechanism of 
organismal death in C. elegans. Cellular homeostasis supports membrane integrity, 
and as cellular homeostasis declines with age, membrane integrity also begins to fail, 
especially in the int1 cells. In particular, loss of lysosomal membrane integrity 
(perhaps driven by increased Ca2+ leakage) leads to proton leakage, cytosolic acidosis 
and, eventually, cellular necrosis. This then initiates an intercellular cascade of 
necrotic cell death, propagated by Ca2+ signalling, leading to organismal death. In this 
view, lysosomal membrane integrity represents the breaking point in the cell, and int1 
intestinal cells the breaking point in the organism. 
 
3.3.3. The evolution of cellular and systemic necrosis 
 As discussed in section 1.3, evolutionary theories seek to explain ageing as a 
negative product arising from other beneficial mechanisms. One theory suggests 
ageing results from a quasi-programme of hyper-function (Blagosklonny, 2007, 
2008). Another theory hypothesizes that ageing may arise as a result of antagonistic 
pleiotropy. Here genes which confer a youthful selective advantage will be selected 
for irrespective of any deleterious effects, such as ageing, experienced when older. It 
is possible that cellular necrosis may also have arisen as a non-adaptive product of 
antagonist pleiotropy, or a quasi-programme (Blagosklonny, 2007; Williams, 1957). 
By this view, elements of the necrosis pathway contribute to early life fitness, while 
cellular necrosis is an unselected, deleterious consequence of their action under lethal 
stress or as a result of aging.  
 The existence of the mechanism systemic necrosis, which brings about 
organismal death in C. elegans also raises the question of its evolutionary origin. 
Systemic necrosis could arise simply from uncontrolled cellular necrosis. 
Alternatively, given that death fluorescence is conserved in the related nematode 
species of C. briggsae and P. pacificus, it is possible that the existence of this 
systemic necrosis and generation of DF serves an evolutionary purpose. Systemic 
necrosis may also arise from pleiotropy or hyper-function, but it is possible that this 
organismal self destruct mechanism may also serve an evolutionary purpose. When 
food is limited, gravid hermaphrodites typically die with multiple embryos in their 
uterus, which hatch internally and consume their mother’s corpse (matricidal 
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endotoky or “bagging”). Potentially, this improves the mother’s fitness by increasing 
survival of her genetically identical offspring, and it has been suggested that this 
frequently occurs in the wild (McCulloch and Gems, 2003). Thus, systemic necrosis 
may have evolved to enhance fitness by aiding efficient transfer of nutrients from 
mother to offspring during endotoky.  
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5. BIOCHEMICAL IDENTIFICATION OF DEATH  
FLUORESCENCE AS ANTHRANILIC ACID DERIVATIVES 
 
5.1 Introduction to the kynurenine pathway 
 
5.1.1. The biochemical composition of death fluorescence 
As discussed in chapter 3, C. elegans intestinal LRO blue fluorescence 
increases with death, not with age. Moreover, we showed that, unlike mammalian 
lipofuscin, C. elegans blue fluorescence does not increase with increased oxidative 
damage. We thus concluded at the end of chapter 3 that C. elegans blue fluorescence 
was most probably not lipofuscin. Consequently, we were interested in trying to 
determine the biochemical composition of both gut granule and death fluorescence. 
Death fluorescence may well arise anew at death: however if both types of 
fluorescence are biochemically identical it would imply that death fluorescence is 
generated from gut granule fluorescence.  
 
5.1.2. Flu mutants  
 One clue to the nature of death fluorescence came from a series of papers 
published in the 1970s – 1980s describing Flu mutants (Babu, 1974; Bhat and Babu, 
1980; Siddiqui and Babu, 1980; Siddiqui and Von Ehrenstein, 1980). Flu mutants 
display altered colours of intestinal fluorescence (please see Table 5.1, details taken 
from Babu, 1974). The mutations have been provisionally mapped to different linkage 
groups but have not been cloned (Table 5.1). However enough work has been done on 
flu-1 and flu-2 to begin to unravel their functions. flu-1 mutants demonstrate 
significantly reduced kynurenine-3-hydroxylase activity; most alleles have ~5% of 
wild type enzyme activity (Siddiqui and Babu, 1980).  Kynurenine-3-hydroxylase 
catalyzes the conversion of kynurenine into 3-hydroxy kynurenine (Babu, 1974). 
FLU-2 also uses kynurenine as a substrate: flu-2 mutants have less than 7% of the 
activity of wild type kynureninase (Bhat and Babu, 1980). Kynureninase catalyzes the 
conversion of kynurenine to anthranilic acid (Babu, 1974). Both genes have been 
identified through altered enzymatic activity rather than structural identification; the 
identification of both hinged on failure to metabolize their respective substrates in situ 
(Bhat and Babu, 1980; Siddiqui and Babu, 1980). However, the best BLAST homolog 
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matches for both genes lie on the same linkage groups that they have been 
provisionally mapped to. 
 
Gene Tentative gene 
identification 
Putative gene 
product 
Intestinal 
fluorescence colour 
Provisional 
linkage group 
mapping 
flu-1 R07B7.5 Kynurenine 
hydroxylase 
 
Blue-purple 5 
flu-2 C15H9.7 Kynureninease 
 
Dull green X 
flu-3 ? ? 
 
Purple 2 
flu-4 ? ? 
 
Bright blue X 
flu-1; 
flu-2 
- - Green-blue - 
Table 5.1: Summary of known or proposed genotypes and phenotypes of Flu mutants. 
 
 The best BLAST match for mammalian kynurenine hydroxylase (R07B7.5) 
sits on chromosome 5, and the best BLAST match for mammalian kynureninase 
(C15H9.7) sits on the X chromosome (Altschul et al., 1990; Kanehisa, 2012). Taken 
with these probable homologs, and the fact that flu-1; flu-2 double mutant contains 
much higher levels of kynurenine than either of the individual mutants (Babu, 1974), 
the identification of these genes as enzymes within the kynurenine pathway seems 
likely to be correct.  
 
 5.1.3. The kynurenine pathway 
 
5.1.3.1. Tryptophan is catabolized by the kynurenine pathway 
Tryptophan, the rarest essential amino acid, has two forms (Rongvaux et al., 
2003). L-tryptophan is the most common and found in all proteins, whilst D-
tryptophan is found in secreted peptides (Chung and Gadupudi, 2011). The structure 
of L-tryptophan is shown in Figure 5.1. There are three pathways that catabolize L-
tryptophan (L-Trp): the 5-hydroxytryptamine (serotonin), indole and kynurenine 
pathways. L-Trp catabolism is required for the generation of multiple important 
compounds, including the ubiquitous enzyme co-factor nicotine adenine dinucleotide 
(NAD), the neurotransmitter serotonin and the vitamin niacin (Stone et al., 2012).  
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The mammalian kynurenine pathway, shown in Figure 5.2, catabolizes ~90% of L-
Trp. In mammals, L-Trp catabolism by the kynurenine pathway is controlled by two 
rate limiting enzymes, tryptophan dioxygenase (TDO) and indoleamine-2,3 
dioxygenase (IDO) (Chung and Gadupudi, 2011). Of these, IDO is ubiquitously 
expressed except for the liver, where only TDO is found. TDO is also found at low 
concentrations in the central nervous system (Chung and Gadupudi, 2011).  
 
Figure 5.1: The structure of L-tryptophan.  
 
Both IDO and TDO catalyze the same reactions, but TDO is highly substrate 
specific for L-Trp whereas IDO can also catalyze D-tryptophan (Chung and 
Gadupudi, 2011). Perhaps because of this, in mammals the primary site of L-Trp 
catabolism is the liver, catalyzed by TDO. TDO was discovered in 1951 to be induced 
by tryptophan ingestion: the first example of an inducible enzyme in mammals (Li et 
al., 2007; Rongvaux et al., 2003). By contrast, IDO synthesis responds not to L-Trp 
levels but instead to inflammatory stimuli, including bacterial and viral products 
(Rongvaux et al., 2003). Moreover, TDO activity decreases following IDO induction, 
suggesting a co-ordinated shift from L-Trp catabolism to non-hepatic tissues as an 
immune response (Rongvaux et al., 2003).  
 For many years after the discovery that the kynurenine pathway generated 
NAD, little attention was paid to the biological functions of kynurenine pathway 
intermediates (“kynurenines”). However recent investigations have shown that many 
kynurenines are both biologically active and significant, and seem to play important 
roles in both neurodegeneration and immunity.  
 
5.1.3.2. Biological function of the kynurenine pathway  
The first kynurenine discovered to have a major biological function was 
quinolinic acid (QA). QA was found to be a potent, direct stimulator of NMDA 
receptors (Stone and Perkins, 1981).  
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Figure 5.2: The kynurenine pathway. Conversion steps are labelled a-j, as follows:  
(a) indoleamine2,3-dioxygenase, EC 1.13.11.17  
(b) tryptophan2,3-dioxygenase, EC 1.13.11.11  
(c) kynurenine formamidase, EC 3.5.1.9 
(d) kynurenine aminotransferase (2- oxoglutarate aminotransferase), EC 2.6.1.7 
(e) kynurenine 3-hydroxylase, EC 1.14.13.9 
(f) kynureninase, EC 3.7.1.3  
(g) 3-hydroxyanthranilate 3,4-dioxygenase (3-hydroxyanthranilic acid oxidase),EC 1.13.11.6  
(h) picolinic carboxylase,EC4.1.1.45  
(i) non-enzymic cyclization   
(j) quinolinic acid phosphoribosyltransferase, EC 2.4.2.19. 
Figure reproduced from Heyes et al., 1997. 
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Intra-cerebral injection of QA caused seizures in mice (Lapin, 1978), and 
subsequent research has shown that NMDA receptor activation is required for all 
neurobiological effects of QA (Schwarcz et al., 2012). Interestingly it was then 
discovered that kynurenic acid (KA) is a competitive antagonist of all excitatory 
amino acid receptors (Perkins and Stone, 1982; Schwarcz et al., 2012). Upon this 
discovery, Perkins and Stone suggested that the combination of endogenous agonist 
and antagonist arising from the same pathway implicated that pathway in control over 
neuronal control and modulation (1982).  
Recent work is beginning to support this suggestion as multiple kynurenines 
are discovered to play roles in neurodegeneration. The best studied disease in which 
kynurenines has been shown to play an important role is Huntington’s disease. 
Huntington’s disease is a neurodegenerative disorder clinically characterized by 
personality alterations, movement disorders and eventual dementia (Zheng et al., 
2012). It arises from a mutation in the huntington gene which causes increased 
numbers of  CAG repeats, encoding a polyglutamine sequence at the N-terminus of 
the huntingtin protein. The severity of the disease increases in a dose dependent 
manner with the number of CAG repeats (Walker, 2007). In 1976 it was discovered 
that when rats’ straitum were injected with the potent NMDA agonist kianic acid, the 
rats exhibited many of the same phenotypic traits as Huntington’s patients (Coyle and 
Schwarcz, 1976). Huntington’s disease was consequently established to be a disease 
of excitotoxic neuronal cell death (please see section 4.1.2. for discussion on 
excitotoxicity).  
Further research has demonstrated that striatal injections of QA gives a 
Huntington’s phenotype in many different species, characterized by specific cellular 
and neurochemical changes (Stone et al., 2012). These experimental data are reflected 
in endogenous changes found in post mortem brains of Huntington’s patients: QA 
levels are substantially increased, and KA are reduced (Schwarcz et al., 2012). In the 
R6/2 mouse model of Huntington’s, QA and its precursor 3-hydroxykynurenine (3-
HK) was found at high levels (Guidetti et al., 2006). It was then shown that there was 
a substantial increase in the activity of the enzyme kynurenine 3-monooxygenase 
(KMO), which synthesizes 3-HK from kynurenine (Sathyasaikumar et al., 2010). 
These data confirm that the changes seen in Huntington’s models arise from 
dysregulation of the kynurenine pathway. 
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Interesting data from Drosophilia further demonstrates this. Drosophila lack 
QA but otherwise have an intact kynurenine pathway. Campesan and colleagues 
showed that increasing the levels of KA relative to 3-HK levels through genetic and 
pharmacological manipulation ameliorated neurodegeneration in a fly model of 
Huntington’s (Campesan et al., 2011). They also demonstrated that inhibition of 
TDO, the rate limiting enzyme in the kynurenine pathway, shifted the ratio towards 
production of KA, also leading to increased neuroprotection in the model. Strikingly, 
they found that these interventions did not have any effects in non-Huntington’s 
controls, suggesting that the Huntington’s model is especially vulnerable to 
kynurenine pathway dysregulation (Campesan et al., 2011).          
Kynurenine dysregulation has also been implicated in neurodegeneration 
caused by acute neurological insults, such as stroke (Stone et al., 2012). As discussed 
in Chapter 4, neurones can die by excitotoxic cell death in response to ischemia and 
other insults. There is much data showing that high levels of glutamate are produced 
and released to induce excitotoxic death. However, the discovery that glutamate 
antagonists do not entirely ameliorate neurodegeneration in animal models and 
humans implies that other factors are also important. It has subsequently been shown 
that QA levels increase following ischemia, and that the levels of QA correlate with 
increased neurodegeneration (Saito et al., 1993a). Strikingly these changes in 
response to ischemia were shown to be associated with increased activity of 
kynurenine pathway enzymes within the brain, as well as with upregulated IDO 
activity (Saito et al., 1993b). Upregulation of IDO accompanied an immune response, 
with macrophages invading the ischemic tissue and the release of inflammatory 
cytokines. Thus, the kynurenine pathway appears to contribute to post-injury 
neurodegeneration through both active stimulation of excitotoxicity and through a 
damaging inflammatory response (Stone et al., 2012). Subsequent to this discovery, 
other examples of the kynurenine pathway have roles in immunity have come to light.  
 In 1998, it was demonstrated that IDO function was required to prevent 
maternal rejection of the allogenic foetal placenta in mice. When IDO function was 
inhibited, potent T cell stimulation and proliferation was observed (Munn et al., 
1998). The mechanism by which kynurenine pathway activation and immunity 
interact is still unclear. One possibility is that activation of IDO deprives the local 
cellular environment of the rarest, and thus most important, amino acid L-Trp, thus 
inhibiting growth of invading viruses, bacteria and other pathogens (Grohmann et al., 
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2003). However other work has demonstrated that kynurenines themselves have a 
role: for example, 3-HA and QA have been shown to induce apoptosis specifically in 
activated T-cells in mice (Fallarino et al., 2002; Piscianz et al., 2011).  
 Thus the kynurenines themselves have important roles within neurotoxicity 
and immunity: it is clear that the pathway does not exist simply to generate NAD. 
Recent work in model organisms has begun to examine the role of kynurenines in 
ageing. Age-related changes in kynurenine metabolism have been observed in rats 
(Braidy et al., 2011), and genetic and pharmacological inhibition of TDO has shown 
to extend longevity in Drosophilia (Oxenkrug, 2010; Oxenkrug et al., 2011). 
However, aside from the discovery of Flu mutants, very little work has been carried 
out in C. elegans on the kynurenine pathway. Based on Flu mutations and BLAST 
sequencing, the kynurenine pathway appears to be well-conserved between mammals 
and C. elegans (Babu, 1974). The NCBI has constructed a putative C. elegans 
kynurenine pathway based on sequence homology; however this has not been 
biologically verified (Kanehisa, 2012). Consequently very little is empirically known 
about the kynurenine pathway structure and function in C. elegans and so it presents 
an intriguing subject for investigation.   
 
5.2 Results 
 
5.2.1. glo-1 animals do not show blue fluorescence or death fluorescence 
 As discussed in section 3.1.2., C. elegans Glo mutants do not contain 
lysosome related organelles (LROs) (Fig 3.2) (Hermann et al., 2005). The easiest way 
of determining the biochemical nature of gut granule and death fluorescence would be 
to compare the metabolites of a mutant lacking both with wild type. We therefore 
investigated both living and death fluorescence in age-related changes in glo-1(zu437) 
animals.  
The glo-1(zu437) allele contains a Trp106 to stop mutation in the Rab GTPase 
required for lysosomal biogenesis, and results in 100% of embryos and adults 
possessing a Glo phenotype (Hermann et al., 2005). Intestinal fluorescence in 
individual glo-1 animals was followed over age as previously described (see section 
3.2.2). DF in glo-1 cohorts were measured via plate reader as described in Section 
2.1.6.  
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We found that glo-1 animals did not accumulate any blue fluorescence over 
the course of their lives (Figure 5.3A). We also found that glo-1 animals did not show 
death fluorescence, either when they died of age or when young animals were killed 
(Figure 5.3B). These data confirm that glo-1(zu437) animals do not show any 
intestinal fluorescence, either increasing with age or rising at death. This finding has 
three implications. Firstly, it adds to the body of evidence against equating C. elegans 
intestinal fluorescence with lipofuscin: given that lipofuscin accumulates by oxidative 
damage, it would be expected that some increases or change would be seen over life, 
even if the fluorescence was mislocalized. Secondly, the discovery that glo-1(zu437) 
mutants show neither living nor death fluorescence strongly implies that both types of 
fluorescence have a common origin. Finally, these data confirm that  glo-1(zu437) 
animals can serve as a negative control for chemical identification of the blue 
fluorescence.  
 
Figure 5.3: glo-1(zu437) animals do not show any increases in fluorescence. (A) 
Animals were monitored daily for fluorescence, as described in Section 2.2; here 29 animals 
were followed. (B) Animals were killed by heat, as described in Section 2.1.6, data is mean of 
3 biological replicates. All error bars ± SD, Student’s t test. Negative fluorescence arises from 
background subtraction.  
 
5.2.2. Extraction of C. elegans blue fluorescence 
 The first step in trying to biochemically analyze the blue fluorescent substance 
was to isolate it in a sample. To this end, an aqueous extraction protocol was 
developed based on protocol details in Davis et al (1982). For full protocol see 
Section 2.4.1.2. Briefly, large number of animals were washed off plates using 
distilled water, lysed by sonication, and the resulting homogenate was centrifuged to 
obtain a pellet and a supernatant. The resulting pellet and supernatant were then 
analyzed. The sample supernatant was aspirated off, and the pellet was re-suspended 
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in distilled water. The re-suspended pellet and supernatant were measured for death 
fluorescence  (λex/λem 340/430nm) in a plate reader, along with a water control. The 
supernatant was found to contain significantly more fluorescence (Figure 5.4A).  
 
Figure 5.4: Blue fluorescence is unlikely to be proteinaceous. (A) Fluorescence can be 
isolated to the supernatant of a homogenate and remains even after removal of protein (B). 
Data is mean of three (A) or two (B) biological replicates, error bars ± SD. 
 
Once the fluorescence had been isolated to the sample supernatant, cold 
ethanol was added in a 1:9 ratio to precipitate out protein from the sample. The 
sample was incubated overnight, centrifuged down again and the supernatant re-
measured for fluorescence (Figure 5.4B). Given that the fluorescence isolated initially 
to the supernatant and remained after protein had been precipitated out of the sample, 
this data implied that the fluorescent substance was non-proteinaceous.  
  
5.2.3. DF can be isolated via HPLC and is not protein 
 In order to try and biochemically identify the nature of blue fluorescence, we 
used high performance liquid chromatography (HPLC). HPLC is used to isolate 
substances from a homogenous compound; please see section 2.4.1. for more details. 
Using the protein-purified supernatant described above (5.2.2), we attempted to 
devise an HPLC protocol to extract and separate blue fluorescence peaks. After some 
trial and error, a protocol was devised which gave clearly separated compound peaks 
with blue fluorescence spectral characteristics (λex/λem 340/430nm) (see Section 
2.4.1).  
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Figure 5.5: HPLC chromatograms showing differentially expressed metabolites (indicated by 
arrows) in N2 and glo-1 backgrounds. 
 
This protocol shows five clear peaks, implying five distinct compounds, in a 
wild-type background which were not visible in a glo-1(zu437) background (Figure 
5.5). Of the five peaks, two are much greater, with one peak at ~4 minutes’ elution 
being particularly high (Figure 5.5). These findings confirm that glo-1(zu437) animals 
are biochemically distinct from wild-type, and lack several blue fluorescent 
compounds.  
We also examined the UV absorbance of these compounds. The peptide bonds 
present in proteins absorb UV light of different wavelengths depending on the forces 
of interaction within the protein (Goldfarb et al., 1951). Consequently, it is possible to 
identify different protein structures by measuring their UV absorbance. We measured 
the UV absorbance at 215, 254 and 280nm. However, we found no UV absorbance in 
the eluted mobile phase at the time which corresponded with the appearance of the 
differentially expressed fluorescent peaks (Figure 5.6). This, taken with the finding 
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that protein precipitation did not abrogate fluorescence, as discussed above, strongly 
suggested that the blue fluorescent substance was not comprised of protein.  
 
Figure 5.6: No UV absorption at 215, 254 or 280nm was detected at the time of the 
differentially eluted peaks.  
 
5.2.4. NMR and DANS identification of DF as anthranilic acid derivatives 
 Once we had determined that glo-1(zu437) was biochemically distinct 
from N2, we used these samples as a negative control for NMR and DANS 
(Differential Analysis of 2D NMR Spectra). This work was carried out in coloration 
with Parag Mahanti and Frank Schroeder, in Cornell University. DANS is used isolate 
unique signals from different metabolomes by graphically comparing their 2D NMR 
spectra; for further details please see section 2.4.2. Again we used the protein-purified 
supernatant samples derived from N2 and glo-1 animals, as described above. When 
the 2D NMR spectra were analyzed, there were multiple differentially expressed 
signals between the two metabolomes. Detailed analysis of the fine structures of the 
differential signals indicated that the compounds absent in glo-1 mutants include three 
anthranilic acid moieties, an N-substituted indole, as well as four β-glucosyl units 
(Figure 5.7). The chemical shift values of the protons in the four β-glucosyl moieties 
suggested that two of these are attached to anthranilic acid moieties forming two 
glucosyl esters, whereas the two remaining glucose units appeared to be part of N-
glucosyl indoles.  Furthermore, a characteristic downfield shift and additional J-
splitting of the protons in position 3 of two of the four glucose moieties indicated that 
anthranilic acid glucosyl ester (angl#1) and N-glucosyl indole (iglu#1) were both 
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accompanied by the corresponding 3'-phosphorylated compounds (angl#2 and iglu#2) 
(Figure 5.8).       
N2 sample 
                        
glo-1(zu437) 
                        
Figure 5.7: DANS analysis shows differentially expressed metabolites between N2 and 
glo-1 backgrounds. The figure is comprised of graphically overlaying multiple 2D NMR 
spectra. Signals highlighted in blue boxes are those which contribute significantly to blue 
fluorescence signal; signals in black boxes are significantly differentially expressed 
metabolites which do not contribute to fluorescence.  
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Figure 5.8: Blue fluorescence is comprised of glycosylated anthranillic acid derivates.  
Differentially expressed metabolites between glo-1 and N2 backgrounds are derivatives of 
anthranilic acid. angl1 and angl2 form blue fluorescence. 
 
These structural assignments were confirmed via high-resolution mass 
spectrometry and synthesis of authentic samples of anthranilic acid glucosyl ester and 
N-glucosylindole (Please see Appendices 2 - 4). In addition, wild-type but not glo-1 
extracts contained smaller quantities of free anthranilic acid. 
Anthranilic acid (AA) is derived from L-tryptophan (Trp) via the kynurenine 
pathway and its presence has previously been noted in C. elegans (Figure 3G) (Babu, 
1974; Rongvaux et al., 2003); however neither angl#1 nor angl#2 have previously 
been identified in animals. AA derivatives show characteristic fluorescence at λex/λem 
340/430 nm (Nakken, 1963), and their absence from glo-1 extracts strongly suggests 
that these compounds are responsible for the blue fluorescence observed in the wild 
type. Furthermore, the HPLC retention times of the identified AA derivatives match 
those of the fluorescent peaks detected in the initial HPLC analysis of the wild-type 
extract (Figure 5.5 and Appendix 4). The two indole glucosides iglu#1 and iglu#2, 
also previously unreported from animals, do not contribute to the blue fluorescence. 
 
5.2.5. DF arises from tryptophan 
 The absence of angl#1, angl#2, iglu#1, and iglu#2 in glo-1 extracts indicates 
altered Trp metabolism in this mutant, which, strikingly, appears to affect both the 
tryptophanase and kynurenine pathways (Figure 5.9).  
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Figure 5.9: glo-1 metabolites are differentially expressed. glo-1 differentially expresses 
metabolites via both the tryptophanase and kynurenine pathway. 
 
Differences in Trp metabolism between glo-1 and N2 worms were also 
revealed by fluorescence spectroscopy, carried out in collaboration with Filip 
Matthijssens and Bart Braeckman in the University of Ghent. Live animals of both 
genotypes showed a fluorescence peak at λex/λem 290/~340nm (Figure 5.10), which 
has been previously observed, and is believed to correspond to Trp (Davis et al., 
1982). After killing, a large peak at λex/λem 340/430nm, corresponding to DF, 
appeared in N2 but not glo-1 animals (Figure 5.10). Notably, in N2 there was a 
marked reduction (~35%) in the size of the Trp peak, compared to a reduction of only 
~20% in glo-1. These data are consistent with conversion of Trp to AA derivatives 
during death. 
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Figure 5.10: L-Trp is converted to DF in an N2 background, but not in a glo-1  
background. At death there is a 35% loss of L-Trp in N2, compared to a 20% loss in glo-1.  
 
5.2.6. TDO RNAi abrogates DF and LRO fluorescence 
As discussed in the introduction, the anthranilic acid generating kynurenine 
pathway catabolizes L-Tryptophan (L-Trp) via the two rate limiting enzymes TDO 
and IDO. We therefore sought to genetically confirm that DF is generated by AA. The 
C. elegans gene C28H8.11 encodes a putative TDO: the C. elegans homolog of IDO 
is unknown or not present (Rongvaux et al., 2003). We obtained an RNAi feeding 
clone of C28H8.11 from the Ahringer library (see Section 2.3), this work was done by 
Abbie Mandel. Reduction of expression of C28H8.11 by RNAi suppressed both living 
gut granule blue fluorescence and death fluorescence (Figure 5.11). The finding that 
TDO RNAi abrogates both gut granule and death fluorescence is striking as it implies 
that both types of fluorescence arise from the same pathway and are the same 
substance. 
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Figure 5.11: RNAi of TDO abrogates both gut granule fluorescence and DF in N2 
animals. (a) Both gut granule and death fluorescence are reduced by TDO RNAi. Both types 
of fluorescence were measured using a plate reader; DF generated by freeze-thaw killing. 
Data is mean of three biological replicates, error bars are ± SD. (b) Representative images of 
TDO RNAi knockdown of DF.  
 
5.2.7. TDO RNAi extends longevity but Flu mutants are not long lived 
Once we had positively confirmed the identity of the blue fluorescent 
substance as AA derivates, we were interested in seeing what, if any, biological 
function they had. Work in Drosphila showed that genetic and biochemical inhibition 
of their TDO homolog extended lifespan (Oxenkrug, 2010; Oxenkrug et al., 2011). 
Consequently we wondered if manipulating the kynurenine pathway altered lifespan 
in C. elegans.  
 Lifespan was measured in TDO RNAi animals by Abbie Mandel, as 
described in Materials and Methods (lifespan assay, section 2.1.3., RNAi, section 
2.3.1). TDO RNAi caused a 12% increase in lifespan relative to the L4440 control 
(Figure 5.12, Table 5.2). 
We also measured the lifespan of two Flu mutants, flu-1(e1002) and flu-2(e1003). 
These mutations have been shown to decrease the activity of kynurenine-3-
hydroxylase and kynurenine respectively (Babu, 1974). Both of these enzymes lie 
downstream of TDO in the kynurenine pathway (Figure 5.2). However, unlike TDO 
RNAi, both flu-1 and flu-2 mutants were significantly short lived, with only 58.7% 
and 67.2% of wild type lifespan respectively (Figure 5.12, Table 5.3).  
However, it is unknown if either Flu strain is backcrossed. Flu mutants were 
generated by exposure to the mutagenic compound ethylmethane sulfonate (EMS), 
selecting for progeny with altered intestinal fluorescence (Babu, 1974). Thus this 
mutagenesis may have induced secondary or background mutations elsewhere in the 
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genome which may affect lifespan (Partridge and Gems, 2007). To avoid these 
unwanted background effects, it is standard procedure to extensively backcross 
mutant progeny to a wildtype background. Babu does not state whether these strains 
were backcrossed, nor is there any record of them being so (Babu, 1974). Thus it is 
possible that Flu mutants’ reduced longevity can be attributed to a background 
mutation.   
 
 
Figure 5.12 Inhibition of kynurenine pathway components affects longevity. (a) flu-1 
and flu-2 mutants have significantly reduced lifespans compared to N2. Data mean of two 
repeats. (b) TDO RNAi significantly extends lifespan compared to empty vector control. Data 
mean of three repeats. All assays were carried out at 20°C, with 10µM FUDR applied 
topically, n = 100 animal per strain in each trial. 
 
Strain Mean lifespan (days) % of N2 mean lifespan p vs N2 
N2 (control) 18.5 - - 
TDO RNAi 23.0 124 <0.0001 
 
Table 5.2: TDO RNAi significantly extends lifespans compared to L4440 control, long-
rank test.  
 
Strain Mean lifespan (days) % of N2 mean lifespan p vs N2 
N2 (control) 18.5 - - 
flu-1 10.9 59 <0.0001 
flu-2 12.4 67 <0.0001 
 
Table 5.3: Flu mutants have significantly shortened lifespans compared to wild-type, 
log-rank test.  
These data imply that alteration in kynurenine pathway activity can affect 
lifespan, depending on which pathway component is inhibited. RNAi-mediated TDO 
knockdown probably decreases whole pathway activity whereas flu-1 and flu-2 
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mutations most likely alter the ratio of kynurenine metabolites generated. Thus TDO 
knockdown may reduce the production of other potentially toxic kynurenine 
metabolites, such as quinolinic acid, leading to increased longevity. By contrast, if an 
excess of any one metabolites is generated, as would be expected in the Flu mutants 
(Siddiqui and Babu, 1980), this could have potentially toxic and lifespan shortening 
effects. These data also rather argues against the idea that DF accelerates death. If it 
did, then flu-2 mutants, which are predicted to generate lower levels of AA via 
kynurenine inhibition (and consequently have green intestinal fluorescence) should be 
long lived too. As they are not, generation of AA derivatives specifically most 
probably correlate with death, rather than cause it.  
 
5.2.7. Kynurenine pathway mutants confer stress resistance 
 Given that necrosis mutants do not show extended lifespan but are stress 
resistant, we wondered whether or not kynurenine pathway mutants might show the 
same property. As discussed in Section 4.2.5, death from ageing is most likely 
determined by many pathologies acting in parallel, and consequently suppressing a 
single cause may not markedly increase lifespan (Olshansky et al., 1990). We 
therefore exposed Flu mutants and wildtype animals on TDO RNAi to heat stress 
(35°C) in order to test for thermotolerance. 
  
Figure 5.13: Preliminary data shows that inhibiting kynurenine pathway activity 
increases thermal stress resitance relative to WT. Flu mutants and N2 on TDO RNAi are 
significantly more resistant to thermal stress than N2. Data from one biological repeat, n = 40 
animals. Please note that flu-1 and flu-2 share almost identical survival curves and so it is 
difficult to distinguish them on this figure.    
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Table 5.4: Kynurenine pathway inhibition increases more thermal stress resistance.  
 
Inhibiting the kynurenine pathway through mutation and RNAi strongly and 
significantly extended thermotolerance (Table 5.4). However, it is important to note 
that this data is preliminary as only one biological replicate has been done. Moreover, 
only N2 was used as a control; an appropriate control for TDO RNAi would be an N2 
animals grown on empty vector L4440 containing HT115 bacteria.  
Assuming this data is replicable, given Flu mutants’ reduction of lifespan this 
data might suggest that thermotolerance resulting from TDO RNAi is not the cause of 
life extension. Alternatively, flu-1 and flu-2 mutants may be more pleiotropic, other 
traits shortening lifespan. There is a growing body of data which shows that 
kynurenines have been shown to stimulate necrotic mammalian neuronal death 
(Schwarcz et al., 2012). Given that we have now shown that a mechanism similar to 
this occurs during C. elegans organismal death, it is possible that kynurenine pathway 
mutations protect against this type of cell death by reducing the formation of necrosis-
stimulating metabolites. Another possibility is suggested by the fact that both AA and 
other kynurenine pathway metabolites are highly redox active (Schwarcz et al., 2012). 
Again, lowering the concentration of these metabolites may be insufficient to extend 
lifespan but may protect oxidative damage leading to cell death. It is possible that 
TDO RNAi  increases the L-Trp:kynurenine ratio thus reducing the levels of damage 
redox active metabolites. However, this data needs to be replicated, and further work 
will be required to fully test these hypotheses.   
 
Discussion 
 
5.3.1 Biochemical identification of blue fluorescence as anthranilic acid 
derivatives 
 Through the use of the mutant glo-1, HPLC and NMR, we biochemically 
identified DF as the glycosylated anthranilic acid derivatives angl#1 and angl#2. We 
confirmed this identification by genetically manipulating AA generation through 
Strain Mean survival time 
(hours) 
% N2 mean  
survival  time  
p vs N2 
N2 (control) 7.1   
flu-1 8.6 121 <0.0001 
flu-2 8.9 125 <0.0001 
TDO 9.7 136 <0.0001 
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TDO (C28H8.11) RNAi. C28H8.11 RNAi led to loss of both gut granule and death 
fluorescence, presumably due to inhibition of kynurenine pathway. These results are 
valuable for several reasons. Firstly, we have clearly demonstrated the biochemical 
source of gut granule and death fluorescence, and thus shown it not to be lipofuscin. 
Secondly, we have shown that the kynurenine pathway is, at least partially, 
functionally conserved in C. elegans. Finally, as we have shown that both gut granule 
and death fluorescence is generated by this AA pathway. These findings provoke 
many interesting new questions about the biological function of the kynurenine 
pathway in C. elegans. 
 
5.3.2. How is DF generated at death? 
Both gut granule and death fluorescence issue from AA derivatives. An 
unanswered question is how the fluorescent burst arises at death. There are several 
possibilities. The enzymes of the kynurenine pathway are required for AA generation. 
Consequently the change in intensity and distribution of blue fluorescence at death 
may arise from a change in enzyme distribution. If the enzymes are localized to the 
gut granules then presumably they would act upon L-Trp freed by proteolytic 
enzymes within the gut granules. We have shown that necrosis leads to lysosomal 
lysis during C. elegans organismal death (section 4.2.4). Lysosomal lysis causes 
acidosis and releases the lysosomal contents into the cystol, including low-pH 
activated non-specific proteases. These proteases may degrade cytosolic proteins, 
releasing large amounts of free L-Trp as substrate for the newly released kynurenine 
pathway enzymes. Consequently, DF could arise from high concentrations of 
cytosolic free L-Trp being converted to AA derivatives within the cytosol, thus 
explaining both the increase in fluorescence (greater substrate concentration) and the 
alteration in distribution at death.  
 Alternatively in a slightly different scenario, low-pH dependent kynurenine 
enzymes could be ubiquitously distributed throughout the cell. Only active in low pH 
gut granules, AA derivative generation would be localized to gut granules until 
lysosomal lysis and cytosolic acidosis. At this point, activated kynurenine enzymes 
would again generate DF as outlined above. Neither the mammalian or C. elegans 
sub-cellular location of the kynurenine enzymes are known. However, we are 
currently in the process of cloning the flu-1 and flu-2 genes. Once cloned, we hope to 
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tag them with a fluorescent marker and observe their sub-cellular distribution pattern 
which will begin to answer this question.  
 
5.3.3. The role of kynurenines in C. elegans 
 Our data identifies glycosylated anthranilic acids as the differentially 
expressed compounds responsible for death fluorescence. However despite their 
identification, the reasons underlying the presence of AA derivatives in gut granules 
and their large and rapid increase at death are unknown. There are several possibilities 
to explore.  
Firstly, it is possible that AA derivatives may have a protective function. 
There is evidence that the kynurenine pathway is involved in immunity, as described 
above. AA can inhibit growth of bacterial pathogens, e.g. Legionella pneumophila 
(Sasaki et al., 2012), and 3-hydroxyanthranilic acid can induce cell death in 
lymphocytes (Piscianz et al., 2011) and neurons (Smith et al., 2009). Thus perhaps gut 
granules act as a store of anti-bacterial agents in the event of pathogen attack. This 
may also explain why the gut granules are unique to the intestine, the site most likely 
to experience pathogenic invasion in C. elegans (Hodgkin and Partridge, 2008).  
Alternatively, the kynurenines may contribute to organismal death in some 
fashion. angl#1 and angl#2 have not previously been biologically identified, but AA 
in its non glycosolated form has been shown to have, like other kynurenines, a role in 
disease. It was found that a greatly increased AA to 3-HA ratio in patients suffering 
from stroke, Huntington’s, chronic brain injury and depression, amongst other 
diseases (Darlington et al., 2010). Especially interesting from our point of view is the 
discovery that stroke patients who eventually died of their neuronal injuries had 
significantly lower levels of 3-HA to AA than those who survived, and there was a 
significant negative correlation between the size of their infarct and the levels of 3-
HA (Darlington et al., 2007).Thus, at least in stroke victims, there appears to be an 
increase in AA generation at death, as seen in C. elegans. The authors hypothesized 
that increased production of AA may be acting to protect already damaged tissues 
from the production of the cytotoxic QA, a 3-HA metabolite (Darlington et al., 2010). 
However, they do not comment on the fact that AA can be metabolized into 3-HA and 
subsequently into QA, which would not be predicted to be protective.  
Given that we have shown organismal death in C. elegans is dependent on 
necrosis and spreads in an excitotoxic-like manner, it is intriguing to note that 
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kynurenines have also been shown to be heavily involved in excitotoxic neuronal 
death. It may be possible that somehow AA derivatives are involved in stimulating 
necrotic cell death, perhaps through conversion to QA and subsequent over-
stimulation of endogenous NMDA receptors in the C. elegans CNS (Brockie and 
Maricq, 2003). Thus it could be that necrosis triggers hyper-activation of the 
kynurenine pathway which eventually contributes to organismal death in some 
manner. Moreover, we have shown that as with Drosophilia, inhibition of TDO 
expression by RNAi extends lifespan (Oxenkrug, 2010; Oxenkrug et al., 2011). We 
have also shown that kynurenine pathway manipulation confers resistance to thermal 
and osmotic stressors. TDO RNAi has been shown to reduce the toxicity of α-
synuclein formation in a C. elegans Parkinson’s disease model (van Ham et al., 2008). 
Clearly the kynurenine pathway does play a biological role in C. elegans other than 
simple NAD generation and its manipulation does appear to act in a protective 
manner. Thus the kynurenine pathway may contribute to C. elegans organismal death, 
although the mechanisms remain unclear.  
  
5.3.4. The biological function of gut granules  
Despite the biochemical identification of the blue fluorescence contained 
within C. elegans gut granules, the nature of these lysosome related organelles 
remains unknown. One possibility, touched on above is that gut granules could act as 
a store of angl#1 and angl#2. The glycosylation of anthranillic acid may promote its 
accumulation in gut granules. For example, in Arabidopsis, glycosylation by UDP-
glucosyltransferases promotes AA accumulation due to increased compound stability 
(Quiel and Bender, 2003).  
Another possibility is that gut granules could protect against UV damage. 
Being pigmented lysosome-related organelles, gut granules resemble mammalian 
melanosomes, which confer UV resistance (Raposo and Marks, 2007). However, 
some preliminary trials performed by Abraham Mandel showed that, against 
expectations, glo-1 animals showed the highest survival rates when exposed to UV 
radiation (data not shown). Consequently it seems unlikely that gut granules have 
evolved to confer UV protection.  
glo-1 mutants appear to develop and age normally, implying that gut granules 
are not necessary for survival (Hermann et al., 2005). However, preliminary work 
done by Michele Riesen, a postdoctoral researcher in the Gems lab, suggests that glo-
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1 RNAi abrogates the increased longevity of daf-2 mutants. Taken together these data 
could imply that Glo-1 may play an important role in regulating stress resistance, and 
consequently suggest a functional role for gut granules.    
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6. CONCLUSIONS 
 
 The initial aim of this project was to verify a biomarker of ageing; instead we 
discovered a biomarker of death. Consequently, to C. elegans’ multiple advantages as 
a model organism, we can add another useful trait.  Using death fluorescence (DF) as 
a biomarker, we have already discovered that organismal death in C. elegans involves 
a cascade of systemic necrosis. DF is already being investigated as a potential means 
of automating lifespan trials. Continued characterization of  C. elegans DF could 
provide insights into this new biology of death.  
 In our discovery of DF, we have removed a key piece of evidence for the 
oxidative damage theory in C. elegans ageing: the age accumulation of the molecular 
damage product lipofuscin. Whether C. elegans possess lipofuscin remains an open 
question.  
 Our results demonstrate that blue fluorescence is not lipofuscin but rather 
anthranlic acid glucosyl esters. They also reveal the issue of the use of fluorescence as 
a biomarker of ageing to be a complex one. In worms observed in situ in culture, blue 
fluorescence does not increase with age but with death. However, for unknown 
reasons, when mounted on microscope slides worms do show an age increase in blue 
fluorescence, perhaps due an age-related increase in frailty. By contrast, red 
fluorescence showed a non-condition dependent age increase and so could be a useful 
biomarker of ageing in C. elegans, assuming its death-dependent increase is 
accounted for.  
  The mechanisms which underpin the systemic necrotic cascade are 
homologous to calcium-dependent necrotic propagation in mammals during 
excitotoxic neurodegeneration. Consequently, the study of organismal death in C. 
elegans may prove to be a useful model for studying mammalian neurodegeneration.  
The kynurenine pathway has been implicated in excitotoxic mammalian 
neuronal death; our findings suggest it also has a role in C. elegans organismal death. 
Is the burst of AA derivatives or other kynurenine metabolites peculiar to C. elegans 
and other soil dwelling nematodes? Increases in blue fluorescence associated with 
death have been reported, e.g. in budding yeast (Liang 2007) and porcine hepatocytes 
(Anderson 2004). Anecdotal data suggest that some kind of fluorescence arises from 
the necrotic interior of human cancers  (personal communication, Ralph DaCosta, 
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University of Toronto). Further investigation may reveal conserved mechanisms 
which link the kynurenine pathway to necrotic death. 
To the best of our knowledge, this is the first account of the mechanisms of 
organismal death in C. elegans. As ageing once was, the process of death is 
considered to be a catastrophic processes of a sort that is not amenable to scientific 
analysis. However, as discussed in Chapter 4, there is no reason why this necrotic 
cascade of death itself cannot be viewed through the prism of evolution as the result 
of a quasi-programme or antagonistic pleiotropy. Death, as all other biological 
processes, can and should be studied.  
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Appendix 1: C. elegans intestinal fluorescence has been used a biomarker of 
ageing in many different research papers. C. elegans autofluorescence has also 
been equated with lipofuscin in some cases. Many papers have used this as a way of 
distinguishing between progeria and life-shortening genetic or environmental 
interventions.  
Paper reference Example of usage 
Apfeld et al., 
2004 
While preliminary evidence suggests that aak-1 does not appear 
to be required for the control of lifespan (data not shown), aak-
2(ok524) mutants have a 12% shorter lifespan than wild-type 
animals. Moreover, a lipofuscin-like fluorescent pigment that 
accumulates in an age-dependent manner in the intestine 
accumulates at a faster rate in aak-2 mutants than in wild-type 
animals. 
 
Baeriswyl et al., 
2009 
As age-dependent accumulation of autofluorescent compounds is 
a universal biomarker of aging, we also measured this in C. 
elegans fed different bacterial strains. … . The autofluorescence 
was 17% stronger in nematodes fed on IAI1 than on OP50 
(N = 40 and N = 41, respectively, Mann–Whitney U test: 
P < 0.05). Therefore, faster accumulation of the autofluorescence 
in nematodes exposed to bacteria causing higher mortality may 
result from self-injury inflicted by the innate immune response.  
 
Boehm and 
Slack, 2005 
To determine whether the short life span of lin-4(lf) mutants is 
due to accelerated aging or to an unrelated, pleiotropic cause, we 
monitored the accumulation of intestinal autofluorescence in adult 
animals. Intestinal autofluorescence, which is caused by 
lysosomal deposits of lipofuscin, accumulates over time in the 
aging animal and is an established marker for aging. In agreement 
with its short life span, the lin-4(lf) mutant accumulated intestinal 
autofluorescence more rapidly than the wild type. 
 
Chavez et al., 
2007 
The presence of the NADPH oxidase inhibitor DPI in the plates 
significantly reduces lipofuscin accumulation in wild-type 
worms. 
 
Clokey and 
Jacobson, 1986 
The nematode Caenorhabditis elegans contains autofluorescent 
lipofuscin granules, located exclusively in the 32-34 intestinal 
cells. 
 
Fisher and 
Lithgow, 2006 
Accumulation of autofluorescent material in the gut of the worm 
has been associated with aging, and mutations that alter 
organismal aging have been shown to speed or slow the rate of 
development of autofluorescence consistent with the effects on 
lifespan. We find that in comparison to N2 and daf-12(rh273), the 
shorter-lived daf-12(rh61rh411) accumulates autofluorescent 
material earlier in adulthood. 
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Fujii et al., 2009 Caenorhabditis elegans shows increasing fluorescence signals in 
intestinal cells with advancing age. These fluorescent materials 
contain lipofuscin consisting of oxidized and cross-linked 
macromolecules such as lipids and. In the oxygen-sensitive 
mutant mev-1, the fluorescent materials accumulate at a greater 
rate than in N2, and the accumulation rate depends on the 
concentration of oxygen. We then examined the fluorescence 
signals in N2 and oxy-4 at day 10 with fluorescence microscopy, 
and found that a significant portion of oxy-4 worms (ca. 30%–
50%) showed increased fluorescence signals, compared with N2 
worms. 
 
Gardner et al., 
2004 
Most significantly, S. ratti exhibits an acceleration in age-specific 
mortality rate, one which is more rapid than that seen in C. 
elegans. Several characteristics of organismal aging previously 
documented in C. elegans also occur in S. ratti, but at a faster 
rate. For example, with increasing age, levels of autofluorescence 
(lipofuscin) increase. 
 
Garigan et al., 
2002 
Several short-lived mutants that accumulate lipofuscin granules 
more rapidly than normal have been postulated to age rapidly, on 
the basis of this one age-related phenotype. 
 
Gerstbrein et al., 
2005 
That age pigments might reflect physiological aging state has 
been suggested based on other work that correlated metabolic rate 
with lipofuscin levels (Sohal, 1981; Sohal & Brunk, 1989). Our 
observations sug- gest that screening for genetic or 
pharmacological interventions that block or delay age pigment 
accumulation might identify genetic manipulations that extend 
middle age healthspan, a goal of considerable importance. 
Evaluating healthspan by age pigment scores is far more rapid 
than other indicators that have been carefully quantitated, such as 
locomotory or cellular decline. 
 
Gill, 2006 The accumulation of fluorescent pigment is also associated with 
increased age in C. elegans and correlates with lifespan in a 
variety of mutants. This raises the possibility that automated 
fluorescence detection could be used to screen for compounds 
that delay the age-related rise in auto-fluorescence signal.  
 
Hartman and 
Ishii, 2007 
To distinguish between these, we measured three biomarkers 
(body movement, pharyngeal pumping and intestinal lipofusin 
autofluorescence) that others have shown to correlate strongly 
with normal aging in both wild-type and long-lived mutants of C. 
elegans. Cessation of fast body movement, decreases in 
pharyngeal pumping and increases in lipofusin autofluorescence 
all occurred precociously in the “dosage compensation” Dpy's 
relatively to the “non-dosage compensation” Dpy's, consistent 
with the suggestion that the former age through normal 
mechanisms, albeit at accelerated rates. 
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Hosokawa et al., 
1994 
Fluorescent material accumulated in both wild type and mev-1 
animals with increasing age. The mev-I mutant accumulated 
more fluorescent ma- terial at a greater rate than dose wild type. 
Furthermore, the accumulation rates depended on concentration 
of oxygen. Since this phenotype has been widely used as an aging 
marker, these results validate mev-l's use as a model to study 
aging. 
 
Ishii et al., 1998 Strains bearing this mutation accumulate markers of ageing (such 
as fluorescent materials and protein carbonyls) faster than the 
wild type. 
 
Ishii et al., 2006 Fluorescent materials (lipofuscin) and protein carbonyl 
derivatives are formed in vivo as a result of metal-catalyzed 
oxidation and accumulate during aging in disparate model. The 
presence of fluorescent materials and protein carbonyl 
modifications can be a specific indicator of oxidized lipid and 
protein. The mev-1 mutants accumulated fluorescent materials 
and protein-carbonyl derivatives at significantly higher rates than 
did their wild-type cohorts. Thus, the aging process in mev-1 
animals approximates that of wild type except for its precocious 
nature.  
 
Jain et al., 2009 Worms also produce lipofuscin, a marker of oxidative stress, in 
intestinal cells as they age, and lipofuscin is produced earlier in 
development when young worms are infected with a pathogen 
that elicits ROS production.  
 
Joeng et al., 2004 Lipofuscin accumulation, a typical aging marker, began 2−3 d 
later in F25−2 worms than in N2 controls, indicating that 
telomere length has an effect not only on the mean lifespan but 
also on the rate of aging.  
 
Kampkotter et al., 
2007a 
Lipofuscin is generated by oxidative degeneration and autophagy 
of cellular components and its accumulation only in the intestinal 
cells of the worm correlates with the life span making it an 
established marker for ageing in C. elegans. The treatment of 
wild type worms with kaempferol resulted in a significant 
reduction of lipofuscin autofluorescence of 25% whereas after the 
fisetin treatment a non-significant decrease (12%) was measured 
The effect of kaempferol and fisetin on lipofuscin accumulation. 
 
Kampkotter et al., 
2007b 
The higher antioxidative activity of quercetin may explain the 
protection against lethal thermal stress and the reduction in 
accumulation of the ageing marker lipofuscin exerted by 
quercetin but not by rutin. 
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Kim et al., 2008 Lipofuscin accumulation in the nematode intestine. Shown are 
Nomarski images (A–C) and intestinal autofluorescence from 
lipofuscin (a–c) of age-synchronized N2 animals of Day 10: (A 
and a) Control; (B and b) 0.5 mM nano-Pt; (C and c) 0.5 mM 
EUK-8. 
 
Kimura et al., 
2007 
Therefore, the reduced motility and life span found in hsp-
6(RNAi) in the present study were thought to be premature aging 
or progeria-like phenotypes. To examine this hypothesis, we 
assayed autofluorescence in hsp-6(RNAi) because lipofuscin-like 
fluorescent pigment is reported to accumulate with age and can 
be used as a general marker for aging in C. elegans … The level 
of autofluorescence gradually increased in both mock- and RNAi-
treated worms (D2 and D4) during aging, but the level of 
autofluorescence remained significantly higher in RNAi-treated 
worms up to 4th day of the RNAi treatment (D4, about 18%). 
This is consistent with progeria-like phenotypes in adult hsp-
6(RNAi) similar to those found in daf-16 and mev-1 mutants. 
 
Lee et al., 2004 To determine whether the reduced life span of wrn-1(RNAi) 
worms was due to progeria or to sickness, symptoms of normal 
aging, such as lipofuscin accumulation and tissue deterioration in 
the head. 
 
Masse et al., 
2008 
 We next tested whether the previously isolated smg-1(r861) null 
allele also shows a lifespan phenotype. The average lifespan of 
smg-1(r861) mutant animals was not increased compared to wild-
type animals (data not shown). Nonetheless, despite the fact that 
these mutants did not live longer than wild-type, we observed a 
delayed accumulation of the aging marker lipofuscin during the 
first week of life of smg-1(r861) mutants, as observed in smg-1 
RNAi treated animals. 
 
Mehta et al., 
2009 
Consistent with the observed longevity effects, the accumulation 
of autofluorescent age pigments, which has been proposed as a 
biomarker of aging and health span in C. elegans, was reduced in 
vhl-1(ok161) animals. This reduction was also fully suppressed 
by deletion of hif-1. 
 
Minniti et al., 
2009 
We found that msra-1 mutants also show increased accumulation 
of lipofuscin autofluorescence in the intestine compared to the 
WT (Supporting Data S1). Premature lipofuscin accumulation is 
indicative of tissue aging. 
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Neumann-
Haefelin et al., 
2008 
To further support the hypothesis that the short life span of shc-
1(ok198) mutants is due to accelerated aging rather than due to a 
more general pathology, we monitored the accumulation of 
intestinal autofluorescence in adult animals. Intestinal 
autofluorescence, which is caused by lysosomal deposits of 
lipofuscin, accumulates over time in the aging animal and is an 
established marker for aging. Consistently with its short life span, 
the shc-1 mutant accumulated intestinal autofluorescence more 
rapidly than the wild type. 
 
Ookuma et al., 
2003 
Thus, we observed the accumulation of lipofuscin-like intestinal 
fluorescence, which is one of the major markers of ageing in C. 
elegans. At 5 days after L4, no autofluorescence was observed in 
daf-2(e1370) or daf-2; scl-1(RNAi), and only a slight 
fluorescence could be observed in N2. At 10 days after L4, 
marked accumulation of intestinal fluorescence was observed 
both in daf-2; scl-1(RNAi) and N2, but not in daf-2(e1370). 
Additionally, in 12-day-old daf-2; scl-1(RNAi), N2-like tissue 
deterioration occurred in the intestine. These data indicate that 
daf-2; scl-1(RNAi) animals age faster than daf-2 animals.  
 
Pluskota et al., 
2010 
In order to validate the life span results formation of lipofuscin 
was analysed in untreated WT worms and C. elegans fed on 
different NPs. Fluorescence quantification revealed that control 
worms accumulated nearly identical amounts of lipofuscin over 
time compared with C. elegans which were fed on PS-NPs (YO, 
carboxy) or plain silica-NPs. These results confirm the life span 
assays suggesting that nematodes fed with NPs that differ in 
composition, labelling and functional groups on the particle 
surface, do not differ from untreated control worms with respect 
to age-related oxidative processes. 
 
Aubert et al., 
2005 
The accumulation of lipofuscin as a cause of cell death in ageing 
is receiving fresh attention. Its contribution to cell death in NCL, 
and the role of PPT-1 and saposins in this, could be readily 
addressed in an enhanced worm model of INCL. 
 
Samuelson et al., 
2007 
Aging C. elegans show intestinal autofluorescence partially as a 
result of lysosomal deposits of the pigment lipofuscin. Aging 
tissues accumulate this pigment in secondary lysosomes due to 
the oxidative degradation and autophagocytosis of cellular 
components…We tested whether gene inactivations that 
shortened life span also led to a pre- mature accumulation of age 
pigment. Out of 39 strictly daf-2 pathway-specific clones, 17 
gene inactivations caused strong or moderate acceleration in age 
pigment accumulation. 
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Shibamura et al., 
2009 
Nematodes were examined for lipofuscin, the so-called “age 
pigment” that accumulates with aging, at 5, 7, 10, and 15 days of 
age. In addition, 7-day-old worms were fed salmonella instead of 
OP50 for studies of the effects of chemicals on host defense. 
Liposome-mediated oral supplementation with antioxidants or the 
anticonvulsant trimethadione neither clearly altered the lipofuscin 
accumulation nor enhanced the host defense to salmonella. 
 
Taub et al., 1999 Another measure of ageing in C. elegans is the accumulation of 
fluorescent material. ctl-1 mutants contain much more fluorescent 
material at 15 days after hatching than do wild-type animals. 
These observations suggest that ctl-1 is an important determinant 
of normal ageing in C. elegans. 
 
Toth et al., 2008 An important question is whether short-lived mutant nematodes 
deficient in autophagy age more rapidly than normal animals or 
become simply sick and die earlier for reasons unrelated to aging. 
To address this issue, we assayed the levels of lipofuscin granules 
in adults at different ages. Lipofuscin is a pigment that 
accumulates progressively, in particular during the 
postreproductive period, in aging tissues as a result of the 
oxidative degradation of cellular components. We found that bec-
1, unc-51 and atg-18 mutants accumulated lipofuscin more 
rapidly during the course of life than wild-type animals. 
 
Uccelletti et al., 
2008 
In agreement with short life span, the apy-1(RNAi) animals 
accumulated intestinal autofluorescence more rapidly than the 
control worms. 
 
Vanfleteren and 
Braeckman, 1999 
Next, they enter the postreproductive phase of the life cycle, in 
which symptoms of senescence accumulate, including …and the 
accumulation of …. lipofuscin-like granules. 
 
Willett et al., 
2010 
Lipofuscin and other age-related compounds have been shown to 
accumulate with age in CE (58,59). Axenic Cohort A (adult) 
epifluorescence values (intensity per pixel per individual- 
pixels/nematode) ranged from 1,051 to 3,450 (with a mean of 
2,512) in 25 live CE and 912 to 2,116 (with a mean of 1,414) in 
22 live monoxenic adult CE Cohort A.  
 
Wilson et al., 
2006 
One marker for cellular damage during aging is the intracellular 
level of lipofuscin, autofluorescent material that accumulates in 
aging cells. Lipofuscin levels increase with aging in many 
organisms, including C. elegans. We examined lipofuscin levels 
in the intestines of control and BB-treated adult day 16 animals. 
Consistent with the expectation that BB polyphenols could slow 
aging, intestinal lipofuscin levels were reduced 20% in BB-
treated animals, compared with controls.  
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Yasuda et al., 
2006 
or example, both carbonylated protein and lipofusucin 
accumulate with advancing age, but there is little straightforward 
evidence to suggest that they strongly act to limit life span. 
However, accumulation is more rapid in short-lived mutants and 
slower in long-lived mutants, thus making these molecules 
excellent biomarkers of aging if nothing else. 
Zheng et al., 
2010 
…in C. elegans, lower levels of lipofuscin in age-matched worms 
correlated with greater motility, suggesting that lipofuscin 
accumulation reflects biological versus chronological age.  
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Appendix 2: NMR spectroscopic data for angl#1  
Position angl#1 
δ 13C 
[ppm] 
angl#1 
δ 1H 
[ppm] 
angl#21 
δ 1H 
[ppm] 
angl#1 1H-1H-
coupling  
constants [Hz] 
angl#1 HMBC 
correlations 
1 95.2 5.70 5.77 J1,2’’ = 7.8 C-2, C-3, C-4,  
C-5, C-1’-
COO 
2 73.8 3.50 3.67  C-1, C-3 
3 77.8 3.47 4.11  
(JH,P = 
8Hz) 
 C-2, C-4 
4 70.8 3.40 3.59  C-5 
5 78.5 3.44   C-1, C-4 
6a 62.1 3.86  J6a,6b = 12.1,  
J5,6a = 5.2 
C-4, C-5 
6b  3.70  J5,6b = 2.1 C-4, C-5 
1’-COO 167.8     
1′ 109.8     
2′ 153.1     
3′ 117.5 6.75  J3,4 = 8.5, J3,5 = 
1.1 
C-1’, C-5’,  
C-1’-COO 
4′ 135.5 7.26  J4,5 = 7.1, J4,6 = 
1.7 
C-2’, C-6’ 
5′ 116.1 6.57  J5,6 = 8.2  C-1’, C-3’ 
6′ 132.1 7.89   C-2’, C-4’,  
C-1’-COO 
1Characteristic 1H NMR signals of angl#2.  
1H (600 MHz), 13C (151 MHz), and HMBC NMR spectroscopic data for angl #1 in 
methanol-d4. Chemical shifts were referenced to (CD2HOD) = 3.31 ppm and 
(CD2HOD) = 49.05 ppm.  
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Appendix 3: Spectroscopic data for iglu #1 
Position iglu#1 
δ 13C 
[ppm] 
iglu#1 
δ 1H 
[ppm] 
iglu#21 
δ 1H [ppm] 
iglu#1 1H-1H-
coupling  
constants [Hz] 
iglu#1 HMBC 
correlations 
1 86.5 5.46 5.55 J1,2 = 9.0 C-2, C-3, C-5,  
C-2’, C-7a’ 
2 73.4 3.94 4.12 J2,3 = 9.0, C-1, C-3 
3 78.9 3.60 4.24 
(JH,P = 
8Hz) 
J3,4 = 9.0 C-2, C-4 
4 71.2 3.50 3.68 J4,5 = 9.0 C-3, C-5, C-6 
5 80.4 3.58  J5,6a = 5.8 C-1, C-3, C-6 
6a 62.5 3.70  J6a,6b = 12.1 C-4, C-5 
6b  3.88  J5,6b = 2.2 C-4, C-5 
2′ 126.2 7.40  J2’,3’ = 3.3 C-1 (weak), C-
3', C-3a’, C-7’ 
(weak), C-7a’  
3′ 103.2 6.49   C-2’, C-3a’, 
C-4’ (weak),  
C-7a’ (weak) 
3a′ 130.3     
4′ 121.3 7.52  J4’,5’ = 8.0,  C-3’, C-6’, C-
7a’ 
5′ 120.7 7.05  J5’,6’ = 7.4, J3,5 = 
1.1, 
C-3a’, C-7’ 
6′ 122.4 7.15  J6’,7’ = 8.0, J4’,6’ = 
1.0 
C-4’, C-7a’ 
7′ 111.2 7.54   C-3a’, C-5’ 
7a′ 137.8     
1Characteristic 1H NMR signals of iglu#2. 1H (600 MHz), 13C (151 MHz), and 
HMBC NMR spectroscopic data for iglu #1 in methanol-d4. Chemical shifts were 
referenced to (CD2HOD) = 3.31 ppm and (CD2HOD) = 49.05 ppm. 
	   139 
Appendix 4: High-resolution MS data angl#1, angl#2, iglu#1, and iglu#2  
Compound Ion Ion formula Calculated m/z 
Observed 
m/z 
angl#1 [M-H]- C13H16NO7- 298.0932 298.0910 
angl#2 [M-H]- C13H17NO10P- 378.0596 378.0600 
iglu#1 [M-H]- C14H16NO5- 278.1034 278.1071 
iglu#2 [M-H]- C14H17NO8P- 358.0697 358.0701 
High-resolution MS data for previously unreported C. elegans metabolites angl#1, 
angl#2, iglu#1, and iglu#2, acquired using negative-ion electrospray ionization (ESI-).  
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